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ABSTRACT
This thesis presents the results of studies aimed at the development of general
strategies for the synthesis of azasugars, which act as glycosidase inhibitors. In the
first Chapter a review is made of the role of carbohydrates and glycosidases in
biological systems. The strategies developed for the synthesis of azasugars are
discussed, as well as the aims of this project and the literature relevant to the
synthetic aspects of this project.

The successful synthesis of y-amino-a.p-unsaturated ketones from allylic
sulfoximines utilising a palladium(O) catalysed rearrangement is presented in
Chapter 2. The regioselectivities and diastereoselectivities of these transformations
are also discussed.

In Chapter 3, the palladium(O) catalysed amination of allylic sulfoximines utilising
external nucleophiles is described. The regioselectivities of these reactions with
various allylic sulfoximines is reported, as are the results of competition reactions
between the external nucleophile and the sulfinamide anion. The results of attempts to
induce asymmetry into the reaction via the use of enantiomerically pure sulfoximines,
chiral ligands and chiral external nucleophiles are also discussed.

The attempted synthesis of azasugars from allylic sulfoximines is presented in Chapter
4. Results from investigations into the use of both the intramolecular rearrangement
examined in Chapter 2 and the allylic amination reaction described in Chapter 3
towards the synthesis of azasugars are detailed.

In Chapter 5, the attempted synthesis of azasugars from a carbohydrate source is
reported. The key steps in the synthetic path are elongation via Grignard addition,
palladium(O) catalysed allylic amination, oxidation of a double bond and cyclisation.

A brief s u m m a r y of the work carried out in this thesis is provided in Chapter 6, as
well as current and future work in this area.
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The following abbreviations have been used throughout this thesis.
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specific rotation
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acetyl
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acetic acid

AD

asymmetric dihydroxylation

Ar
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asparagine

aq

aqueous

Boc
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benzyl

br
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butyl
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carbonyl group
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DMAP

4-dimethylaminopyridine

DMDP

2ft,5ft-dihydroxymethyl-3ft,4R-dihydroxypyrrolidine

DME
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enantiomeric excess
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(molar) equivalents

ES

electrospray

Et

ethyl

ether

diethyl ether

EtOH

ethanol

FDA

Food and Drug Administration (US)

g

grams

Gal

galactose

Glc

glucose

GlcCer

glucosylceramide

GlcNAc

/V-acetylglucosamine

HIV

H u m a n Immunodefiency Virus

HMPA

hexamethylphosphoramide

HPLC

high performance liquid chromatography

hr

hours

HRMS

high resolution mass spectroscopy

Hz

Hertz

/

ISO

/'- P r

iso- propyH

J

coupling constant

LDA

lithium di-/so-propylamide

Ln

unspecified number of ligands

m

multiplet

M
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M

molecular ion

Man

mannose

m-CPBA

mefa-chloroperoxybenzoic acid

Me

methyl

MeOH

methanol

MHz

megahertz

min

minutes

mL

millilitre

mmol

millimole

mol

mole

Ms

methanesulfonyl

MS

mass spectrometry

MSH

O-mesitylsulfonylhydroxylamine

m/z

mass to charge ratio

NB-DGJ

/V-butyl-1-deoxygalactononojirimycin

NB-DNJ

/V-butyl-1-deoxynojirimycin

n

neo

NeuAc

sialic acid

NMO

A/-methylmorpholine-A/-oxide

NMR

nuclear magnetic resonance spectroscop

nOe

nuclear Overhauser effect

nOESY

nuclear overhauser effect spectroscpy

Nuc

nucleophile

0/N

overnight*

Pent

pentyl

Ph

phenyl

PHAL

phthalazine

ppm

parts per million

p-Tol

para-toluene

q

quartet

R

unspecified substituent

Rf

retention factor

RT

room temperature

s

singlet

Ser

serine

t

triplet

t

temperature

t

tertiary

TBDMS

ferf/'a/y-butyldimethylsilyl

f-Bu

tertiary- butyl

Tf

trifluoromethanesulfonyl

THF

tetrahydrofuran

Thr

threonine

TLC

thin layer chromatography

TMS

trimethysilyl

tosyl

para-toluenesulfonyl

Ts

para-toluenesulfonyl
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INTRODUCTION
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1.1 Glycobiology

Glycobiology is the study of carbohydrates and their role in biological events. For
years carbohydrates were not as well studied as proteins and D N A for two main
reasons. Firstly, many researchers did not believe that carbohydrates had a significant
role aside from providing structural support and energy storage, for example,
cellulose and starch, respectively. Secondly, the small amounts of carbohydrates
present in m a n y cases were too minute and too complex to be studied with the
technology available at the time. Changes in attitudes and technology have led to the
12 3
field of glycobiology rapidly expanding. ' '

1.2 Carbohydrates

Carbohydrates differ from other biopolymers such as proteins and DNA in their
potential for variation. Carbohydrate chains can be branched, can link at several
different points with other sugars, can exist as both a and p anomers, and can undergo
4
modifications such as sulfation, phosphorylation, acetylation and lactonisation. This
means an extraordinary number of isomers can be formed from a short oligosaccharide
chain. T w o identical amino acids or nucleotides can only produce one dipeptide or
dinucleotide. Whereas two identical pyranose monosaccharides can give 11 different
5
disaccharides, considering only those without any modifications.
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Carbohydrates have been found to be implicated in both normal and abnormal cell

behaviour. The fundamental cellular -processes of recognition, adhesion, growth, an

regulation are dependent upon sugars, although as yet no single general function has
been ascribed.

1.3 Glycoconjugates

Glycoconjugates are proteins and lipids with a carbohydrate chain attached. These
glycoproteins and glycolipids are common components of cell membranes, cell walls,
and organelle membranes. The exposed carbohydrate chains act as receptors for
proteins, enzymes, and other cells, as well as bacteria and viruses. ' Even
mammalian egg-sperm recognition is believed to be mediated by recognition of a
7 8
glycoprotein. '

Figure 1.1: Cell Interactions Mediated by

Carbohydrates
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Most glycoconjugates have a limited lifespan before being degraded in order to provide
the raw materials for the biosynthesis of other glycoconjugates. In this manner cells
are able to regulate the amount and types of glycoconjugates present.

1.3.1 Glycoprotein Biosynthesis

There are two main classes of glycoprotein: /V-linked and O-linked. The /V-linked
glycoproteins are the more common of the two. As shown in Scheme 1.1, the

carbohydrate chain is attached to the nitrogen of the asparagine residue in the sequen
Asn-X-Ser/Thr. The initial oligosaccharide chain (GIC3MangGIcNAc2) is assembled on

a phospholipid carrier called dolichol. The oligosaccharide is then transferred en blo
to the growing polypeptide chain. Trimming enzymes (see Section 1.5) remove the
outer three glucoses, followed by the removal of four of the mannoses by the
corresponding enzymes to give a common core of sugars called the trimannosyl core.
After trimming, mannose and other sugars such as A/-acetyl-glucosamine, galactose,
g

sialic acid, and fucose m a y be added by the appropriate enzymes.

The reason why the cell builds the oligosaccharide structure, then deconstructs it, on
to reconstruct it once again is unknown. Possibly it acts as a marker for the cell's
machinery to keep track of the maturation status of the newly formed protein.
Another suggestion is that the process allows an oligosaccharide chain to be attached
widely differing proteins without having to code the information into the DNA segment
for each protein.
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S c h e m e 1.1: Biosynthesis of N-linked

Glycoproteins
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There are three main classifications within the /V-linked glycoproteins: high mannose,
complex, and hybrid. High mannose-types, as could be expected from their name,
contain only oc-mannosyl residues attached to the core. Complex types contain no
mannose apart from the core, but have branches consisting of GlcNAc, Gal, and NeuAc
(sialic acid). They can also have a fucose and a GlcNAc branching off the trimannosyl
9
core. Hybrids have characteristics of both high mannose and complex type glycans.

Man

Man

Man

NeuNAc

NeuNAc

Man

Man

Man

Gal

Gal

Mari

Man \

Man

Mart

Man

Man

NeuNAc

Gal

GlcNAc
GlcNAc
^GlcNAc
^Man^
^Marf
Man
GlcNAc

GlcNAc

GlcNAc

GlcNAc

GlcNAc-

Fuc

Asn-X-Ser(Thr)

Asn-X-Ser(Thr)

(a)

(b)

Figure 1.2: Types of /V-linked

Glycoproteins: (a) High

M a n n o s e , (b)

Complex

O-Linked glycoproteins are linked via serine, threonine, or hydroxy-lysine. They do
not share a common core structure in contrast to the /V-linked glycoproteins. The
sugars are added sequentially to the parent protein.

The attachment of oligosaccharides to nascent polypeptide chains makes intermediates

in

the folding process more soluble. They can also act as recognition markers for
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molecular chaperones that participate in the folding process, so that the newly
synthesised protein reaches its proper functional form.

The carbohydrate portion of glycoproteins also confer conformational stability,
quaternary structure, resistance against proteolytic degradation, charge, and water
2
binding capacity.

1.3.2 Glycolipid Biosynthesis

There are many types of glycolipids, which are defined by the type of lipid. The
glycolipids are synthesised by sequential addition of carbohydrates to the parent lipid.
An example of glycolipid biosynthesis is given below in the synthesis of gangliosides
12
found in the cells of the nervous system.
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NH2

HOL

^ \

NH2

+CH 3 (CH 2 )i 4 COSCoA
'COOH

L-serine Palmitoyl-CoA
several
steps

O
HJsr^(CH 2 )i6CH 3
(CH2)i2CH3

.OH
HN

X

^(CH 2 )CH 3

(CH2)i2CH3

Glucosylceramide (GlcCer)
addition of
sugars
Glysphingolipids including
gangliosides
Scheme 1.4: Biosynthesis of Gangliosides

1.4 Roles of Sugars and Glycoconjugates

It is difficult to fully encompass the wide range of biological roles in which
carbohydrates and glycoconjugates have been implicated. Currently most of the

knowledge about the roles of carbohydrates in biological events is empirical. T

at present no set of rules that carbohydrates seem to follow. A carbohydrate th
performs one function on a certain protein may perform a completely different
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function on another. The following sections serve merely to highlight the wide and
diverse roles of carbohydrates in biological events.

1.4.1 Blood Group Antigens

Among the first oligosaccharides whose importance was recogiriised was the blood
group antigens. Immunochemical experiments to investigate the antigens recognised by
serum antibodies began in the 1940s and began to yield results in the 1960s. These
antigens were eventually shown to be glycoconjugates. Many tumour associated
13 14
antigens are chemically modified forms of the blood group antigens. '

1.4.2 Cell Recognition, Adhesion, and Regulation

The cell recognition process is the initial step in virtually all biological events. '
The Sections 1.4.3, 1.4.4, 1.4.5 all contain examples where the" recognition
process is mediated by carbohydrates.

Cell-cell and cell-matrix adhesions are essential for the structural organisation and
behaviour of cells in tissues. Many of the cell adhesion receptors are transmembrane
glycoproteins such as the integrins and proteoglycans. Defects in adhesion between
cells and their underlying basement membrane can lead to diseases such as muscular
u 18
dystrophy.
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The survival of many cell types require adhesion to extracellular matrix proteins. In
the absence of specific signals from these proteins the cells enter into a programmed
cell death pathway called apoptosis.

9

Many hormones are glycoproteins for which the attached carbohydrates are essential
for full expression of their regulatory activity. The initial binding to a cell surface
receptor stimulates a chain of events involving chemical messengers along a specific
20
response pathway to generate the hormonal action.

Cell surface glycoproteins have been shown to modulate the activity of growth factors.
Many growth factors need to exist as oligomers before they can interact with their
specific signaling receptors. Formation of a complex with low binding affinity glyco21
proteins allows the oligomerisation of the growth factors to proceed.

1.4.3 Immune System

Recognition of a carbohydrate antigen on a foreign body can elicit an immune system
response. A glycolipid in the outer membrane of the bacterial cell wall of the pathogen
Salmonella contains a tetrasaccharide repeating unit that is recognised by the human
body's immune system as being non-self, and the immune system is then activated to
22
destroy the invader.
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Selectins are a class of lectins (carbohydrate binding proteins)

that reside on both

the endothelial cell surface and the leukocyte (white blood cell) surface. They media
the initial recognition in immunological important events such as leukocyte
recruitment to an injury site. The lectins bind to a tetrasaccharide named sialyl

Lewis (1) on the leukocytes. After this initial recognition the leukocytes are able t
24
pass through the endothelium to the site of injury or infection.

COH

OH /OH
OH

HO^OH

H0

/

Jl

OH

WZ0H
OH

W

Sialyl Lewis* (1)

W h e n too many leukocytes are recruited to the injury site, normal cells can be

damaged causing inflammation. Control of this process by inhibiting the adhesion step

has been considered as a new anti-inflammatory strategy. Sialyl Lewis in solution has
been shown to directly compete with sialyl Lewis on the surface of white blood cells

for binding to the selectins, and as such gives a useful lead as an anti-inflammatory
25,26
drug.

The two trisaccharide structures below (2) and (3) have been shown to play a
fundamental role in the rejection of organs in xenotransplantation from pigs to man.
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Both trisaccharides are on the endothelial cells of the graft and act as antigens for
27

xeno-reactive antibodies.

OH/OH

OH
R = Et or Bu or Ph
(2)
OH/OH

NHAc
(3)

1.4.4 Cancer

Transformation of a normal cell into a tumour cell is accompanied by changes in the
chemical composition, metabolism, and organ-isation of cell surface glycoconjugates.
28 29 30
Glycoconjugates in m a n y h u m a n cancers contain novel glycosylation patterns.
The accumulation of specific glycoconjugates within tumour cells opens up the
possibility of using the recognition of these unique features as a diagnostic tool for
early detection of cancer.

31
Metastasis is the process of the spreading of cancer throughout the body.

The

increase in activity of glycosyltranferases in some tumour cells and resultant novel

glycosylation patterns have been shown to be associated with the metastatic potential of

Chapter 1
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the cancer.

13

it is not certain at this time whether the increased activity of the

glycosyltransferases is a cause or effect of metastasis.

It has been shown that tumour cells may be recognised by endo-thelial cell surface
molecules that are normally involved in the adhesion of blood leukocytes (see Section
1.4.3). The tumour cells are able to utilise the same mechanisms as the leukocytes to
33
pass through the endothelium into the tissue where a n e w tumour can begin to grow.

1.4.5 Infections

The initial step of any infectious cycle is the recognition between the host cell and the
pathogen. Many of these recognition processes are mediated by carbohydrates whether
they are on the host cell or the pathogen.14'34,35 The envelope proteins of the HIV
virus are heavily glycosylated, and approximately half the apparent weight of many of
the glycoproteins are carbohydrate in nature. The HIV infectious cycle requires an
interaction between the viral glycoprotein gp120 and a specific receptor on the
surface of CD4 T-cells. '

Some viruses do not have the enzymes to produce /V-linked oligosaccharides, and thus
they rely upon the host cell's glycosylation machinery. Due to this, the characteristics
of the viral oligosaccharides are very similiar to that of the host and cannot be
recognised by the immune system as non-self. The oligosaccharide chains may further
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assist the virus to escape detection by masking the polypeptide chain which could be
p

recognised as non-self by the immune system.

1.5 Glycosidases

Glycosidases are enzymes that cleave carbohydrates. They are involved in several
important biological processes such as digestion of dietary carbohydrates, and the
biosynthesis (see Section 1.3.1) and catabolism of glycoconjugates.

Absence of glycosidases can lead to serious illness. In Tay-Sachs disease the enzyme |3
hexosaminidase A is deficient. This enzyme is involved in the degradation of several
glycosphingolipids. Its absence causes accumulation of the ganglioside GM2 in neuronal
cells, which then swell and eventually die. Sufferers have a life expectancy of 3-4
38
years.

1.5.1 Glycosidase Mechanism

There are two basic types of glycosidase, one where the anomeric configuration of the

sugar is retained, and the second where it is inverted. The retaining glycosidases work
via a double displacement mechanism involving an enzyme nucleophile as shown in the
39 40
diagram below. '
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Scheme 1.3: Mechanism of a Retaining Glycosidase
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Inverting glycosidases act via the single displacement by a nucleophilic water molecule
via a process that is enhanced by a general enzymatic base40

X

o-^o

5

HOH2C
HO
H
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B

0 0
H

HOH2C
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H

^O

& $

©

OH ^)

H^HO.
B

B
INVERSION

X

0 0

^O

HOH2C

©B^

H

S c h e m e 1.4: Mechanism of an Inverting Glycosidase

1.6 Glycosidase

Inhibitors

Glycosidase inhibitors have the potential to be investigative and therapeutic agents in
cancer, viral infection, genetic disorders, diabetes, and obesity. They work by
interfering with the biosynthesis and degradation of glycoconjugates. The effects of
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these changes can then be studied. They also serve to investigate the mechanism of

action, binding specificity, and the topography of the active site of the glycosidase

1.6.1 Types of Glycosidase Inhibitors

The most c o m m o n types of glycosidase inhibitors are carbohydrate analogues. The two

main categories of these carbohydrate analogues are where the ring oxygen is replaced
by another atom or where the anomeric hydroxyl group is replaced 41

,*OH
CH2OH

CH2OH
X
X
X
X

=
=
=
=

C, Carbasugars
N, Azasugars
S, Thiosugars
P, Phosphasugars

X = C, C-glycosides
X = N, Glycosylamines
X = S, Thioglycosides
X = P, P-glycoside

However most work in the literature, especially in recent years, has been directed
, 41,42,43
towards azasugars.

1.6.2

Azasugars

Azasugars are analogues of sugars in which nitrogen replaces the oxygen of the sugar
44
ring. There are several naturally occurring azasugars, including nojirimycin (4),
45 46
dihydroxymethyldihydroxypyrrolidine
castanospermine (7) 47

(DMDP)

(5),

swainsonine (6),

and
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OH
HO

HO,,, X.OH
HCT^ N"^CH2OH HOH2CxX'
H
nojirimycin (4)
HO OH

X

.OH

N CH2OH
H
D M D P (5)

•••OH

swainsonine (6)

castanospermine (7)

The biosynthesis of azasugars is not exactly clear. The most obvious biosynthetic route

occurs from natural sugars, which undergo oxidation and reductive amination, foll
by cyclization (Scheme 1.5).41 However, it has also been shown that swainsonine
48
(6) can be synthesised from pipecolic acid in fungi and plants (Scheme 1.6).

HO—

Glucose

HO v

"1ST ^CH 2 OH
H

mannonojirimycin
Scheme 1.5: Possible Biosynthetic Pathway of Azasugars
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H
r^COOH
Lysine

,NH
Pipecolic
acid
H

*°H

..i\OH-*-

„l\GB<-

(6)
S c h e m e 1.6: Postulated Biosynthesis of Swainsonine (6)

Azasugars are believed to be metabolically inert in mammalian tissue and generally
43
inhibit in a reversible and competitive manner.

They mimic the positive charge on

the sugar ring of the high energy glycosyl cation intermediate (see intermediate C in
Scheme 1.3) since the heterocyclic nitrogen is protonated at physiological pH.
Furthermore, the heterocyclic ring adopts a flattened half-chair conformation similar
49
to that of the glycosyl cation.

T h e furanose type azasugars tend to be more general in inhibiting different
glycosidases than the pyranose type. It is assumed that the envelope shape and positive
charge of protonated furanose azasugars resemble the flattened chair shape of the
intermediate glycosyl cation much better.

T h e reversible nature of the binding has already led to the use of suitably linked
azasugars as affinity chromatography ligands for the purification of glycosidases.
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Affinity chromatography is one of the best methods for the separation of enzymes. It
takes advantage of the biologically specific binding interactions that occur on protein
surfaces. Correct selection of the ligand makes it possible to separate different
enzymes that perform the same function e.g. glucosidase I can be separated from
50
glucosidase II using 1-deoxynojirimycin (8).

OH

'N
H

^CH2OH

deoxynojirimycin (8)

A more recent application has been the use of the A/-aryl azasugar (9) to generate

antibodies in vitro that are capable of cleaving glycosidic bonds. The rate of hydrolysi
of (10) by the generated antibodies is 10 faster than by acetic acid. These antibody
glycosidases could be used to chemically manipulate oligosaccharides when the natural
51
glycosidase either does not exist or cannot be isolated from natural sources.

(9)

(10)
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1.6.3 Biological Activity

Several azasugars have been shown to be effective agents against various diseases such
as diabetes, HIV infection, and cancer. The following sections are meant only to give an
overview of the medical research into the use of azasugars as theurapeutic agents, and
as such this section is by no means comprehensive or detailed. It only serves to
highlight the diverse nature of the roles in which carbohydrates are used in biological
processes. As more becomes known about the functions of carbohydrates it more than
likely that carbohydrate analogues will play a larger role in the field of therapeutic
and preventative medicine.

1.6.3.1 Diabetes

Diabetics absorb glucose much more slowly due to the lack of insulin. Type II noninsulin dependent diabetes mellitus is a disease that usually develops in adulthood and

is due to a relative insufficiency of insulin and impaired sensitivity to its actions. Th
subsequent slow absorption of glucose can be offset by slowing down the release of
glucose from sources such as starch and sucrose. This can be acheived by the inhibition
52
of intestinal glucosidases. Miglitol (11) is an intestinal cc-glucosidase inhibitor
that has been approved for market, under the name Glyset, by the FDA in the United
States.53 It has been developed by Bayer (BAY m1099) and is only for the treatment of
Type II non-insulin dependent diabetes.
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N^

'CH2OH

CH2CH2OH
miglitol (11)

Other intestinal cc-glucosidase inhibitors have been tested as possible anti-diabetic
therapies. The diglucose analogue (12) has also been shown to be a useful adjunctive
therapy for the treatment of diabetes mellitus, but thus far has not made it onto the
, * 54,55
market.

** ^IST ^ C H 2 O H
HOH2G

1.6.3.2

Viral

(12)

Infections

A range of sugar analogues have been screened for anti-HIV activity. ' ccGlucosidase inhibitors have been found to be most effective in inhibiting viral
infectivity. 6-O-Butanoyl-castanospermine (Bucast) (13) and /V-butyl-1 deoxynojirimycin (NB-DNJ) (14) were found to be good inhibitors of HIV replication
at concentrations well below cytotoxic levels. Both NB-DNJ and Bucast have undergone
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Phase I and II clinical trials. The use of a hydrophobic substituent, in this case a butyl
group, is most likely to help the drug to penetrate the cell wall before enzymatic
cleavage releases the active form of the drug. It is believed that the aberrant
glycosylation patterns induced by the drugs cause an alteration of local conformation
57
the glycoprotein gp120 which leaves it unable to interact with cells,

(see Section

1.4.5)

N

Bucoa

^CH2OH

Bu
Bucast (13)

NB-DNJ (14)

The secretion of Hepatitus B virus can be prevented by treating cells with the aglucosidase inhibitor NB-DNJ (14). It was found that if the Hepatitus B viral M
glycoprotein is improperly glycosylated then the viral DNA, accompanied by the
envelope and core proteins, accumulate within the lysosomal compartment of the

infected cell. This suggests that correct glycosylation is necessary for the processe
58 59
involved in the transport of the virus out of the cell.

1.6.3.3

Cancer

Several azasugars have shown anti-cancer potential. Swainsonine (4) has undergone
Phase I clinical trials and was shown to have minimal toxicity when administered
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intravenously to patients with advanced malignancies. It is believed that swainsonine
works by enhancing the sensitivity of tumour cells to natural killer cells. The natural
killer cells discriminate between targets on the basis of the carbohydrates present on
the cell surface. Those with high mannose oligosaccharide chains are much more likely
to be targeted. Swainsonine inhibits the removal of the mannose from the
oligosaccharide core thus leaving the cells with terminal mannose residues.

1.6.3.4 Gaucher's

Disease

Gaucher's disease is an autosomal recessive disorder characterised by the impaired
ability to degrade glucosyl ceramide (GlcCer) due to defects in the gene encoding the
enzyme needed. By partially inhibiting the biosynthesis of the glycolipid, the impaired
catabolism of GlcCer can be offset, thus balancing the levels of GlcCer. NButyldeoxygalactononojirimycin (NB-DGJ) (15) has been shown to inhibit GlcCer

biosynthesis by inhibition of the glucosyl-transferase specific to ceramide. It does this
without inhibiting the lysosomal p-glucocerebrosidase which degrades GlcCer in the
fi2
normal catabolic pathway.

NB-DGJ (15)
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Antifeedant

Properties •

Trace amounts of DMDP (5) have been shown to deter locusts from feeding on plants,
while castanospermine (7) has a similar effect on aphids. Natural biodegradable
pesticides like this, which do not kill the insects, but simply deter them from feeding
CO CA

would m a k e an ideal agent for crop protection. '

1.7 Synthesis of Azasugars

Due to the great potential of azasugars as therapeutics, there have have enumerable
strategies devised for their synthesis and have utilised a wide range of starting
materials. These include carbohydrates, chiral natural products, and other nonnatural starting materials.41 -65'66-67 it would be impossible to cover all the
synthetic methods that have appeared in the literature. Hence only a few
representative syntheses will be shown to highlight the work being carried out by
laboratories all over the world towards the synthesis of azasugars.

1.7.1 Synthesis using Carbohydrate Starting Materials

Due to the high number of stereocentres in many of the azasugars, numerous
researchers utilise naturally occurring sugars as their starting materials. The
advantages of using sugars is two-fold: firstly, many sugars are relatively inexpensive
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and are widely available, and secondly, the stereogenic centres already exist in the
correct form. Many other factors increase their attractiveness to chemists including
availability in both cyclic and acyclic forms, presence of functional groups, varying
_.1 fift fift RQ

chain lengths, and different oxidation and reduction states. ' ' '

A c o m m o n approach to azasugar synthesis is the conversion of a hydroxyl group of a
sugar derivative to an azide followed by a reductive cyclisation. In the example below
the azide (16) is reduced by tin(ll) chloride and the resultant amine reacts with the
carbonyl group to form the lactam (17).

OBn
HQ ^n

nw

\
/
SnCI2, MeOH

'>,. ^ ^ \ , ,Un
A

<Ac/y N

3

OBn
(16) 07)

In another example, the lactol below (18) undergoes Wittig elongation when treated
with the appropriate phosphorane. Diastereoselective conjugate addition of ammonia to
the double bond followed by cyclisation of the resultant amine with the mesylate gives
the protected azasugar (19).
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X
\

F
O^OH

1. Ph3P=CHCOO_t,A
. pyridine, CH2CI2

2 MsC|

MsO

COOEt

(18)
NH3, EtOH

MsO^
COOEt

/
H2N

\
COOEt

(1 9)

Reductive amination of dicarbonyl compounds (20) with a protected amine followed by
72
deprotection provides a very convenient and simple route to azasugars (21).

CH2OH
HQ

J3H

JDH

H2,Pd(OH)2-C

•H BnNH2,NaBH3CN

HO-

HQ

•OH

H-

= 0

OH

Bn

OH

OH

H

OH

CH20H
(21)

(20)

1.7.2

Synthesis

from

Non-Carbohydrate

Starting

Materials

Chemoenzymatic methods have been extensively utilised by W o n g to synthesise a broad
range of azasugars with excellent enantioselectivity. One of the many syntheses
published by W o n g is shown here. The condensation of the azido aldehyde (22) with
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dihydroxyacetonephosphate (23) is catalysed by the enzyme Fuc-1-P aldolase. The
phosphate group is then removed from the terminal hydroxyl by the enzyme acid
phosphatase. Reductive cyclisation then gives the final product (24) 73

O

N3
*CHO
(2 2)

+

H

1. Fuc-1-P aldolase
0PO3©

2. Acid phosphatase

(2 3)

HO
OH
* f H2, Pd-C

XX *

H3C^ "N
H

"|
'OH

N3

OH

OH

O

(2 4)

The protected cyclohexadiene derivative (25) can be dihydroxylated and then

converted into the azide (26) via a triflate. Ozonolysis of the double bond followe
74
reductive cyclisation gives the protected azasugar (27).
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1. O s 0 4
2. TBDMSCl/imidazole
—

.

Cl

•

3. Tf20, pyridine
4. NaN3

N3
OTBDMS

(2 5)

(2 6)

1.03
2. NaBH4

X
X,Xr

'//^ O T B D M S

O

H
(2 7)

OH

I

The methyl ester of L-serine (28) is firstly protected as an oxazoline. Reduction of

the ester followed by Wittig elongation provides the vinyl ozazoline (29) which can
then be dihydroxylated with OSO4. Hydrolysis of the oxazoline with aqueous acid and
then cyclisation gives the lactam (30), which can then be converted to the azasugar
7 5

(31).
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NH
COOMe

COOMe

Ph-?

CEt
HO

<X^ N

NH 2

Ph

(2 8)

1.NaBH4
2. Ph3P=CH2COOMe
COOMe

COOMe
Os0 4

HCI(aq)

HO
''•

HO

OH
/

PhCOO H2C*^ N^^O
H
(3 0)

JDH

B2He

HO^C^^N
H
(3 1)

1.8 A i m s of the Project

The proven potential of azasugars as pharmaceutical agents and as probes in the
investigation of the mechanisms of glycosidases make them an attractive target for
synthesis. The main challenge in the synthesis of carbohydrates and their analogues is

the high number of stereocentres. This can be overcome by either utilising the existing
stereocentres in natural sugars or employing highly enantioselective and
diastereoselective synthetic methods to procure the required stereochemistry.
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The aim of this thesis is the development of general strategies that are flexible enough
to be applicable to the synthesis of a wide range of azasugars and their analogues. Two
synthetic paths were devised: one using non-carbohydrate starting materials and the
other from a carbohydrate source.

1.9 Asymmetric Synthesis of Azasugars from Non-Carbohydrate Starting
Materials

The first proposed synthetic route is outlined in the retrosynthetic analysis below. The
key steps are: (a) the palladium(O) catalysed rearrangement of an allylic sulfoximine
to an allylic amine, (b) asymmetric dihydroxylation, and (c) deprotection and
reductive amination.

HO

OH

(<0

RiNH
v
>

s

R2^N^R3
H

R 2

OH

'TT
OH

0
(b)

\

V

Ph
R 1 N=S=0
^^

||
0

R^H

(a)
<

R2

f

•

^sr

2

fl

0

S c h e m e 1.7: Synthesis of Azasugars from Allylic Sulfoximines
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Allylic

Sulfoximines

T h e synthetic route proposed above begins with an allylic sulfoximine. Sulfoximines
7 fi 77 7 ft

are readily accessible and have a rich and diverse chemistry.

'

' " The

sulfonimidoyl group imparts both chirality and carbanion stabilising properties to the
molecule. Allylic sulfoximines can act both as nucleophiles in a basic medium and as
_79
electrophiles in the presence of a Lewis acid

1.9.1.1

Preparation

of Allylic

Sulfoximines

There have been several published syntheses for the assembly of allylic sulfoximines.
Harmata and Claisen reacted sulfimidoyl halogens (32) and (33) with metallated
8 0

allyl groups to provide allylic sulfoximines (34).

?

p-Toh- S — F +

jf^SLi

NPh
(3 2)

II >Tol
PhN
|\\G\3

O
p-Tor-S-CI + ^^/SnBu3

(3 4)

NPh
(3 3)

Reggelin and Weinberger synthesised cyclic sulfonimidates (36) from protected
amino acid derivatives such as O-trimethylsilylvalinol (35). Allyl magnesium

33
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bromide underwent addition to (36) to afford the /V-valinol allyl sulfoximines
(37).81

O
II
p-Tol^CI

P

EtNMe 2
+

p-Tol^

H2N

N

OTMS
1. f-BuOCI
2. KF, 18-crown-6
'3. separate diastereomers
O

OTMS
(3 5)
0

II

p-Tof'W
.a

+ p-Tol^NQ

(3 6)
,MgBr

MgBr
^

^

?
+

p-Tor i

O
II
v
p-Tol j

V^

\

OH

^

OH

(3 7)

Pyne and Boche iminated the known allyl phenyl sulfoxide (38) with Omesitylsulfonylhydroxylamine (MSH) to give the corresponding allyl phenyl
sulfoximine (39) 82
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?

MSH

(38)

(39)

Lithiated S-methyl sulfoximines (40) undergo 1,2-addition with aldehydes and
ketones to afford (3-hydroxy sulfoximines (41) which are then dehydrated to the allyl
8 3
sulfoximines (42).

Ph
i

0=S=NMe

O
II Ph'

*CHO

Ph-S—CH^eLi
NMe

Ph'

T

J

OH
4 1)

(4 0)

1.MsCI,Et3N
2. DBU
<

Ph
0= SI= N M e

Ph"
(4 2)

1.9.1.2 Reactions

of Allylic Sulfoximines

Lithiated allylic sulfoximines (43) can undergo Michael type conjugate additions with
high diastereoselectivities. The products (44) can be isolated via low temperature
protonation, however warming to room temperature sees the electrophilic nature of
the sulfoximine realised and it can act as a leaving group to provide highly
79
functionalised cyclopropanes (45).
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Ph
I
0=S=NTs
0+
©Li

Ph,

O
Ph

0©©Li

(4 3)
NH4CI(aq)

O

RT

-78°C

PhSNHTs

0
Ph
I
0=S=NTs

Ph

V
O
(4 5)

(4 4)

Allylic sulfoximines (46) have been shown by Gais et al. to undergo S N 2 and S N 2 ' like
displacement reactions with organocuprates selectively in the y-position in the
go

presence of boron trifluoride and lithium iodide to give terminal alkenes (47).

Ph
Q_S=NTs

^J

Ph

(46)

Bu

BuCu, Lil, BF 3

Ph'
(47)

Pyne and Boche reacted the protected allylic sulfoximine (48) with benzaldehyde to
give exclusively the oc-1,2 product (49) when the reaction was carried out in THF.
However the use of THF/HMPA gave both the cc-1,2 (49) and y-1,2 products (50) in
the ratio of 2.3:1.82
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Ph
t
I
0=S=NSiPh
2 Bu

Ph
I
f
0=S=NSiPh 2 Bu 1
.Ph
OH

1. BuLi, THF
2. PhCHO

(48)
Ph
0=S=_NSiPh 2 Bu t 1 • BuLi, THF/HMPA

0=S=NSiPh2Bu
(4 9)

2. PhCHO

0=S=NSiPh 2 Bu 1
(5 0)

Gais et al. have shown it is possible to direct the regioselectivity of the reaction

between lithiated allylic sulfoximines (51) and aldehydes by judicious utilisation o
transmetallation with titanium compounds. When CITi(0/'Pr)3 is used y-1,2 addition
is favoured and gives (52),84 while CITi(NEt)3 is selective for a-1,2 addition
Q C

product (53).
Ph
I
;=NMe

1

P

0=S=NMe

©©Li

/-Pr'
(5 1)

CITi(0/ Pr)3
/-Pr'

Ti(0/Pr)3
/-PrCHO
Ph
I
HO 0=S=NMe
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Ph

5*
/'-Pr'

0=S=NMe
©©Li

NMe

CITt(NEt)3
/-Pr'

(5 1)

Ti(NEt)3
/-PrCHO

(5 3)

1.9.1.3 Rearrangement

of Allylic Sulfoximines to Allylic Sulfanamides

T h e first palladium(O) catalysed rearrangement of a n allylic sulfoximine to a n allylic
ftfi

sulfinamide w a s reported by P y n e a n d D o n g .

Previous attempts to rearrange allylic

80 82

sulfoximines via thermal m e t h o d s h a d generally failed. '

T h e only success coming

from Gais et al., who were able to rearrange some y-phenyl allylic sulfoximines
87

(54), albeit in generally low yields a n d with m o d e s t regioselectivity.
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M e v ^S(0)Ph

(54)

M e ^ ^S(0)Ph

(55)

R
H
H
Me
Me

(56)

solvent
T(°C) t(hr) (5 4)/(5 5)/(5 6)(%)
52/26/ND
neat
80 15
26/74/ND
toluene
110 20
74/15/11
O C H 2 C H 2 a 85 5 0
84/5/11
1 , 2 C 6 H 4 a 2 8 5 50

Table 1.1: Thermal Rearrangement of y-Phenyl Allylic

Sulfoximines

With this resistance to rearrangement, allylic sulfoximines are very different to

allylic sulfilimines that readily undergo thermal [2,3] sigmatropic rearrangemen
the corresponding sulfonamides. The allylic sulfilimines are so reactive that it
QQ

impossible to isolate them at room temperature before the rearrangement occurs.

MSH

H

s^^h
Ph
NH

PhS'/

*v^%

Semi-empirical calculations by both Pyne and Harmata have indicated that the allylic
sulfinamides are thermodynamically more stable than their isomeric allylic

sulfoximines. Harmata found the heat of formation for the sulfoximine (57) was 11
80

kcal/mol compared to 32 kcal/mol for the isomeric sulfinarnide (58).
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f?

H
0=S=NH '

(57)

^ N ^ H

(58)

For the sulfoximine (59) Pyne calculated the heat of formation was 145 kcal/mol

while the sulfinamide (60) was 57 kcal/mol. Both calculations indicated that a larg
82

kinetic barrier must exist for the thermal rearrangement to proceed.

Ph
0=S=NH

(59)

i?
H
S

N

/

S\
Ri

(60)

Later ab initio calculations by Harmata found the conversion of (57) to (58) was
exothermic by 24.1 kcal/mol and the activation energy was estimated at 28
kcal/mol.

The palladium(O) catalysed rearrangement neatly overcomes this kinetic barrier to

provide allylic sulfinamides under mild conditions as shown by the facile conversio
Q C

(61) to (62) by Pyne and Dong.
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PhS(O). > T s
Pd(PPh 3 ) 4
THF, RT,10mins

,

NaOHf
H20/MeOHl

The sulfinamides can be subjected to mild base hydrolysis to provide protected allylic
amines. These types of amines are extremely useful for organic synthesis,90 as key
91
92
structural components for peptide isosteres, and as antimycotic agents.

The mechanism of palladium(O) catalysed allylic alkylations and aminations is well
93 94 95 96
documented.

' ' '

The rearrangement of the allylic sulfoximines is likely to go

through a similar mechanism as shown in Scheme 1.8. (For more details on the
mechanism of palladium catalysed allylic aminations see Section 1.10.2)

0
II
RNSR

Pd(0)
L'

(A)

©

Pd®

INVERSION

R'S(O)

INVERSION
^L

(B)

(C)

S c h e m e 1.8: Likely Mechanism of the Palladium(O) Catalysed
Rearrangement

of Allylic Sulfoximines
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The palladium attacks anti to the sulfoximine leaving group via an oxidative addition
process to form a cationic (ri3-allyl)Pd(ll) complex (B). Next the sulfinamide anion
acts as a nucleophile and adds anti to the palladium to form the allylic product (C).
Overall this results in a retention of configuration at the substituted carbon.

An asymmetric version of this rearrangement can in theory be realised by either using
optically active sulfoximines or by the use of chiral ligands on the palladium.

Pyne and Dong found the palladium catalysed reactions of primary and secondary
sulfoximines were completely regioselective with the formation of only primary
allylic amines. The reaction rates of the palladium(O) catalysed rearrangement
correlated closely with the electron withdrawing ability of the nitrogen substituent on
the sulfoximine. As the electron withdrawing ability increases, the reaction time
decreases and the yield after conversion to the final amine increases as shown in Table
1.2.97'98

M
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'H

'SOPh
Pd(PPh3)4

NaOH
MeOH/H 2 0

THF

(66)

(65)

(64)

t(min)* Yield(%)#

R
Ts
COOMe
Me

10

89

30

66
21

60

" Reaction time for paJmdU<m(0) catalysed rearrangement
# Yield of (66) after cleavage of the 5u!finamide group
Table 1.2: Reaction Rate Dependence Upon Electron Withdrawing A*tilit\
of the Nitrogen Substituent

1.9.1.4 Y-Amino-a,p-Unsaturatec: Esters and

Ketones

oc Q7 no

In their papers Pyne and Dong

' ' examine tne rearrangements of primraayyasnc!

secondary allylic — ,roxim 'nes to the corresponding allylic sulfinamides. Howee_rrno
«rOrk was performed upon substrates that would provide Y-amino-a,p-unsa_ir_ted

esters and ketones such as would be required for this proposed synthesis of azaao&
(Scheme 1.1).

X = OR, R

Chapter 1

43

Previous work by Jackson and Strauss showed that the allyl palladium complexes of

a,|3-unsaturated esters and ketones are regioselectively functionalised with stabilise
99 •
carbanions at the y position to give (67).

This indicates that a similar

regiochemistry could be expected from the allylic sulfoximine rearrangement with the
incoming sulfinamide anion attacking the allyl substrate at the y-position.

N

^

/

,CEt
^ Y '

Pd ®

°

Na©QCH(COOEt)R ^
R = CN, S 0 2 M e , PO(OEt) 2

r L
(67)

These y-amino-cc,p-unsaturated esters and ketones are useful as "vinylogous amino
acids" in the preparation of novel polypeptides to study the effects on the secondary
and tertiary structures.100 The y-amino-oc,p-unsaturated carbonyl compounds also

appear as intermediates in the synthesis of natural products as structurally diverse a
101 ... i • t u-* 102
cytotoxic marine sponge metabolites,

macrocyclic serine protease inhibitors,

pyrrolidine antibiotics,103 and transition state mimics for renin inhibition.

These compounds are usually prepared from cc-amino aldehydes (68) via a WittigHorner reaction. The a-amino aldehydes (68) are derived from naturally occurring
oc-amino acids in a few short steps. Consequently, it is not possible to prepare yamino-cc.p-unsaturated esters and ketones that do not come from "the pool" of
., 105
naturally occurring a-amino acids.
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NBn2
- *
^

CHO

+

O Na
EtOO) •
P-CHCOOEt

NBn2
r
• J*^s0^

^OEt

EtO"

(68)

(69)

(70)

A reaction analogous to the palladium(O) catalysed amination has also been used for the
synthesis of y-amino-cc,p-unsaturated esters. The (7i-allyl)tetracarbonyliron
complex (72) was formed in an stoichiometric reaction between Fe2(CO)g and the ybenzyloxy unsaturated ester (71) and then reacted with amines to provide the yamino-a,p-unsaturated esters (73).

°Bn
-OCH 3
2. HBF4 [
O
(7 1)

1.Fe2(CO)9,CO

B F 4 © © Fe(0O) 4
^ ^^L^^OCH,
O
(7 2)
Bn 2 NH

(7 3)

1.9.2 Asymmetric Dihydroxylation of Allylic Amines

The osmium catalysed vicinal dihydroxylation of olefins has found wide applicability in
organic synthesis. The usefulness of the reaction increased when Sharpless introduced
cinchona based chiral ligands to provide diols in high enantioselectivity. Two
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preformed admixtures containing potassium osmate, chiral ligand, co-oxidant, and
base are now available commercially from Aldrich as AD-mix a and AD-mix p .

As mentioned before the main challenge in the synthesis of carbohydrate analogues is
the high number of stereocenters and the need to be able to procure the required
stereochemistry. Much of the asymmetry of this reaction pathway will be generated by
the dihydroxylation of the allylic amine. The y-amino-oc,p-unsaturated ketones will
provide an essentially flat environment around the double bond and as such will
provide an excellent substrate for the dihydroxylation.

1.10 Asymmetric Synthesis of Azasugars from Carbohydrate Starting
Materials

The second synthetic pathway to be explored in this thesis uses a carbohydrate starting
material as outlined in the retrosynthetic analysis below. Analogues that vary in the
stereochemistry of the hydroxyl groups can be prepared by changing the carbohydrate
starting material. The key steps are: (a) chain extension, (b) palladium(O) catalysed
allylic amination, (c) oxidation of the alkene, either by dihydroxylation or
epoxidation, followed by conversion of the primary hydroxyl group into an amine, and
(d) cyclisation and then deprotection.
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HO

OH

OXD

(d)

y

OH

CR

R'2N

RD

NHo

NR2
(c)

X
HO

X

(b)

_4

HO

HO'
NR2

(a)

O

OH

S c h e m e 1.9: Synthesis of Azasugars from Carbohydrates

The final product shown in S c h e m e 1.9 can, in principle, also be further cyclised to
produce analogues of bicyclic azasugars such as swainsonine (6) and castanospermine

(7).

HO

OH

HO
cyclisation

NH2

OH

,OH

U

H
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1.10.1 Addition to the Lactol

The first step in the second synthesis is the addition of a Grignard reagent to the lactol
(73). The lactol is in equilibrium with the hydroxy aldehyde (74).

*CT ^OH

HO"

°

~H

(73) (74)

The two faces of this masked aldehyde functionality are diastereotopic due to the
adjacent chiral centre. The reaction of similiar carbonyl groups with organometallic
compounds is known to proceed with good selectivity and is a frequently employed
108

strategy for the diastereoselective chain extension of carbohydrates.

The basis for

the selectivity can be explained by the Felkin-Anh transition state model for the
109,110
addition to carbonyl groups.

>°x
Nuc

x

-H
HO

HO"

Nuc

The largest group, in this case the acetonide, is at an angle of 90° to the plane of the
carbonyl and the incoming nucleophile has a preferred trajectory which is at an angle
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of -109° to the carbonyl. This gives predominantly the anti product where the newly
formed hydroxyl group is anti to the existing acetonide.

1.10.2 Palladium(O) Catalysed Allylic Amination

93
Palladium(O) complexes catalyse a wide variety of reactions.

Like the first

synthetic route this pathway also employs a palladium(O) catalysed allylic amination,
in this case to convert a secondary hydroxyl group into a primary amine. Other
nucleophiles such as alkoxides, thiols, and stabilised carbanions, could be utilised to
introduce any number of functionalities at the primary position. This introduces a
large degree of flexibility in order to produce analogues.

Palladium(O) catalysed allylic amination is a versatile process that has been known
for over 30 years and encompasses a wide range of allyl systems and
Q4 Q"i Q6

nucleophiles.

'

Both primary and secondary amines, but not ammonia,

efficiently aminate allylic substrates.

Central to this reaction is the facile redox nature of palladium and the ease with which
it can change between a zero oxidation state and a +2 oxidation state via oxidative
addition and reductive elimination reactions. As with a number of transition metal
catalysed reactions, allylic amination is a stepwise process as shown in Scheme
1.10.
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The first step is the coordination of the palladium(O) with the alkene on the face
opposite to the leaving group (A). The electron density around the palladium then
initiates the expelling of the leaving group to produce a (rc-allyl) intermediate with
inversion of configuration (B) via oxidative addition. The final step is the reductive
displacement of the palladium species by a nucleophile to give the product (E) and
regeneration of the palladium(O) catalyst.

X©

hard" Nu

Scheme

1.10: M e c h a n i s m

of Palladium(O) Catalysed Allylic Alkylation
and Amination
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"Soft" nucleophiles, such as amines, attack the allyl group directly (C) with
inversion of configuration and overall 'retention of configuration. "Soft" nucleophiles
are defined as those whose conjugate acids have a pKa > 25, although this definition is
not rigid. "Hard" nucleophiles attack the metal centre first (D) and then migrate to
the allyl ligand to give overall inversion of configuration.

A number of variables influence the regioselectivity including the steric environment
of the complex, electronic factors, and the relative stability of the terminii in the
intermediate (71-allyl) complex.

1.10.3 Completion of the Second Proposed Synthetic Pathway

In the final few steps the double bond of the allylic amine is oxidised either by
dihydroxylation or epoxidation. The diastereoselectivity of this reaction should be
enhanced by the chiral acetonide group adjacent to the double bond. The free primary
hydroxyl group will then be converted via a sulfonate into an amine. This step can be
varied with other nucleophiles such as thiols or phosphines or even stabilised
carbanions used to produce other carbohydrate analogues. The final two steps are
cyclisation and deprotection to give the pyrrolidine azasugar, which can undergo
further cyclisation to give a bicyclic azasugar (see Section 1.10).

CHAPTER 2
SYNTHESIS OFy-AMINOa,p-UNSATURATED KETONES
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Introduction

The first synthetic pathway outlined in Scheme 1.7 (see Chapter 1) has as its
crucial step the palladium(O) catalysed rearrangement of an allylic sulfoximine. No
previous work had been carried out on allylic sulfoximine substrates that
would provide y-amino-cc,p-unsaturated ketones as would be required for the
synthesis of azasugars. Thus it was necessary to investigate the rearrangement of these
substrates.

2.2 Preparation of Allylic Sulfoximines

As a model system it was decided to use the allylic sulfoximines (75) shown below. The
chosen protecting group for the nitrogen was the methyl carbamate as it was
anticipated that a carbamate would be an useful protecting group in the actual synthesis
of azasugars. Pyne and Dong had previously shown in simpler systems that the best
yields and shortest reaction times were obtained with the strongly electron
98
withdrawing tosyl substituent on the sulfoximine nitrogen.

Consideration w a s

therefore given to the tosyl group as the protecting group. However AMosyl groups are
normally deprotected under relatively harsh conditions and for this reason were
not considered suitable for a general synthetic path that has to be tolerant of other
functionalities. This caveat does not apply to the electron withdrawing carbamates
which can be deprotected under a variety of mild conditions depending upon the specific
carbamate used.
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?a

Ph
I
0=S=NCOOMe Pd(0) m N

(75)

2.2.1

Synthesis

^COOMe

(76)

of 2-(A/-Methoxycarbonyl-S-phenylsulfoximidoyl)-1-

phenyl-ethan-1-one (80)

The

starting

material

was

112
phenylsulfoximine (77).

the

readily

available

racemic

S-methyl-S-

This was protected as the methyl carbamate by treatment

with sodium hydride and methyl chloroformate in dimethoxyethane at 45°C
113
overnight.

After purification by column chromatography the yield of the protected

sulfoximine (78) was 77%.

O

Q

II

NaH, CICOOMe

II
NH

DME
(77o/o)

IT

Ph— S— Me *- Ph—S—Me
II
NCOOMe

(77) (78)
The protected S-methyl-S-phenylsulfoximine (78) was deprotonated with LDA in THF
at -78°C. The resulting lithiated sulfoximine underwent 1,2-addition with
benzaldehyde at -78°C for 30 minutes to furnish the p-hydroxy sulfoximine (79) as
a 82:18 mixture of diastereomers.
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P
1.n-BuUjTHF,-78°C
Ph—S—Me
"
»
ff 2. PhCHO
NCCOMe
(7 8)

Jones
reagent
Ph
I

Q=S=NCOOMe
.Ph
O
(8 0)

The alcohol moiety was then oxidised with Jones reagent in acetone at R T to give the pketosulfoximine (80) in an overall yield of 35% from the protected S-methyl-S-

phenylsulfoximine (78). None of the isomeric enol form of (80) could be detected in
the 1H NMR spectrum of the compound. The 1H NMR spectrum of (80) showed doublets
at 85.5 and 5.1 (J=13.8Hz) as shown in Figure 2.1 for the diastereotopic methylene
protons a to the carbonyl group.
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Figure 2.1: Partial

H N M R Spectrum

I

5.1

5.0

(CDCI3) of (80) Showing the

Resonances Assigned to the Diastereotopic Methylene Protons

2.2.2 Knoevenagel Condensations of (80)

The next step was the base catalysed Knoevenagel type condensation between an aldehyde
and p-ketosulfoximine to produce the allylic sulfoximines (81).

Ph
I

0=S=NEWG
'CHO

Ph
I
0=S=NEWG

+
O

R = alkyl or aryl, R' = alkyl or aryl
E W G = C O O M e , Ts, etc

(81)
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Knoevenagel condensations are reactions between carbonyl compounds and methylene
groups activated by the presence of two electron withdrawing substituents. There are
two known mechanisms for the condensation as shown in Scheme 2.1 (which
omits the many proton transfer reactions for reason of brevity). The first is known as
the Knoevenagel mechanism and involves the activation of the carbonyl compound via
formation of an iminium compound with a nitrogen base. This is followed by addition to
the active methylene compound and subsequent elimination of the amine to give the
vinyl product (82). The Hann-Lapworth mechanism involves deprotonation of the
active methylene compound followed by 1,2-addition to the carbonyl group to give an
intermediate hydroxyl compound. This hydroxyl compound undergoes dehydration to
furnish the vinyl product (82). The actual path taken depends upon the catalyst used.
Many catalysts are available for the reaction including primary, secondary and
11 R
tertiary amines and their salts, basic metal salts, Lewis acids, silica gel,
alumina,117 microwave irradiation118 and many others. Both mechanisms give the
same vinylic product (82) which can then, in the presence of base, isomerise to the
allylic compound (83).
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Ri

X.

R

R

J / base

X

HNR 2 R 3
I
i Ri
R
2

-HNR 2 R 3

X
allylic product

.^
base

(8 3)

R
(8 2)

base

X
l

-H 2 0

1

' Ac"

X

_^ 1 v R i
Y ^

1

1 R,

R
(8 2)
t

base

allylic product

(8 3)
S c h e m e 2.1: K n o w n Mechanisms of the Knoevenagel Condensation with
Knoevenagel Mechanism (top) and Hann-Lapworth Mechanism (bottom)

In this study on the Knoevenagel condensation of (80) with aldehydes, catalytic

amounts of piperidine and acetic acid in acetonitrile was used. It is believed tha
piperidium acetate catalysed Knoevenagel condensation follows the Hann-Lapworth
119 •
mechanism.

The 4A molecular sieves were added to absorb the water released

during the dehydration step.
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P1

0=S=NCOOMe
K

^CHO

piperidine, A c O H

Ph

+

0=S=NCCOMe

4A sieves, C H 3 C N

0

(8 4)

(8 0)
R

time(hr) vield(°/c) d.r.

a) Me

24

b) Et

24

c) Bu

24

d) Pent

24

18
42
46
65

67:33
66:34
76:24
69:31

Table 2.1: Synthesis of Allylic Sulfoximines (84) Utilising a
Knoevenagel Type Condensation

The results of the Knoevenagel condensation between the p-ketosulfoximine (80) and
various aldehydes are presented in Table 2.1. In all cases only the allylic
sulfoximines were observed and there was no evidence of the isomeric vinyl

sulfoximines. The chemical yields were directly related to the length of the alkyl ch
of the aldehyde. The condensation with heptanal (R=Pent) gave an acceptable yield,
while propanal (R=Me) gave a very poor yield.

The low yields are most likely due to competing base catalysed self-condensation of the
aldehyde to give p-hydroxy aldehydes.120 This reaction occurs quite easily for low
molecular weight aldehydes such as acetaldehyde and propanal, while higher

homologues such as heptanal require heating for the self-condensation to occur. In th

example below the self-condensation of propanal occurs at RT under the catalysis of a
basic ion-exchange resin. The corresponding reaction involving heptanal has to be
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heated to 120°C for the reaction to occur. The high temperature for the heptanal selfcondensation leads to dehydration of the" intermediate alcohol to give the enal.120

2 x

x

basic ion-exchange
resin
25°C

2 x Cs^ f

v

*CHO

CHO

OH
'5H11

basic ion-exchange
resin
*CHO

C5H11

'CHO

120°C

In light of these findings, since the Knoevenagel reactions of the p-ketosulfoximines
(80) were carried out at RT it would then be expected that the low molecular weight
aldehydes would give low yields of the Knoevenagel products due to the competing selfcondensation while higher homologues would give better yields of Knoevenagel
products. Indeed this is what is observed as shown in Table 2.1.

The two diastereomers of (84) that formed in these Knoevenagel reactions could not be
separated by column chromatography. However the diastereomeric ratios could be
determined from their H NMR spectra as shown for (84a, R=Me) in Figure 2.2.
The proton a to the sulfoximine group in the H NMR spectra for the four derivatives
of (84) appeared as a doublet at -87.1 (J=~9.3Hz) for the major diastereomer and at
-86.5 (J=~9.0Hz) for the minor diastereomer. Apart from (84c, R=Bu) all the
allylic sulfoximines were formed in very similar diastereomeric ratios of
approximately 2:1.
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Figure 2.2: Partial

1

H

N M R Spectrum
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6.S

6

<4

(CDCI3) of the T w o Diastereomers

of (84a) Showing the Resonances for the Proton a to the Sulfoximine

The relative stereochemistry of the diastereomeric allylic sulfoximines (84) could
not be determined by NMR experiments as there were no significant nOes and
furthermore all the products were oils and therefore not suitable for X-ray
crystallographic analysis.

The allylic sulfoximines (84) formed exclusively the (E) stereochemistry around the
double bond. This was determined from their 1H NMR spectra which showed coupling
constants of J=15-16 Hz between the olefinic protons. In comparison, a coupling
121
constant of J=~10 H z would be expected for the (2) stereochemistry.
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2.3 Palladium(O) Catalysed Rearrangements Of Allylic Sulfoximines

As mentioned in Chapter 1, the palladium(O) catalysed rearrangement of allylic
sulfoximines to allylic sulfinamides proceeds in good to high yields under very mild
reaction conditions. The allylic sulfinamides can then be cleaved under basic conditions
to provide allylic amines.

2.3.1 Mechanism of the Sulfinamide Cleavage

The method chosen for the cleavage of the sulfinamide group was treatment with
catalytic amounts of triethylamine in methanol to furnish the desired amine. The
mechanism of the cleavage of the sulfinamide group is likely to involve attack of a
methoxide anion on the sulfur, followed by cleavage of the sulfur nitrogen bond as
shown below.

\\ MeOH/Et3N II _) ,_ ^"sO
Ph^NR^l

*" P h ^ N R ^

PrfT* NRiRg

J

CMe

MeO©
MeOH

J
R,R2NH - ^

e + ff
R,R2N

R^N*.

MeO©

Scheme 2.2: Mechanism of the Cleavage of the Sulfinamide Group
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The nitrogen anion then abstracts a proton from methanol to regenerate the methoxide
ion. Thus only catalytic amounts of triethylamine are required for the cleavage of the
sulfinamide group.

2.3.2 The Palladium(O) Catalysed Rearrangement and Sulfinamide
Cleavage of the Allylic Sulfoximines (84)

Treatment of the prepared allylic sulfoximines (84) with freshly prepared
tetrakis(triphenylphosphine)palladium(0) (5 mol%) in dry THF for approximately
one hour at RT gave, after evaporation of the THF in vacuo, the allylic sulfinamides
(85) which were not isolated due to extensive decomposition when subjected to column
chromatography. Mild base cleavage of the sulfur-nitrogen bond with triethylamine in
methanol for 30 minutes at RT gave the monoprotected y-amino-oc,p-unsaturated
ketones (86).
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P

0=S=NCCOMe

/^A^Ph •
R

^ S ^ ^COOMe
Pd(PPh3)4

PIT

¥

THF, RT

O
(8 4)

(8 5)
Et3N, M e O H

K^CCOMe

(8 6)
R t(min )yield(%)t d.r.*
a) M e 60
50
67:33
b) Et 85
31 69:31
c) Bu 65
64
67:33
d) Pent 60
49
62:38
t yield of allylic amine (8 6)
* d.r. of allylic sulfinamide (85)
Table 2.2: Palladium(O) Catalysed Rearrangement of Allylic
Sulfoximines Followed by Cleavage of the Sulfinamide Group

The yields shown in Table 2.2 are modest to acceptable and are the overall yields for
the final amines (86) after cleavage of the sulfinamide moiety and then purification
via column chromatography on silica gel. The slightly lower yield for (86b, R=Et) is
due to the reaction initially being worked up too early after the TLC appeared to
indicate that the reaction was complete. The mixture of product plus starting material
was then retreated with identical amounts of catalyst. The time indicated in Table 2.2
is the combined time for the two reactions.
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There was no observable (E)-(Z) isomerisation during these reactions. The coupling
constants in the H NMR spectra between the olefinic protons are approximately
J=15-16 Hz indicating (E) stereochemistry. If isomerisation were to occur it would
involve the formation of a less stable anti complex, which has severe steric
interactions with the coordination sphere of the palladium.

Pd

Pd v ^

T

Ph

Ph

f

—

O
syn complex

anti complex

a-complex

•Pd(0)

•Pd(0)

(2) products

(E) products
S c h e m e 2.3: Interconversion of Syn and Anti

2.3.3

Diastereoselectivity

of

the

Complexes

Palladium(O)

Catalysed

Rearrangements

The diastereomeric ratios of the allylic sulfinamides (85) were determined from
analysis of the 1H NMR spectra of the crude reaction mixtures prior to treatment with
triethylamine in methanol. In the case of (85b) this ratio was determined by
integration of the terminal methyl resonances for the two diastereomers as shown in
Figure 2.3.
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H NMR

Spectrum (CDCI3) Showing the Terminal

Methyl Resonances of (85b)

There were some slight differences between the diastereomeric ratios of the starting
sulfoximines (84) and the intermediate sulfinamides (85). This is possibly due to
either configurational instability of the sulfinamide anion or the interconversion of
enantiomeric intermediate palladium complexes (C and D) as shown below in Scheme
2.4.
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Ph
.1
0=S=NCCOMe
Ph

(A)

(B)

O
Pd(0)
PhS(0)NCOOMe

©
Pd

(C)

(D)

f@

Ph

O
PhS(0)NCOOMe

Pd(0)

Pd(0)-

i?
^Sw

?

^COOMe

.S. XOOMe
Ph^* NT

(E)

Ph

R"

(F)

O
Scheme 2.4: Interconversion of Intermediate Palladium Complexes

The most likely mechanism for the interconversion of the (w-aHyOpalladium

complexes (C and D) is nucleophilic attack by free palladium(O) upon the
1992, Backvall and Granberg were able to isolate both the cis and trans
(87) which were then treated with Pd(PPh3)4. Since the complexes were
diastereomeric, utilisation of both 1H and
isomerisation between the two forms even at -14°C

31

122

P NMR spectroscopy could dete
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CCOCH3

CCOCH3
Pd(PPh 8 ) 4

Pd(PPh3)2(OTf)

Pd(PPh3)2(OTf)

c/'s-(87) trans-(87)

2.3.4 Regioselectivity

of the Palladium(O) Catalysed

Rearrangement

The allylic rearrangements of the sulfoximines (84) were completely regioselective
with only y-amino-a,p-unsaturated ketones being observed. The

H N M R spectra of

(84) showed the presence of two vinyl protons, one as a doublet and the other as a
doublet of doublets as seen in the Figure 2.4 below which is from the spectrum of

(86b).
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99
As noted in Chapter 1, previous work by Jackson and Strauss

found that the

palladium complexes of oc,p-unsaturated esters also undergo nucleophilic addition
exclusively at the y position. The basis of the selectivity is most likely to be the
electronic effects of the ketone functionality. The intermediate rc-allyl palladium
complex can be portrayed as an interconversion of two isomeric complexes with the
positive charge on either allylic terminus. When the charge is on the terminus next to
the ketone the partial positive charge on the ketone carbon gives an unfavourable
electronic interaction with the positive charge. Thus the complex where the positive
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charge is y to the ketone is more stable and more likely to react with the incoming
nucleophile which agrees with the observed regioselectivity.

©
Ph
I
0=S=NCOOMe

S+^Ph

o

Pd
n

' .Ph _!*__

^y

o

©

8+^Ph
Pd

O

Furthermore the product formed from nucleophilic attack at the y-carbon would be
expected to be thermodynamically more stable due to the conjugation of the double bond
with the carbonyl group.

2.4

A

H NMR

Studies of Changes in the Diastereomeric Ratio with Time

H N M R experiment was set up to investigate how the diastereomeric ratio of the

intermediate allylic sulfinamides would change in solution over time. The AMosyl
allylic sulfoximine (88) was prepared in an analogous method to (84d, R=Pent).
Q

The sulfoximine (88) and Pd(PPh3)4 were dissolved in d -THF and placed in a N M R
tube. The H NMR spectrum was taken at regular intervals over the period of one
month and the integrals of the protons a to the sulfinamide group of the two
diastereomers measured.
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?
^ ^

T s

Pd(PPh 3 ) 4
O5H11

C5H1 {

d8-THF

(88)

(89)

The two diastereomers of (89) that were formed were termed D1 and D2 and the ratio
of the two diastereomers was observed over time. After 10 minutes no more starting
material could be seen and D1 was the predominant isomer by a ratio of 3:1. An hour

later the amount of D-| had decreased and the ratio was now 3:2. By the next morning D
was now the more prevalent isomer and the ratio had become 3:4. When one month had
passed and it could be assumed that some kind of thermodynamic equilibrium had been
reached, D2 was now clearly the dominant isomer and the ratio was 1:2.2.

Time

D?:Di
10 mins 0.30
20 mins

0.42

30 mins

0.52

70 mins

0.61

21 hours 1.33
28 days 2.21

Table 2.3: C h a n g e in the Diastereomeric Ratio of (89) over Time
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Figure 2.5: Graph Showing the Changes in Diastereomeric Ratio of (89)
over Time

As there was no starting material present in the H NMR spectrum after 10

the change of the diastereomeric ratio over time seems to indicate the po

the formation of the allylic sulfinamide is reversible. That is, if the f

allylic sulfinamide was irreversible then once it was formed the only way

diastereomeric ratio could change would be via epimerisation of the hydro
sulfinamide nitrogen by a base. However, the identity of a potential base
surmisable.

Therefore it might be possible that the palladium can oxidatively add to

sulfinamide with the sulfinamide acting as the leaving group to reform th
7t-allyl complex as shown in Scheme 2.5 below. This would be facilitated

strongly electron withdrawing substituents on the nitrogen enabling it to
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two electrons associated with the oxidative addition process. The palladium complex can

then undergo isomerisation via nucleophilic attack by free palladium(O) a
122
earlier.

The sulfinamide anion can then act as a nucleophile to again form the

allylic sulfinamide in a different diastereomeric ratio.

PhS(O). /Ts
N

Pd(0)

OsH.r^V^ ^

Ph
©
CsH1f^f'Y
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^

o
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Ph 3 P^ ^ P P h 3

O

Pd(0)
PhS(0)^N/Ts
Pd(0)

r* u x ^ X ^ X / P h C 5 Hif
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y
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C H

1
_ yV
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T
[f
Pd^
o
x
Ph 3 P^ ^ P P h 3

+ PhS(0)NTs
©

Scheme 2.5: Possible Mechanism for the Interconversion of Allylic
Sulfinamides

2.5 Thermal Rearrangement of Allylic Sulfoximines

An attempt was made to thermally induce an allylic rearrangement of (84d). The

sulfoximine was refluxed in THF overnight and after cooling to RT, the s

in vacuo. The crude mixture was then treated with triethylamine in metha

minutes at RT. The 1H NMR spectrum showed mainly starting material plus s
peaks. However after purification via column chromatography, no compound

be unequivocably assigned as structures (86d) or (90) from H NMR analysi
be isolated.
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r-L .COOMe
^N

P1
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0=S=NCCOMe
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II
O

P FtoN
2.
Et3N, Mi
MeOH

CsH!

H^

^COOMe

'N

(8 4d)
C5H11

As mentioned in Chapter 1, very few allylic sulfoximines undergo thermally induced
on op Q"7

rearrangement.

' '

The failure of (84d) to undergo rearrangement when heated,

reinforces the view that the thermal allylic rearrangement is not a generally favo

reaction for allylic sulfoximines, especially when compared to the facile palladiu
catalysed reaction.

2.6 Conclusion

This chapter has shown that the palladium(O) catalysed rearrangement of allylic
sulfoximines to allylic sulfinamides, followed by base catalysed cleavage of the

sulfinamide group, is a general and mild method for the synthesis of monoprotected

amino-oc,p-unsaturated ketones. These compounds would be useful as intermediates f
the synthesis of azasugars and other compounds.

It was noted that the diastereomeric ratio of the starting allylic sulfoximines and

product allylic sulfinamides are different, possibly due to nucleophilic attack of
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palladium(O) upon the intermediate (rc-allyl)palladium complex. A H NMR study
raised the possibility that the formation of the allylic sulfinamides is reversible from
the observation that over the period of one month the diastereomeric ratio continued to
change.

It was also shown that the allylic sulfoximine (84d) does not undergo a thermally
induced rearrangement in stark contrast to its palladium(O) catalysed reaction.

CHAPTER 3
AMINATION OF ALLYLIC
SULFOXIMINES USING EXTERNAL
NUCLEOPHILES
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3.1 Introduction

Previous work on the palladium(O) catalysed rearrangement of allylic sulfoximines
had concentrated solely upon the use of the sulfinamide anion as the incoming
nucleophile during the reductive elimination. No work on the use of an external
nucleophile had been carried out.

It was shown by Pyne and Dong that use of a A/-methyl protected sulfoximine leads to a
98
very poor yield of rearranged product.

Hence it is not feasible to produce usefully

protected allylic amines bearing an electron donating substituent on the nitrogen using
the intramolecular palladium(O) catalysed rearrangement of allylic sulfoximines.
This could in principle be overcome by use of an external nucleophile with electron
donating substituents.

Furthermore, it was of interest to see if the external nucleophile and sulfinamide anion
competed for allylation by the palladium complex. For instance, it could be possible
that sulfinamide anion blocks the attack of an external nucleophile by forming a close
ionic pair with the cationic palladium complex.
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3.2 Preparation of Allylic Sulfoximines

As no prior work had been carried out using external nucleophiles it was decided to
expand the range of substrates used so that the regioselectivity and the
enantioselectivity of the reaction could be investigated.

The /\Mosyl-S-phenyl-S-(2-propenyt)sulfoximine (91) was prepared by reaction
of the known allyl sulfoximine (39) with tosyl chloride, pyridine and 4dimethylaminopyridine in anhydrous DCM to give (91) by a known literature
. 98
procedure.
O
"
•S-ph
NH

O
TsCI,pyridine,DMAP
»
*~ ^ X / ^ P h
DCM,45mins,RT,78%
NTs

(39)

(91)

The second substrate, 2-(A/-tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-198 —
ol (92), was prepared also by a literature procedure.

Treatment of A/-tosyl-S-

phenyl-S-(2-propenyl)-sulfoximine (91) with n-BuLi gave a lithiated salt which
underwent oc-1,2 addition with benzaldehyde to give the desired product (92) as a
mixture of diastereomers in a yield of 87%.
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II

^ X ^ ^ P h
' NTs

n-BuLi

•

•

THF,-78°C,15mins

^^^S"^Ph
Q

NTS

Li©
(9 1)
PhCHO
-78°C,5mins

(9 2)

2-(A/-Tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-one

(93) w a s

prepared by oxidation of 2-(/V-tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en1-ol (92) with Jones reagent in acetone with a yield of 97% after purification. The
product was formed as a 71:29 mixture of diastereomers as determined from the H
NMR spectra as outlined in Section 2.2.2.

Jones reagent
acetone, RT,10mins

(92)

(93)

The next substrate, 2-(/V-tosyl-S-phenylsulfoximidoyl)-1-phenyl-non-3-en-1one (88), was also prepared via a literature procedure.123 In this case a Knoevenagel
condensation (see Chapter 2) between the protected p-ketosulfoximine (94) and
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heptanal gave (88) in a yield of 6 9 % and as a inseparable 72:28 mixture of
diastereomers.

Ph
Ph
I
I
0=S=NTs heptanal,piperidine,AcOH 0=S=NTs
Ph
^ ^ ^ ^
CH 3 CN,RT,5 hours
Cb^i
•

*

-

^Ph

o
(94)

The

(88)

exocyclic sulfoximine, A/-tosyl-S-phenyl-S-(1-cyclohex-1-enylmethyl)-

98

sulfoximine (95), was prepared using the method of Pyne and Dong.

The protected

S-methyl-S-phenylsulfoximine (96) was deprotonated with n-BuLi to give the

lithiated salt. This was allowed to undergo 1,2-addition with cyclohexanone to give t
hydroxy intermediate (97). Dehydration of this hydroxy compound gave the allylic
sulfoximine (95).
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1. n-BuLi,THF,-78°C,40mins
Ph—S—Me
•
NTs
2.
78°C,1h

H

6-

(9 6)
(9 7)

1.MsCI,Et3N,DCM
2. DBU

(9 5)

The final substrate was prepared by methylation of A/-tosyl-S-phenyl-S-(1cyclohex-1-enylmethyl)sulfoximine (95) with lithium diisopropylamide and methyl
iodide. According to Pyne and Dong this methylation proceeds in a diastereoselective
manner to give the product (98) with the (S) stereochemistry at the newly formed
i 98
chiral centre.

(S)

(95)

(98)
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Palladium(O) Catalysed

81

Amination

of Allylic Sulfoximines

in the

Presence of an External Nucleophile

The allylic sulfoximines listed in Table 3.1 were treated with Pd(PPh3)4 (5-10
mol%) and the external nucleophile (1.2 mole equivalent) indicated in anhydrous THF
for the time denoted. The progress of these reactions were monitored by TLC analysis.
The solvent was removed in vacuo and the products were purified via column
chromatography.

3.3.1 Palladium(O) Catalysed Amination of Allylic Sulfoximines Using
Dibenzylamine as an External Nucleophile

The allylic sulfoximines (91), (92), (93), (88), (95) and (98) all reacted very
smoothly and regioselectively with Pd(PPh3)4 and dibenzylamine to provide the
corresponding A/./V-dibenzyl protected allylic amines (99), (101), (102), (103),
(104) and (105) respectively, in 10 minutes at RT in poor to good yields.
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substrate

nucleophile time(mins)

O

Bn2NH

II

10

product

yield (%)

^^x^NBng

(99)

67

^X^'f^Ph
NTs

Boc 2 N0©Li O/N

^^S^NBoca^ooj 54

(9 1)
NBn2

Ph
0=S=NTs

Bn2NH

10

k ^ \ . P h (10 1) 66

T

v^y^
OH
(9 2)

Boc 2 N©©Li O/N

1
P
0=S=NTs

c
^ X x N B oOH
2 ( 1 0 0) 26

NBn2
Bn2NH

10

L v ^ v s s . P h (10 2) 43

^Jx^Ph

T

0

Boc 2 N©©Li O/N

^ s S w / N BOo c 2 ( 1 0 0 )

18

(9 3)

Ph

0=S=NTs

CsHu-^Kf™

NBn2

B 2NH

"

1

°C 5 H

n-^^Y^

0

O

(8 8)

(10 3)

°

.NBn2

^f^Ph
NTs

/L

(9 5)

Bn2NH

10

Me II

1

6

(10 4) 73

Me

H»V N B n 2

H^r NTs
II ^

A

62

(9 8)

Bn2NH

10

AI,

(105) 13

Table 3.1: Allylic Amination Reactions of Allylic Sulfoximines with
Palladium(O) and External Nucleophiles
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The mild reaction conditions required for the allylic amination of allylic sulfoximines
compare very favourably with similar'reactions utilising an acetate as the leaving
group. Those reactions involving allylic acetates often require heating to reflux to
124
proceed.

2-(A/-Tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-oI (92) and 2-(/Vtosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-one (93) both reacted
regioselectively to give the corresponding primary allylic amines (101) and (102)
respectively. None of the isomeric secondary amine could be detected in either the 1H
NMR spectra of the crude reaction mixture nor in any of the fractions isolated by
column chromatography.

In accordance with the results obtained in Chapter 2, only the y-amino enone (103)
was formed in the reaction of 2-(A/-tosyl-S-phenylsulfoximidoyl)-1-phenyl-non3-en-1-one (88) with dibenzylamine. As pointed out in Section 2.3.4 for the
intramolecular allylic rearrangement of (86), this is likely to be due to both the
electronic effects of the ketone functionality and the formation of the
thermodynamically more stable conjugated n system.

In the reaction between dibenzylamine and A/-tosyl-S-phenyl-S-(1-cyclohex-1enylmethyl)sulfoximine (95) again only the primary amine was observed as product.
No isomeric secondary amine could be detected in either the H NMR spectra of the
crude reaction mixture nor in any of the fractions isolated by column chromatography.
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The amination of A/-tosyl-S-phenyl-S-(1-cyclohex-1-enylethyl)-sulfoximine
(98) with dibenzylamine was also very regioselective with amination only occurring
a to the methyl group. The 1H NMR spectrum showed the proton a to the methyl group
as a quartet (J=6.6Hz) at 53.100. If the double bond was in the exocyclic position that
proton would be expected to come at -85-6.

(105)

(104)

r
/ _

LA__
a
Figure 3.1: Partial

H

NMR

1

Spectrum

(CDCI3) of (104) and (105)

Even though both allylic terminii of the intermediate palladium complex shown below
are secondary carbons, the greater steric bulk of the cyclohexene ring compared to the
methyl group is the likely driving force behind the observed regioselectivity in the
reaction of (98) and B n 2 N H .
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Furthermore, attack at the exocyclic position generates the product with the double
bond in the thermodynamically more stable endocyclic position.

The yield indicated for the reaction of /V-tosyl-S-phenyl-S-(1-cyclohex-1enylethyl)sulfoximine (98) with palladium(O) and dibenzylamine is only an
approximation. The initial starting material was a mixture of methylated (98) and
non-methylated (95) sulfoximines in a ratio of 66:33. The methylated sulfoximine
(98) is very unstable and decomposes when subjected to column chromatography and
as such cannot be separated from the non-methylated sulfoximine (95). The product is
also a mixture of methylated and non-methylated, however the ratio had changed to
44:56 (see Figure 3.1 for the 1H NMR spectrum of (104) and (105)). This
implies that the methylated product (105) is also susceptible to decomposition on a
column of silica gel. The instability of both the starting material and product is the
possible reason for the very poor yield of 13%.
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3.3.2 Palladium(O) Catalysed Amination of Allylic Sulfoximines Using
Lithiated Boc2NH as an External Nucleophile

The first report concerning the use of lithiated B0C2NH (106) in allylic amination
125
was an article by Connell et al.

in which allylic acetates were converted into the

corresponding A/,/V-diprotected allylic amines. It was found that the lithium salt of
B0C2NH (106) was much more soluble in THF and DMF than the corresponding
potassium and sodium salts. It was also disclosed that 1,2-bis(diphenylphosphino)ethane was a much more effective ligand than triphenylphosphine. The active
palladium(O) catalyst was generated in situ by the reaction of tris(dibenzylideneacetone)dipalladium(O) and 1,2-bis(diphenylphosphino)ethane.

The reactions involving the lithium salt of B0C2NH (106) and allylic sulfoximines
proceeded much slower than the equivalent reactions with dibenzylamine (Table
3.1). According to the TLC taken during the course of these reactions, starting
material remained long after the equivalent reaction with dibenzylamine would have
been completed. This seems to indicate that the intermediate palladium complex is
forming much more slowly. Since the only difference is the nucleophile used, this
implies that there might be an interaction between the lithiated B0C2NH and the
palladium(O). It must also be noted that there was no evidence of any allylic
sulfinamides resulting from the intramolecular rearrangement of the starting
sulfoximines in both the 1H NMR spectra of the crude reaction mixture and the
fractions isolated via column chromatography. This absence of allylic sulfinamides
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further indicates that it is the formation of the palladium-allyl complex that is rate
determining step in the reactions with lithiated B0C2NH.

A point of interest here is the reactions between the lithium salt of B0C2NH (106) and
the sulfoximines (92) and (93). In both reactions the extended reaction time allowed
the metallated amine to cleave the benzoyl moiety of the molecule. This led to the
subsequent formation of the allylic amine (100) via a palladium(O) catalysed
amination. The allylic amine (100) was the only product from both reactions that
could identified definitively. A possible mechanism for the cleavage of the benzoyl
group of 2-(A/-tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-one (93) is
shown in S c h e m e 3.1 below.

1
F
o=s=r^JTs

%Jx> /Ri
O

(T) NBoc 2

©NBoc2

(9 3)

NBoc2

1. H

Ph
I
0=S=NTs

+

2. Pd(0),
Boc2N©©Li

•X
Ph

NBoc 2

(43)

(100)

S c h e m e 3.1: Mechanism for the Cleavage of the Benzoyl Moiety from

(93)
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The cleavage of the benzyl alcohol moiety from the alcohol (92) is likely to follow a
retro-aldol pathway as shown in Scheme 3.2 below. The alcohol is deprotonated by
the lithiated B0C2NH (106) to form the anion which then undergoes a retro-aldol

reaction to form the lithiated allylic sulfoximine (43). This species is protonated t

undergoes the palladium(O) catalysed allylic amination to form the diprotected allyli

amine (100).

Ph

Boc2N0©Li

Ph

Boc2NH

0=S=NTs J_

Ph
I
0=S=NTs

Ph
I
Ci=S=NTs

©

Boc2N0© Li
Pd(0)
Boc2N3© Li

(4 3)

NB0C2

(10 0)
S c h e m e 3.2: Possible Mechanism of Cleavage of the Benzyl Alcohol
Moiety

from (92)

The low yield of the product allylic amine (100) from substrates (92) and (93) is
probably due to other side reactions involving the anionic allylic sulfoximine (43)
intermediate.
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Between

the Sulfinamide

Nucleophile and

an

External

Nucleophile

As noted in Section 2.4, it was possible that the formation of the allylic sulfinamide
from the intermediate palladium complex is reversible. If this was the case then it
should be possible to firstly form the allylic sulfinamide, then react this with an
external nucleophile in a two step reaction. This would help give a further indication as
to whether the formation of the allylic sulfinamide was reversible.

The allylic sulfoximine A/-tosyl-S-phenyl-S-(2-propenyl)sulfoximine (91), was
treated with Pd(PPh3)4 (5 mol%) in anhydrous THF for 15 minutes to give a bright
red solution. After removal of the solvent the allylic sulfinamide was put on a very
short column of silica gel to remove the palladium. After checking the H NMR
spectrum to ensure that no starting material remained the allylic sulfinamide (107)
was retreated with Pd(PPh3)4 in anhydrous THF, only this time dibenzylamine (1.1
equivalents) was added and stirring continued for 10 minutes. After the standard
workup only the diprotected allylic amine (99) was observed in the H NMR
spectrum.
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O

Ts
Pd

>p

NTs

h

(

PPh

3>4

,c

i

TUI=
THF
15 mins

'

*~ ^ ^ ^

S(0)Ph

>

(9 1)

(10 7)
Pd(PPh3)4
Bn2NH
10 mins
^^x/NBn,
(9 9)

The sole formation of the allylic amine (99) plus observation that the diastereomeric

ratio of allylic sulfinamides changes over time would seem to indicate the formati

the allylic sulfinamide from the intermediate palladium complex is reversible. The

electron withdrawing ability of the two substituents on the sulfinamide nitrogen m

it a good leaving group willing to accept the electrons associated with the bond c
during the oxidative addition process.

PhSlOKS+^Ts
N

V

Pd

**^

M
\f

The

mechanism

+ PhS(0)NTs

L

for the palladium(O) catalysed allylic amination of allylic

sulfoximines originally shown in Scheme 1.8, therefore needs to be adjusted
accordingly to indicate this reversibility.
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9

R'
0=S=NR

»fR R'S(0)v R

Pd(0)

N

<y

Pd(0)

L

(A)

^L

(C)

(B)

Nuc
Nuc

(D)
S c h e m e 3.3: Adjusted Mechanism
Amination

of Palladium(O) Catalysed Allylic

of Allylic Sulfoximines

The reaction of (B) with the incoming external nucleophile could be expected to be
irreversible, provided the nucleophile does not have strong electron withdrawing
substituents. The irreversibility of the nucleophilic addition drives the reaction
towards the formation of the allylated product (D).

3.5

Palladium(O) Catalysed

Allylic Amination

of Enantiomerically

Pure

Sulfoximines

Optically active sulfoximines can be prepared by fractional crystallisation of the
diastereomeric salts of S-methyl-S-phenyl-sulfoximine (77) with (1S)-(+)camphor sulfonic acid, followed by neutralisation with base, to provide the (S)-(+)1 ?fi

S-methyl-S-phenyl sulfoximine (77) in e.e. > 9 9 % .
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_.|[
, . ^ „ A 1- fractional crystallisation
if
P h - S - M e + (+)-CSA —
i
*- P h - S - M e
NH NH
(±)"(77) (+).(77)

The (S)-(+)-S-methyl-S-phenyl-sulfoximine

(+)-(77) was protected with a tosyl

group and following the method outlined in Section 3.2 the (S)-AMosyl-S-phenylS-(1-cyclohex-1-enylmethyl)sulfoximine (95) was prepared. This compound was

then diastereoselectively methylated with LDA and methyl iodide to furnish optical
active (S,S)-/V-tosyl-S-phenyl-S-(1-cyclohex-1-enylethyl)sulfoximine (98).98

As mentioned in Section 3.3.1 the methylated sulfoximine (98) is very unstable and
cannot be purified. This means any reaction has to be performed in the presence of

unmethylated sulfoximine which accordingly complicates the purification process an
the calculation of the yield.

Treatment of (S,S)-A/-tosyl-S-phenyl-S-(1-cyclohex-1-enylethyl)sulfoximine

(98) with dibenzylamine in the presence of palladium(O), regioselectively gave N,Ndibenzyl-/V-(1-cyclohex-1-enylethyl)amine (105) in a yield of approximately

59% after purification via column chromatography. The product had a specific rotat
of [oc]27D = +4.0 (c=0.9,CHCI3).
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H

H

S-4-Ph
NTs

&/NBn 2

Pd(PPh 3 ) 4 ,Bn 2 NH
-•

THF,RT,10mins

(S,S)-(98)

(S)-(105)

Based upon the mechanism for palladium(O) catalysed allylic amination outlined in
Scheme 1.10 the reaction, between the allylic sulfoximine (98) and the "soft"
nucleophile dibenzylamine, would be expected to occur with overall retention of
configuration. Thus the exocyclic amine (105) should have the (S) stereochemistry
at the chiral centre.

The optically active amine was subjected to H N M R chiral shift studies. A conventional
chiral shift reagent tris(2,2,6,6-tetramethyl-3,5-heptanedionato)europium
(Resolve-AI™) gave absolutely no indication of any enantiomeric purity. However use
of (S)-mandelic acid was much more successful. The H NMR spectra of (105)
(Figure 3.2) prepared from both racemic and optically active sulfoximines was
taken in the presence of (S)-mandelic acid. The doublet for the methyl group, a to the
dibenzylamine functionality, appears as two well defined signals for (105) prepared
from the racemic sulfoximine. Only one doublet appears in the spectrum for (105)
prepared from the optically active sulfoximine. This indicates that the product from
the reaction using the optically active sulfoximine is enantiomerically pure.
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l.ZO

Figure 3.2: Partial

H

NMR

1.15

1.10

Spectra (CDCI3) of Racemic (left) and

Optically Active (right) (105) Showing Methyl Doublets in the
Presence of (S)-Mandelic

3.6 Palladium(O) Catalysed Allylic Amination

Acid

Utilising a Chiral Ligand

In principle it should be possible to control the enantioselectivity of the allylic
amination reaction by use of a chiral ligand. The use of achiral ligands leads to two
intermediate enantiomeric palladium complexes which can interconvert. These two
enantiomeric complexes will react with an incoming nucleophile at the same rate to
give racemic products.
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R
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x
Pd(0)

Pd(0)

k.i

Pd©
\S

© 'PcL
\f

Nuc k3

R.

k2 Nuc

R'

R

^^X/ R'

Nuc
Scheme

^L

Nuc

3.4: Interconversion of Intermediate Palladium

Complexes

However the presence of a chiral ligand coordinated to the palladium creates two
diastereomeric intermediate complexes which can react with the incoming nucleophile
at differing rates. If both k2 and k3 are slower than the interconversion (ki and k.-|)
then there will be a preference for the formation of one enantiomeric product over the
other provided k2 is different to k3.

There are m a n y chiral ligands available for use in all types of transition metal
catalysed reactions. These ligands include ferrocene derivatives (108), 127 binapthyls
(109), 128 and even sulfoximine derivatives (110) 129
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(109)

(108)

(110)

It w a s decided to utilise the phosphino-oxazoline chiral ligand (111) based upon the
excellent results that have been obtained with ligands of this type in palladium(O)
130
catalysed allylic aminations.

Ph 2 P

The active palladium complex is formed by reacting the oxazoline ligand (111) and the
dimer [Pd(rc-allyl)CI]2. Since the palladium is in the (+2) oxidation state it needs to

be reduced down to the zero oxidation state. If the palladium is not in the zero oxidatio
state it will not be able to undergo oxidative addition which is the first step in the
allylic amination process (see Scheme 1.10). This reduction is performed in situ
using a reductive elimination process. The incoming nucleophile, which in this case is
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dibenzylamine, attacks the allyl ligand which then undergoes reductive elimination to
provide the allylic amine (99) and the palladium in the zero oxidation state.

+

Bn 2 NH
• ^fX^NBn2
Pd(0)

Pd(ll)

• ^X^NBn2

+ pd(0)

The reaction of the allylic sulfoximine (88) with dibenzylamine in the presence of the
chiral ligand (111) and palladium(O) proceeded much more slowly when compared to
the rate of reaction for when triphenylphosphine was used as the ligand. After being
stirred at RT overnight only a small amount of product (103) had been formed
according to the TLC of the reaction mixture.

Ph
I
0=S=NTs
Ph

[Pd(jI.a||y|)C|]2i (1

Bn 2 NH, RT, T H F
(88)

! 1}
*>

NBn 2
Cs^ {
(103)

The slowness of the reaction is probably due to the nature of the ligand. In an
investigation into the influence of ligands on the rates and regiochemistry, Akermark
et al. found that ligands with greater rc electron accepting abilities such as
triphenylphosphine increase the rate of the reaction when compared to sulfur and
nitrogen containing ligands. This is due to the ligands drawing electron density away
from the metal and hence increasing the overall positive character of the allyl
ligand.131 The chiral oxazoline contains one phosphine but it also contains a nitrogen
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which participates as a ligand. Thus the reaction with the oxazoline ligand is slower
than the corresponding reaction with triphenylphosphine.

Despite being incomplete the reaction was worked up in order to investigate the
enantioselectivity of the product produced. The H NMR spectrum of the crude reaction
mixture confirmed that only a small amount of product had formed and the majority of
the reaction mixture was still starting material. It also showed the presence of the
allylic amine (99) formed during the reduction of the palladium(ll) to palladium(O).

22
The

purified

product

( 1 0 3 ) had

a specific rotation of [a]

D = +12.2

(c=0.475,CHCl3) which indicated that it was not racemic. H NMR studies of the
product (103) with chiral shift reagents including tris(2,2,6,6-tetramethyl-3,5heptanedionato)europium (Resolve-AI™) and tris(6,6,7,7,8,8,8-heptafluoro-2,2dimethyl-3,5-octane-dionato)europium (Resolve-AI EuFOD™) were inconclusive as
to the enantiomeric purity of the compound. The only effect of the shift reagents was to
move the signals of the double bond downfield so that they were hidden under the signals
belonging to the aromatic rings.

It was then attempted to resolve the product via a chiral HPLC column. The column used
was a Regis Pirkle column using D-A/-(2-naphthyl)alanine covalently bound to 11undecyl silica. The column is manufactured specifically to separate amines, amino
acids and alcohols. Chromatographic separations were attempted with the product
(103) prepared not only with the chiral oxazoline ligand (111), but also with
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triphenylphosphine as the ligand. All attempts at resolving the racemic compound were
unsuccessful, even in solvents of low polarity (0.5% ethyl acetate/petroleum spirit)
the product (103) came off the column very quickly as one peak.

Later attempts to resolve these compounds on a range of Chirasil HPLC columns by
collaborators in Prof. H. Pfaltz's group at Muelheim were also unsuccessful.

Possibly the reason for the failure of the chiral HPLC column to separate any
enantiomers is due to the sheltered nature of the single chiral centre in the molecule.
The chiral centre is surrounded by a phenyl ketone on one side, a pentyl chain on the
other and an amine protected with two bulky protecting groups. The steric bulk of the
molecule also shelters the nitrogen making it difficult to interact with the D-/V-(2naphthyl)alanine of the column. Thus the enantiomeric excess of the amine could not be
determined and hence the selectivity induced by the chiral oxazoline ligand is at
present unknown.

3.7 Palladium(O) Catalysed Amination Utilising Chiral Amines

Another method to theoretically induce asymmetry into the allylic amination reaction
is the use of chiral nucleophiles. As shown in Scheme 3.4 the oxidative addition of
palladium to the allylic substrate produces two enantiomeric complexes when the
ligands are achiral. The incoming chiral nucleophile will have a preference for one of
the enantiomeric complexes thus leading to an excess of one diastereomeric product.
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The initial reaction tried w a s with A/-benzyl-A/-a-methylbenzylamine (112) as the
nucleophile and 2-(A/-tosyl-S-phenylsulfoximidoyl)-1-phenyl-non-3-en-1-one
(88) as the substrate.

0=S=NTs

W,-^V

ffi +

4

Pd(PPh3)4

* H ** X~RT~' NOreaC"°n

o
(88)

Despite

its apparent

(112)

similarity

to

dibenzylamine,

the

A/-benzyl-/V-cc-

methylbenzylamine (112) did not react with the substrate (88) even after being left
to stir overnight with palladium(O). Both the amine and the allylic sulfoximine were

recovered intact. Rather than spend time tracking down the reason for the failure of the

reaction it was decided to try a different chiral amine. It was decided to proceed using
the less sterically hindered cc-methylbenzylamine (113). *

F ?H3 X^H
H^ pA* P^3)4

r

" ^

^ ^ . ^ A ^Ph +Ph
C5H11^[f^ ™F'RT C5Hl 1'
0
(88) (113) (114)

NH2

*-

An interesting result was obtained for the reaction between (S)-cc-methylbenzylamine
(113) and the allylic sulfoximine (88). The allylic amine (114) cyclised to produce
the substituted pyrrole (115) in a yield of 67%.
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Ph

^ ; + ^ rH 2 ^ ^ "Ff

O5H1 f

THF, RT

Ph

Cs^1

O

(8 8)

H 1 3)
(S)-(1

C5Hi A NNA p h

O

(114)

^_

H3cAph

H<Sh/^Ph
H3C

Ph

(115)

The structure of (115) was assigned from its H N M R spectrum, as shown below in
Figure 3.3, which showed two doublets (J=3.6Hz) at 86.2 and 6.0 corresponding to
the two pyrrole protons. The proton at the chiral centre adjacent to the nitrogen

appears as a quartet at 85.6 when it would be expected to be 83-4 for the allylic
(114). There was also no doublet and doublet of doublet at approximately 87-7.1,

where the two olefinic protons of the allylic amine (114) would be expected to ap

Figure 3.3: Partial

H

NMR

Spectrum

(CDCI3) of the Pyrrole (115)
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Only one previous case where a similar reaction occurred has been reported. In 1980,
Trost et al. reported that the allylic acetate (116) spontaneously cyclised to the
1 32
pyrrole after undergoing a palladium(O) catalysed allylic amination.

?* Pd(PPh3)4, BnNH, , \\
pfi Y

°
(116)

(47%)

toluene, A

™

X
N

^

k
^Ph
(117)

It must be mentioned that the conditions employed by Trost et al., of refluxing in
toluene, are m u c h more harsh than those used with allylic sulfoximines. This is due to
the use of an acetate as the leaving group for the allylic amination step.

3.8 Comparision of Reaction Conditions with Allylic Sulfones

The reaction conditions required for the intramolecular and intermolecular
rearrangements of allylic sulfoximines are m u c h milder than those for c o m m o n
leaving groups such as allylic acetates. It was decided that it would be preferable to be
able to compare the reactivity of the allylic sulfoximines in the allylic amination
reaction to similar compounds. Therefore the known allyl phenyl sulfone (118) was
®
thus prepared by oxidation of allyl phenyl sulfide (119) with Oxone .
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°

iPPh
*~ <^^h
O
(119)

(118)

The sulfone (118) w a s treated with Pd(PPh3)4 and dibenzylamine in refluxing
anhydrous THF overnight. After removal of the solvent in vacuo, the 1H NMR spectrum
showed only starting material.

O
I Pd(PPh3)4, BnNH2 Nlnroaotinn
>. ™
•
THF, RT, O/N
0
II Ph

No reaction

Thus when compared to the reaction conditions of 10 minutes at R T for the equivalent
sulfoximine, this experiment showed that the reaction conditions required for the
amination of allylic sulfoximines are very mild.

3.9

Conclusion

This chapter showed that it is possible to use an external amine instead of the
sulfinamide anion as the incoming nucleophile in the palladium(O) catalysed amination
of allylic sulfoximines. The reactions proceed under mild conditions to provide the
allylic amines in acceptable to good yields.
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Further evidence was obtained to show that the formation of allylic sulfinamides from
allylic sulfoximines is reversible. It was also shown that the use of optically active
sulfoximines can lead to optically active allylic amines. The use of a chiral ligand in the
palladium(O) catalysed intermolecular rearrangement produced an allylic amine that
was not racemic, however the enantiomeric excess was not able to be determined.

Extended treatment of the allylic sulfoximine (88) with palladium(O) and (S)-ocmethylbenzylamine allowed the allylic amine product to undergo spontaneous
cyclisation to furnish the substituted pyrrole (115).

A comparision of the reaction conditions required for allylic amination, showed that
allylic sulfoximines react under much milder conditions compared to the structurally
similar allylic sulfones.

CHAPTER 4
SYNTHESIS OF AZASUGARS
FROM ALL YLIC SULFOXIMINES
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Introduction

The first proposed pathway for the synthesis of azasugars was outlined in S c h e m e
1.7 (see Chapter 1). This chapter documents the attempts to bring that scheme to
fruition. The actual target chosen as a model system was the aryl azasugar (120).
This is structurally similar to the natural products codonopsine (121), 1 33
codonopsinine (122)

HO

33

and anisomycin (123).134

OMe

OH

OMe
(120)

(121) R = O M e (122) R=H

(123)

4.2 Choice of Protecting Group for the Nitrogen

Since the final cyclisation involves the reduction of a cyclic imine formed in situ from

a y-amino-oc.p-dihydroxy ketone, it was decided that the protecting group for the

nitrogen in the y-amino-cc,p-dihydroxy ketone should be cleavable under reductive
conditions.
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NR 2

OH

Ph
OH

NH 2

[H]
O

OH

•
OH

O

[H]
HO

OH

xA
H

The two main contenders for the role of protecting group were the benzyl (Bn) and the

carbonylbenzyloxy (Cbz) groups. As the benzyl protecting group was an ele

donating group, it could only be introduced as an external nucleophile (s

3). While the Cbz group as an electron withdrawing carbamate would be eas

introduce as the protecting group of the sulfoximine nitrogen in an intra
allylic sulfoximine rearrangement.

Since work had already be done on the amination of allylic sulfoximines with

dibenzylamine to provide y-amino-oc,p-unsaturated ketones (see Chapter 3)
decided to follow this route.

Chapter 4

108

4.3 Synthesis of Azasugars

Utilising a Palladium(O) Catalysed Allylic

Amination of an Allylic Sulfoximine

2-(/V-Tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-one

(93) w a s

prepared and subjected to an intermolecular palladium(O) catalysed allylic amination
with dibenzylamine as outlined in Chapter 3 to give the y-amino-a,p-unsaturated
ketone (102).

Ph
i

0=S=NTs

NBn2

Pd(PPh3)4. Bn 2 NH

f

L X ~

THF, RT, 10 mins ^^ ]f
O O
(93) (102)

The ketone (102) could also be produced by the oxidation of the A/,A/-dibenzyl-4amino-1-phenyl-but-2-en-1-ol (101), which can be prepared by'the allylic
amination of the corresponding p-hydroxy sulfoximine (92). Oxidation with
pyridinium dichromate in DCM at RT overnight gave the ketone (102) in 53% yield. A
much better yield was obtained with Jones reagent in acetone which gave the ketone
(102) in a yield of 98%.

^ PDC, DCM (53%) V3"2

^Y^ oT * W"
L

(101) (102)

Jones reagent, acetone (98%)

^

Chapter 4

109

With the y-amino-a,p-unsaturated ketone (102) in hand there were two final steps
in the synthetic pathway to azasugars. These two steps were dihydroxylation and
cyclisation.

The y-amino-a,p-unsaturated ketone (102) w a s subjected to standard Sharpless
asymmetric dihydroxylation conditions of either AD-mix a or AD-mix p in tert135
butanol/water in the presence of methanesulfonamide.

After stirring at 0°C for 11

days the TLC of the reaction mixture indicated complete consumption of the starting
material, which was verified by the 1H NMR spectrum of the crude reaction mixture
after work-up.

AD-mix a or p
MeS02NH2

NBn2

.Ph

^
f-BuOH/H20
0°C, 11 days

(102)

NBn2 O H

A^A^
^<

fl^
Q_|

0

c/s-diol (124)

The 1H NMR spectrum of the crude reaction mixture showed what appeared to be
possible product (124). However when subjected to column chromatography this
could not be isolated in a pure form. The 1H NMR spectra of the isolated fractions
indicated that there were more impurities in the "purified" sample than there were in
the crude reaction mixture. Successive attempts to purify the compound further on
another column and on a TLC plate also failed to furnish pure product.
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In an attempt to procure a possibly more stable derivative the crude diol (124) w a s
treated with acetic anhydride and pyridine in anhydrous DCM to form the diacetate
(125).

NBn 2 O H

A c 2 0 , pyridine

Ph

X

NBn 2 O A c

•

k

A^ ^Ph

D C M , RT, O/N
OH

O

OAc O

(124) (125)

However the

H N M R spectrum of the crude reaction mixture w a s inconclusive as to

whether the diacetate (125) had been formed, nor did any fraction isolated by column
chromatography appear to be the desired product. It is possible that due to the basic
A/,/V-dibenzyl amino group that the desired product (125) underwent elimination to
the alkene (126) which could then undergo further reactions to an unknown final
product.

.'TA
^ ^ OAc

0,H
**¥ ? A c

Bn2

V*r*
'°%

•

+

A-

I A .Ph +Ac0Q

< OAc O

O

Bn2N

OAc
O
(12 6)

+ AcOH
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Attempts to deprotect the amine functional group of the crude diol (124) with H2 and
palladium on carbon in methanol gave a complex mixture of compounds whose 1H NMR
spectra when isolated, did not resemble any imaginable products.

NBn2 OH 1Q% pc/c.H^g) % /**

Uv^—x > r\
l
*>
OH

[|
ll
O

M e O H , RT.O/N

X

•'H*^
N
Ph
H

(124) (127)

A likely explanation for these difficulties is the oxidation of the tertiary nitrogen by
either the OSO4 or K3Fe(CN)6 in the reaction mixture to form a highly unstable
compound. If this is the case then there are several options for what the unstable and
unisolatable product might be. If oxidation of the nitrogen occurs at a similar reaction
rate to the dihydroxylation of the alkene then the product would most likely be the
amine A/-oxide (128).

OH

O

(128)

This compound could then undergo a Cope elimination to give the N,Ndibenzylhydroxylamine (129) and the alkene (130) which could undergo further
reactions.

Chapter 4

112

BnN ^C©
Nw J OH

OH

Bn*

YV'

-• Bn2NOH + -V
OH O
(129)

"

-P"

(130)

However if the nitrogen oxidation is faster than the dihydroxylation then there are
several different possible products. The allylic amine /V-oxide (131) produced can
137
undergo

a

Meisenheimer

rearrangement

via either allylic or benzylic

rearrangement to the corresponding hydroxylamine derivatives (132) and (133).
The hydroxylamine derivatives (132) and (133) could then be dihydroxylated or
undergo further decomposition to unknown products.

NBn 2

Os04

(13 1)
allylic
rearrangement

benzylic
rearrangement.

X>^

Bn 2 N N

.Bn

(133)

(132)

S c h e m e 4.1: Possible Meisenheimer Rearrangements of Allylic A m i n e NOxides
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It was decided at this point not to investigate whatever product was being formed in the
dihydroxylation of the allylic amine (102) and instead to pursue the strategy of using
Cbz as the protecting group for the nitrogen. This entailed the synthesis of an allylic
sulfoximine with a Cbz protecting group and utilisation of the palladium(O) catalysed
intramolecular rearrangement of the allylic sulfoximine.

4.4 Synthesis of Azasugars Utilising an Intramolecular

Rearrangement

of an Allylic Sulfoximine

The unprotected S-phenyl-S-(2-propenyl)sulfoximine

(39) w a s synthesised

go

according to a literature procedure.

The allylic sulfoximine (39) was then treated

with benzyl chloroformate, pyridine and a catalytic amount of 4dimethylaminopyridine in anhydrous DCM to give A/-(benzyloxycarbonyl)-S-phenylS-(2-propenyl)sulfoximine (134) in 70% yield.

O ff
J!
^^ff-Ph
NH

Cbz-CI, pyridine, D M A P
D C M , 0°C->RT,70%

-. s ^ „
• ^ ^ ^ n Ph
NCbz

(39) (134)

The protected allylic sulfoximine (134) was deprotonated with n-BuLi and allowed to
undergo oc-1,2 addition to benzaldehyde to give the p-hydroxy allylic sulfoximine
(135). In accordance with the observations of Pyne and Boche there was no y-1,2
addition,82 which would have been easy to detect in the H NMR spectrum by the
presence of an alkyl CH2 as well as a doublet for one of the vinyl protons. The alcohol
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(135) w a s then oxidised with Jones reagent in acetone to give the p-keto allylic
sulfoximine (136) in 62% yield. The product was isolated as an inseparable 71:29
mixture of diastereomers as determined from the integration of the proton a to the
sulfoximine in the H NMR spectrum.

"

1 .n-BuLi,THF,-78°C

(13 4)

(13 5)
Jones reagent
acetone
Ph
I

0=S=NCbz

(13 6)

The p-keto allylic sulfoximine (136) was then subjected to an intramolecular
palladium(O) catalysed rearrangement followed by cleavage of the sulfinamide group
with triethylamine in methanol as outlined in Chapter 2.

Ph
I
0=S=NCbz

-i. P d ( p p h 3 ) 4 i T H F , 30min
2. Et3N, M e O H , 30min

O
(136)

(137)
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As expected only the primary allylic amine (137), in a yield of 6 2 % , was observed in
accordance with previous results. This was confirmed by the 1H NMR spectrum which
showed the allylic CH2 next to the double bond as a doublet of doublets (J=1.5,4.2Hz)
at 84.077.

The asymmetric dihydroxylation of the allylic amine (137) proceeded very smoothly
under standard Sharpless conditions 135 using either AD-mix a or AD-mix p with
methanesulfonamide at 0°C overnight to afford the y-amino-cc,p-dihydroxy ketones
(138) in reasonable yields and excellent enantioselectivity. The specific rotations of
the two products (138a and 138b) had opposite signs but did not have equal
magnitude. This suggested that (138a) and (138b) were enantiomers but had
different enantiomeric purities.

AD-mix a, M e S 0 2 N H 2
Cbzx

M

Cbz^..^H
N*"

OH

Ph

f-BuOH/H20, 0°C, 24hrs

NT

OH
(13 8 a)

(137)

AD-mix p, M e S 0 2 N H 2

Cbz.. M
N

O

OH

f-BuOH/H20, 0°C, 24hrs

Product Yield (%) e.e.
Specific rotation
AD-mix a 13 8a 66 >95% +17.3° (c=1.3,CHCI3)
AD-mix p 138b 73 >99% -11.3° (c=3,CHCI3)

Table 4.1: Asymmetric

Dihydroxylation of the Allylic A m i n e

(137)
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The enantiomeric excesses of (138a) and (138b) were determined from 1H NMR
studies using the chiral shift reagent tris(6,6,7,7,8,8,8-heptafluoro-2,2dimethyl-3,5-octanedionato)-europium (Resolve Al EuFOD™) as well as (-)camphor sulfonic acid. The H NMR spectra taken using Resolve Al EuFOD™ were
inconclusive with regards to the enantiomeric excess. However use of the (1fi)camphor sulfonic acid was much more successful. The two spectra shown in Figure
4.1 display the two methyl groups of (1F?)-camphor sulfonic acid. The left hand
spectrum is for the AD-mix a product and shows a possible second enantiomer between
the peaks for the major enantiomer. The enantiomeric excess was thus characterised as
being greater than 95%. The right hand spectrum is for the AD-mix p product and
shows only one set of peaks, thus the enantiomeric excess was characterised as being
greater than 99%. The enantiomeric purities are not consistent with the magnitudes of
the specific rotations found for these compounds, which suggests the presence of an
optically active impurity in either one or both of the compounds.
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Figure 4.1: Partial

H NMR

Spectra (CDCI3) Showing the Methyl Groups

of (1/?)-Camphor Sulfonic Acid in the Presence of the AD-mix cc Product
(left) and the AD-mix p Product (right)

The isolated diols (138a and 138b) were oils and therefore unsuitable for X-ray
crystal structure analysis. There were also no significant nOes in the 2D nOesy
spectrum that gave a clue to the stereochemistry. Therefore this has been assigned by
analogy to the work by Reetz et al. on mono-Boc protected y-amino-cc,p-unsaturated
esters (139).138
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Boc^. JH
1ST OH

*cArAr
0

OH

Boc.
M
#X
N-

(140a)
+

OEt

H3CV

Boc^

O

N^

OH
,OEt

H3C^'

(13 9)

0

OH

(140b)
140a:140b
AD-mix a
97:3
AD-mix p 9:91

Table 4.2: Asymmetric

Dihydroxylation of Mono-Boc Protected y-

Amino-a,p-Unsaturated

Esters

The final steps in the synthetic pathway were the deprotection of the nitrogen, followed

by cyclisation to the imine and subsequent reduction to give the pyrrolid

Cbz.
X

H.

M
N^

>T

OH

Ph
OH

HO.

H

O

OH

UPh

OH
Ph

* sx
OH

HO

O

.OH

UY
Ph
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Initially the (2F?,3S)-/V-benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenylbutan-1-one (138b) was treated with 10% palladium on carbon in methanol under a
balloon of H2(g). After stirring for 24 hours, 10% HCI(aq) was added and stirring
continued for 1 hour. After working up the reaction mixture, the 1H NMR spectrum
showed no starting material. However there were no signals in the spectrum that
corresponded to what would be expected for the product (141). Nevertheless in the
hope that some product might be in the mixture it was placed on an ion-exchange
column. However no product could be detected in the H NMR spectrum of the fractions
obtained from the column.

O b z v ^W
OH 1. 10% Pd/C,H2(g),MeOH \ ^

ph X
2.HCI
OH O 3. ion exchange H

JDH,

HO

~ LX,

(138b)

X

N^

Ph

(141)

Next it was decided to try transfer hydrogenation which is reputedly a faster and more
139
efficient method than traditional hydrogenation methods.

The diol (138a) was

140
treated with 1 0 % palladium on carbon and formic acid in methanol.

After 24 hours

no reaction could be detected by TLC so the reaction was worked up. The H NMR
spectrum of the crude reaction mixture confirmed that there was only starting
material present.
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Cbz^.X
N"

OH

1

W

10%Pd/C,HCOOH
•

Ph

No reaction

MeOH

OH O

(138a)

The next method tried was the use of ammonium formate in methanol in the presence of

10% palladium on carbon. Again after 24 hours no reaction had occurred a
starting material was present.

Cbz>^ M
^K
OH
W 1 0 % P d / C , H C O O N H
Ph
MeOH
OH O

4

•

No reaction

(138a)

The third transfer hydrogenation method used was 1,4-cyclohexadiene in methanol,
142
again in the presence of 10% palladium on carbon.

This method produced a complex

mixture of compounds after stirring at RT for 24 hours. None of the frac

via column chromatography resembled the desired product in their H NMR s

Cbzv

M

N

,/X

OH

10%Pd/C, O

i^r ^ — > < ^
i T MeOH
OH

V
N

O

(138b) (141)

HO

OH

\.*

>

r\

Ph
H
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Next the palladium catalyst was changed from 1 0 % palladium on carbon to palladium

black. This was prepared by reduction of palladium(ll) chloride to elemen
palladium(O) following a literature procedure.143 Treatment of the diol (138a) with
palladium black in methanol under a balloon of H2(g) again only produced a mixture of

compounds that did not include either the product or starting material. T

was also obtained with (138b) using palladium black with 1,4-cyclohexadie
methanol.

Cbz^ ^ H
N
OH

HO.

Ph

X —
MeOH

OH

OH

Pd black,H2(g)

0

xA
H

Cbz^

(138a)
M
N
OH

Pd black, f l

(141)
HQ <DH

X —
OH

O

MeOH

(138b)

(141)

Regrettably at this point the synthetic path had to be abandoned due to the pressing need

to begin the thesis write-up and the need to synthesise more of the start

(39) in order to procure more of the diol (138). However, it should purely

matter of determining the correct reaction conditions in order to deprote
the diol (138) to form the azasugar (141).
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4.5 Conclusion

Initial attempts to synthesise azasugars utilising the palladium(O) catalysed allylic
amination of (93) with dibenzylamine, faltered when the asymmetric dihydroxylation
of the allylic amine (102) provided an unisolatable product.

A switch to the use of the intramolecular allylic rearrangement of the allylic
sulfoximine (136) provided the allylic amine (137). The asymmetric
dihydroxylation of (137) gave the diols (138a and 138b) with excellent

enantioselectivity. However all attempts to deprotect the amine functionality failed an
disappointingly the synthetic pathway had to be abandoned at a point when it seemed so
close to coming to fruition.

CHAPTER 5
SYNTHESIS OF AZASUGARS
FROM CARBOHYDRATES

Chapter 5
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Introduction

The second proposed synthetic pathway for the synthesis of azasugars was outlined in
Scheme 1.9 and has a carbohydrate as starting material. As mentioned in Chapter
1, carbohydrates are very popular starting materials due to their cheapness and

availability, the already present stereogenic centres, availability of cyclic and ac
forms, different chain lengths, and different oxidation states.41'65'67'68 This chapter
documents the attempts to bring the synthetic pathway to fruition.

5.2 Chain Extension of a Lactol

The lactol (142) was formed by the reduction of the commercially available (-)2,3-isopropylidene-D-erythronolactone (143) with DIBAL in DCM at -78°C
1 44
following

a

literature procedure.

The lactol (142) was not purified, but

inspection of the H NMR spectrum of the crude reaction mixture indicated the
diastereomeric ratio of the products was approximately 95:5.

oA
*

f

cXo
DIBAL, D C M

A

f

/ V -78°C, 2hrs / \

S^O A^OH
(143)

(142)

The crude lactol (142), which is in equilibrium with the hydroxyaldehyde (144),

was then subjected to a Grignard addition. As pointed out in Chapter 1 this is a highl
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diastereoselective reaction with the products having anti stereochemistry between the
carbinol carbon and its adjacent stereogenic carbon. In this case vinyl magnesium
bromide was added to the crude lactol (145) in THF at 0°C to give the vinyl diol.
Inspection of the H NMR spectrum indicated that only one diastereomer was formed in
the reaction.

oX)

cXo
/

/ \

x
HO^

OH
VX^nn

m

(142)

\

THF, OX

oAl
O^H

X X HX

(144)

(145)

Again this compound was not purified, but instead was protected as the dibenzoate
(146) using benzoyl chloride, pyridine, and a catalytic amount of 4dimethylaminopyridine in anhydrous DCM. The overall yield for the 3 steps was 51%
after purification by column chromatography of the dibenzoate (146).

BzCI, pyridine, D M A P
HO

H Of
(145)

X =

DCM, 0->RT y>
'

vV.

BzO^BzO'
(146)
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Palladium(O) Catalysed

Allylic

Amination

The next step of the proposed synthesis involved converting the secondary benzoate
(146) into a primary amine (147). This was achieved by utilising the palladium(O)
catalysed allylic amination reaction, the mechanism of which was outlined in Scheme
1.10

X

X
BzO

BzO'BzO

NR2
(147)

(146)

In this instance the nucleophile used was the lithium salt of B0C2NH. 125 The dibenzoate
(146), the palladium(O) catalyst and the lithiated carbamate in T H F were heated to

50°C and stirred overnight. The reaction was worked up to give the A/,A/-diprotected
primary amine (148) in 69% yield after purification by column chromatography.

x
1

B z O ' B z Otf "

(146)

Pd2(dba)3, Ph 2 P"
B002NH, n-BuLi
THF, 50°C, O/N

,PPh2
•

BzO

NBoc 2

(148)

Only the protected primary allylic amine (148) was observed in the reaction. There
was no isomeric protected secondary amine visible in either the H N M R spectra of the
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crude reaction mixture or in any of the fractions isolated via column chromatography.
This was as expected as any secondary amine would come from attack of the nucleophile
at the more sterically hindered terminus of the palladium-ally! complex.

The alkene exclusively formed the (E) stereochemistry around the double bond as
evidenced by a coupling constant of J=15.3Hz between the olefinic protons in the 1H
NMR spectrum. There was no evidence indicating the existence of the (Z) isomer.

Although it was not explored in this work, it should be possible to utilise other
nucleophiles in this reaction. In such a manner other analogues could be produced with
atoms like sulfur or phosphorus or even carbon at the primary position.

5.4 Dihydroxylation of the Allylic Amine (148)

The allylic amine (148) was dihydroxylated smoothly under both standard Sharpless
conditions,135 with either AD-mix a or AD-mix p and methanesulfonamide at 0°C
overnight, or by treatment with potassium osmate and /V-methyl-morpholine-/V-oxide
at 0°C overnight. These reactions gave a separable mixture of the diastereomeric
oxazolidones (149a) and (149b).
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BzO

X
BzO

Q

O

(14 8)

\

(149a)

Boc

"Os"
f-BuOH/H20, 0°C
NBoc'2
2

k

BzO HO^N
(149b)

\=0
^N
Boc

"Os"
Yield(%)14 9a:14 9b
AD-mix a, CH 3 S0 2 NH 2 61
72:28
54:46
AD-mix p, CH 3 S0 2 NH 2 66
K20s04.2H20, N M O
48
0:100

Table 5.1: Dihydroxylation of the Allylic Amine (148)

135 when there is a nitrogen
In accordance with previous work by Sharpless et al.
protected with two Boc groups in the allylic position, one of the Bocs will cyclise under

the reaction conditions to give the oxazolidone product. The mechanism of

to involve attack of the alkoxide anion upon the carbonyl group of the Bo
subsequent ejection of the ferf-butyloxy anion. The cyclisation provides
selectively differentiating the two newly formed hydroxyl groups.
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©oX-X°P o_t.Bu
L

r<7

Boc
Boc

S c h e m e 5.1: Cyclisation of the Dihydroxylation Product

The oxazolidone structure was determined via N M R spectroscopy. The integrals of the
signals in the H NMR spectrum indicated that the singlet for the Boc methyl group had
only 9 protons instead of the 18 required for two Boc groups. There was also a slight
upfield shift for the carbonyl carbon in the 13,
C N M R spectrum. The oxazolidone
carbonyl appears at 8149.3 compared to the Boc carbonyl at 8152.1. The low
resolution mass spectrum also indicated the loss of the terf-butyl portion of the Boc
group with the [M+Na]+ peak occurring at m/z 474.0 instead of m/z 548.

This type of cyclisation is not seen when the nitrogen is only monoprotected with one
Boc group. Reetz et al. dihydroxylated the mono-Boc protected allylic amine (139) as
shown below and did not report any cyclisation.138 The second Boc group is clearly
needed to make the cyclisation a facile process.
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Boc*. ^M
N— OH

OH O

Boc^ ^ H

(140a)

AD-mix a or p

+

Boc^

^H

N^

OH

CEt

H3C\^

(13 9)

OH
O
(1 4 0b)

The stereochemistry of the products have been assigned by 2D nOesy N M R

spectroscopy. For the compound (149a) there exists a nOe between the free

proton and the proton next to the acetonide group as shown in the spectra
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Figure 5.1: Partial Negative 2D nOesy Spectrum (CDCI3) of (149a)
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This n O e interaction was not seen in the corresponding 2 D nOesy spectra for (149b).
Furthermore there is a coupling constant of J=7.5Hz between HT and H2' in (149a),
compared to J=3.1Hz for (149b), indicating that HT and H2' are trans to each other
in (149a).

Boc

Molecular modelling using Insight II (Biosym/MSI) generated the lowest energy
conformations of the possible products arising from the dihydroxylation of (148),
portions of which are shown below in Figure 5.2. The top model shows the product
(149a) arising from attack of the osmium at the bottom face of the alkene while the
second model shows the product (149b) arising from attack from the top face. The
numbers associated with the dotted lines indicate the calculated distances in angstroms
between the free hydroxyl group and some of the nearby protons.

Although the models are purely theoretical in nature, they do support what is observed
in the 2D nOesy experiments. For (149a) the free hydroxyl group is approximately
2.52A from H2', while for (149b) the separation is 3.40A. It is generally believed
that the limit for nOe interactions is approximately 3A, therefore given the calculated

Chapter S

132

acetonide ring

oxazolidone ring

oxazolidone
ring

acetonide
ring

Figure 5.2: Molecular Models Generated by Insight II S h o w i n g the
Product (149) Arising from Attack from Below (top) and Attack from
Above

(bottom)
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distances, a n O e would be expected between the free hydroxyl group and H2' only for
the product arising from attack at the bottom face of the double bond.

This is indeed what is observed - the 2D nOesy N M R spectrum for (149a) shows this
interaction, while the spectrum of (149b) does not. Furthermore, the dihedral angle
between HT and H2' in (149a) was approximately 175°, while that of (149b) was
approximately 75°, which is also consistent with their respective Jy£' values. Thus
the products (149a) and (149b) would seem to have the stereochemistry as shown
below.

X.
*°V

BzO

Z^ 0

N
Boc
(149a)

BzO^HO^V°\

I^ N /=0
Boc
(149b)

The facial selectivity of the reaction was much better for AD-mix a compared to ADmix p, although neither was particularly good. The predominance of (149a) over
(149b) in the reaction with AD-mix a is consistent with the Sharpless mnemonic
which is designed to act as tool to help prediction of stereoselectivity.
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a-attack
p-attack

a-attack
Figure 5.3: T w o

Possible Orientations of Allylic A m i n e
the Sharpless

(148) Within

Mnemonic

It is not obvious which of the two possible orientations of the substrate is predominant,
but in both of them the acetonide group is pointing above the plane of the double bond.
The stereochemical outcome of the dihydroxylation of (148) in the case of AD-mix a
is consistent with the mnemonic, however in the case of AD-mix p the acetonide would
be expected to hinder attack from the p-face leading to a very poor diastereoselectivity.
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Unlike the reactions with AD-mix a and AD-mix p, the dihydroxylation of the allylic
amine (148) with potassium osmate and A/-methylmorpholine-A/-oxide was
completely stereospecific with only (149b) observed. It would have been expected in
this case that the bulky osmium tetroxide would approach from the sterically less
hindered side to furnish (149a).

In the literature little work has been done on the stereoselectivity of the
dihydroxylation of allylic amines. However, work has been carried out on allylic
alcohols and several theoretical models have been developed. To explain the seemingly
anomalous result obtained from the dihydroxylation of (148) with potassium osmate
and /V-methylmorpholine-/V-oxide, it was attempted to fit the allylic amine (148) to
one of these models.

145
Attempts were m a d e to fit (148) to the Vedejs model

(Figure 5.4) using the

acetonide oxygen as the allylic alcohol as shown in Figure 5.5. In this model, the
osmium attacks the alkene from the same side as the hydrogen a to the alcohol. For
(148) this leads to attack from the bottom face to give (149a).
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Os
/ <

H3C%

/

\ ,H

HO

CH3

Figure 5.4: Vedejs' Model for the Dihydroxylation of Allylic Alcohols

BOC2N—., Hy\
\ /O O
^OBz

Figure 5.5: Allylic Amine (148) in Vedejs' Model

This result with the theoretical model indicates that the dihydroxylation of (148)
with potassium osmate and A/-methyl-morpholine-A/-oxide is likely to be a highly
anomalous reaction. The basis of the selectivity it displays by giving (148b) as the
sole product is difficult to explain using the Vedejs model. Perhaps chelation of the
osmium to one or more of the various heteroatoms in (148) is responsible for the
unexpected stereochemical outcome.

Although the general synthetic pathway was going well it was decided to take a step back
and remove the benzoyl protecting group for the primary hydroxyl group before the
asymmetric dihydroxylation. The rationale behind this was that the base catalysed
1 46
removal of the benzoyl group in (149) would also cleave the oxazoline ring,
thereby removing the selective differentiation of the two secondary hydroxyl groups.
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The alcohol (150) was readily accessable via base mediated debenzoylation of (148),
with 'Woiw/v) NaOH in methanol, in a yield of 83%.

1%NaOH/MeOH
RT, 1 hour

BzO

NBoc 2

NB0C2

(148)

Treatment

(150)

of the alcohol (150) with either AD-mix oc or AD-mix p and

methanesulfonamide under standard Sharpless reaction conditions proceeded very
smoothly to afford the product (151) in good yields.

"Os
f-BuOH/H20, 0°C
NBoc 2
(15 0)

"Os"
Yield(%) 1 5 1a :151b
AD-mix a, C H 3 S 0 2 N H 2 72
100:0
AD-mix p, C H 3 S 0 2 N H 2 85
100:0

Table 5.2: Asymmetric

Dihydroxylation

of (150)
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Surprisingly both AD-mix a and AD-mix p seemed to give the same isomer in

diastereomeric ratio of 100:0. The experiment was repeated and this time b

purification on a column of silica gel, a small aliquot was taken from th

mixtures of both reactions. These aliquots were treated with benzoyl chlo

and 4-dimethylaminopyridine in anhydrous DCM to form the monobenzoate (149

X

BzCI,pyridine,DMAP
HO

HO

X^

\ _
\

0

I-V^HA D T or\rv^:^^
DCM,RT,30mins

bZU

N
Boc

Boc

(151) (149a)

The 1H NMR spectra of the monobenzoates thus prepared were identical to t

(149a) and there was no evidence of (149b) in the crude benzoylation reac
mixture. This indicated that the dihydroxylation of (15 0) was highly

diastereoselective and the stereochemistry of the product (151) was the s
(149a).

Since both of the AD-mix reagents were the same as had been used for the
dihydroxylation of the benzoate (148), it was obvious there must be some

stereochemical control being exerted by the substrate (150). The only dif

between the two substrates is the presence of the free hydroxyl, which mi

directing the attack of the osmium complex by coordinating with the osmiu
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Molecular modelling with Insight II showed that the bottom face of the double bond of
(150) is slightly tilted towards the alcohol. This side of the double bond is also much
more open than the top face which has the bulky Boc groups hindering attack from
osmium on that side.

Figure 5.6: Molecular Model of (150) Showing the Tilt of the Double
Bond Towards the Hydroxyl Group

Although it is certainly unusual for both AD-mix reagents to give the same result, it is
not unprecedented. In 1995 Iwashima et al. reported that the dihydroxylation of the
terminal alkene (152) with AD-mix a and AD-mix p gave identical ratios of the two
147
possible diastereomeric products (153a and 153b).
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OBn

(15 2)

AD-mix a or p
?-BuOH/H2O,0°C

OBn

OBn

OH
(15 3 b)

(15 3 a)

AD-mix 1 53a:153b
R 1 =R 2 =H

cc

P
R 1= H,R 2 =BPS

a

R1==TBDMS,R2==BPS

a

P
P
Table 5.3: Asymmetric

3:1
3:1
5:1
5:1
>20:1
>20:1

Dihydroxylation

of (152)

5.5 Attempted Cyclisation of the Diol (151)

The next step in the synthesis of azasugars was the cyclisation of the diol (151) to the
corresponding pyrrolidine.
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Boc

Boc

(151)

The

diol

was

initially

converted

into

the

bis(mesylate)

(154)

with

methanesulfonylchloride and triethylamine in DCM. Attempted purification of the
bis(mesylate) (154) on a column of silica gel led to extensive decomposition,
therefore the crude reaction mixture was used for the next step. Treatment of the
bis(mesylate) (154) with BnNH2 at both RT and at 110°C in toluene gave a complex
mixture of compounds. The H NMR spectra of both the crude reaction mixture and the
fractions isolated from a column of silica gel did not contain anything that could be
unequivocably assigned as product.
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MsCI, Et3N
O

(15 1)

DCM, 30mins

MsO'

Boc

(15 4)

X

Boc

BnNH2
toluene

Pi

.,»\0

0

Bn

U.N
\

Boc
(15 5)

Next the crude bis(mesylate) (154) was treated with the sodium salt of B0CNH2 in
DMF at RT overnight. Again this gave a complex mixture of compounds that

appear to contain either the pyrrolidine (156) or starting material in th
spectrum of the crude reaction mixture.

X.
.*<*
}= O
N
Boc

MsO

(154)

BocNH2, NaH
x
•
DMF
Boc

Boc
(156)
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This failure of the bis(mesylate) (154) to give the pyrrolidine products was a little
bit odd considering that similar bis(mesylates) had reacted with primary amines to

give the desired cyclisation products. Kim et al. were able to cyclise the bis(mesylate)
(157) with BnNH2 by refluxing in toluene for 24 hours.148

X.

X

BnNH 2

M s O ' M s O ' ">

toluene, A, 24hrs

OTBDMS

o.
Bn

(157)

OTBDMS

(158)

The most obvious reason for the failure to get the desired product was that the
bis(mesylate) system (154) was not stable to the reaction conditions. A possibility is
that the amine is displacing the primary mesylate to give (159), but the cyclisation
is hindered by the bulky acetonide group which forms a steric barrier. Thus it is not
possible to form the desired pyrrolidine and the highly reactive secondary mesylate
undergoes decomposition to an unknown product.

BnNH 2
MsO

Bn,

MsO

Boc
(154)

Boc
(159)
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procure

a

more

stable

system

the

diol ( 1 5 1 )

was

treated

with

toluenesulfonylchloride with pyridine and catalytic amounts of 4dimethylaminopyridine in DCM to form the bis(tosylate). However only the
monotosylate (160) was formed, most probably due to the steric hindrance of the
primary tosylate preventing the formation of the secondary tosylate.

X

TsCI, pyridine, D M A P
DCM, RT, 4hrs

TsO
Boc

Boc
(151)

(160)

The monotosylate (160) was then treated with methanesulfonylchloride and
triethylamine in DCM to form the secondary mesylate (161).

X
MsCI, Et3N

TsO

V_

0

D C M , RT, 30mins

TsO

N

Boc

Boc
(160)

(161)

This was treated with BnNH2 in toluene at R T for two days until TLC analysis showed
complete consumption of the starting material. However, once again the reaction
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product w a s a complex mixture of compounds. None of the fractions isolated via column
chromatography could be definitively assigned as the desired pyrrolidine (155) on the
basis of their H NMR spectra.

X
TsO

MsO

BnNH2
rtQ

^

»

\= O toluene, RT, 2 days
Boc

(161) (155)

The conversion of the diol (151) to sulfonate derivatives appeared to provide highly
unstable compounds that were undergoing decomposition when exposed to the
cyclisation reaction conditions. Possibly the decomposition was occurring initially via
nucleophilic attack of the amine upon the oxazolidine ring and subsequent reactions
following on from this were leading to the complex mixture of products observed.

It was decided at this point to take another tack and convert the primary hydroxyl of
(151) into an azide (162). The secondary alcohol could then be mesylated and the
azide reduced to the corresponding amine and allowed to cyclise onto the secondary
mesylate.

The diol (151) was treated with lithium azide, triphenylphosphine and carbon
tetrabromide in DMF. This method works by converting the hydroxyl group to a
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bromide in situ followed by nucleophilic displacement of the bromide by the azide
149
anion.

However after treatment at R T overnight, only starting material was present

in the H NMR spectrum of the crude reaction mixture.

^=

O

LiN3, PPh 3 , CBr 4
—• No reaction
D M F , RT, O/N

(151)

5.6 Conversion

of the Primary Hydroxyl Group

of (150) to an

Amine

Derivative

Bearing in mind the results obtained in the attempted cyclisation of (151) it was

obvious that a rethink of the general strategy was in order. To this end it was decided
convert the primary hydroxyl of (150) into an amine derivative before the oxidation
of the double bond which would help prevent exposing the compound to amination
conditions it was obviously not stable under.

The alcohol (150) w a s treated with lithium azide, triphenylphosphine and carbon
tetrabromide in DMF at RT overnight. However after working up the crude reaction
mixture, only starting material was present in the H NMR spectrum.
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X

LiN3, PPh 3 , CBr 4
-•

N o reaction

DMF, RT, O/N

HO

NBoc 2
(150)

The

alcohol

(150)

w a s then

converted

into the inflate

(16 3 )

with

trifluoromethanesulfonic anhydride and pyridine in DCM. Due to its sensitive nature
the triflate (163) was not purified, but instead was treated with NaN3 in D M F at 50°C
overnight. The H NMR spectrum of the crude reaction mixture showed a complex
mixture of compounds. None of the fractions isolated via column chromatography could
be definitively assigned the structure of the desired product.

Tf 2 0, pyridine
DCM
NBoc 2
(15 0)

TfO

NBoc 2
(16 3)

XNaN 3 , DMF

NBoc2
(16 4)
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The less reactive mesylate (165) was formed by treating the alcohol (150) with
methanesulfonylchloride and triethylamine in DCM for 30 minutes. This was treated
with sodium azide in DMF at 50°C overnight to once again yield a complex mixture of
compounds that did not appear to contain either the desired product nor starting
material.

OXD
MsCI, Et3N, D C M
NBoc 2
(15 0)

MsO

NBoc2
(16 5)

X

NaN3, DMF

NBoc2
(16 4)

The primary tosylate (166) was prepared from toluenesulfonylchloride and pyridine

in DCM in a yield of 55%. Due to its less reactive nature the tosylate was treated wi
lithium azide, which is more reactive than sodium azide. However after treating the
tosylate (166) with lithium azide in DMF at 50°C overnight, only starting material
was present in the H N M R spectrum.
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X

TsCI, pyridine, D C M

TsO

NBoc 2
(15 0)

NBoc 2
(16 6)
LiN3, D M F

No reaction

To get away from the attempted formation of an azide, the tosylate (166) was treated
with the sodium salt of B0CNH2 in DMF. Initially at 50°C no reaction occurred,
however, increasing the temperature to 100°C led to the formation of the amine
(167) in 56% yield after purification by column chromatography.

X

X

BocNH 2 /NaH
•

TsO

NBoc 2
(166)

100°C, DMF, 24hrs BocHN

NHBoc
(167)

An interesting facet of this reaction is the loss of a Boc group from the other nitrogen.
A possible explanation for this side reaction is that the sodium salt of B0CNH2 attacks
the carbonyl group of one of the Bocs. Subsequent ejection of the former protecting
group leads to the formation of B0C2NH (168) and the nitrogen anion (169).
Protonation of the nitrogen occurs possibly by hydrogen abstraction from B0CNH2 or
during the aqueous work up.
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X^Boc

^
0

0

• /-vQ-NHBoc

HNBoc

©O

t-Bu

A./Boc .
H

w

.Boc

H+

oJX^ ^Boc

O
f-Bu

O

t-BuO NHBoc

(169) (168)
Scheme 5.2: Possible Mechanism for Loss of a Boc Group from the Other
Nitrogen

5.7 Epoxidation of the Allylic Amine (167)

With the diamine (167) in hand the choice now was whether to dihydroxylate or
epoxidise the double bond. Since there had been so many problems associated

attempted cyclisation of the diol (151) (Section 5.5) it was decided to form
epoxide.

Treatment of the alkene (167) with mefa-chloroperbenzoic acid in D C M at RT gave

the epoxide (170) in 23% yield in a diastereomeric ratio of approximately 2:
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X
BocHN

X

m-CPBA, D C M

J

NHBoc

TH4

BocHN

(167)

*/\

NHBoc

(170)

The diastereomeric ratio was determined from the H N M R spectrum as shown below in

Figure 5.7. The partial spectrum shows the H4 proton, a to the acetonide group, as
an apparent triplet for both diastereomers of (170). Two dimensional NMR nOesy
experiments failed to shed any light upon the stereochemistry of these epoxides.

Figure 5.7: Partial

H

NMR

Spectrum

(CDCI3) of Epoxide (170)

5.8 Attempted Cyclisation of the Epoxide (170)

The final step in the synthetic path was the cyclisation of the amine onto the epoxide. It

was believed that the pyrrolidine ring formation would be favoured over the azirid
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OXD
BocHN
NHBoc

The epoxide (170) was treated with sodium hydride in D M F at 50°C overnight.
However, after workup the H NMR spectrum of the crude reaction mixture showed
nothing that could be assigned as product (171).

X

NaH

X
OH

DMF,50°C,O/N

BocHN

X

NHBoc

(170)

Boc L^

NHBoc

(171)

Regrettably at this point the synthetic path had to be abandoned due to the pressing need
to begin the thesis write-up and the need to return to the starting material (143) in
order to procure more of the epoxide (170). However, it should purely be a matter of
determining the correct reaction conditions in order to cyclise the epoxide (170) and
form the protected azasugar (171).
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Conclusion

This chapter detailed the attempts to synthesise azasugars starting from a carbohydrate
source. The lactol (143) was converted into the dibenzoate (146) in three steps. This
was followed by a palladium(O) catalysed allylic amination to provide the allylic amine
(148). The allylic amine (148) smoothly underwent dihydroxylation in good yields,
but very poor stereoselectivity.

To avoid possible complications during deprotection the benzoyl moiety in (148) was
removed to furnish the alcohol (150). The alcohol (150) underwent dihydroxylation
with both AD-mix a and AD-mix p to selectively give the same diastereomer (151).
Despite many attempts the diol (151) could not be cyclised via sulfonate derivatives
to the pyrrolidines (155 and 156) nor could the primary hydroxyl group be
converted into an azide.

The hydroxyl group of (150) also could not be converted into an azide, but conversion
of the hydroxyl into a tosyl derivative (166) followed by nucleophilic displacement
with the lithium salt of B0CNH2 gave the diamine (167). The double bond of the
diamine (167) was treated with m-CPBA to furnish the epoxide (170).
Disappointingly the cyclisation of the amine onto the epoxide could not be realised with
the amount of sample left and frustratingly the synthetic pathway had to be abandoned
at that point.

CHAPTER 6
CONCLUSION AND
FUTURE WORK
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This thesis has documented

155

investigations into the palladium(O) catalysed

rearrangement of allylic sulfoximines to provide y-amino-oc.p-unsaturated ketones,
the palladium(O) catalysed amination of allylic sulfoximines, applications of both
these reactions towards the synthesis of azasugars and the utilisation of carbohydrates as starting material for the synthesis of azasugars.

The rearrangement of allylic sulfoximines to y-amino-a,p-unsaturated ketones
proceeded in moderate to good yields and proved to be very regioselective. The
regioselectivity of the reaction was believed to be driven by the relative stability of
the intermediate allylic cations and the thermodynamic stability of the conjugated
systems formed by nucleophilic attack at the y position.

The palladium(O) catalysed amination of allylic sulfoximines also proved to be highly
regioselective. The use of an optically active sulfoximine led to the formation of an
optically active amine, while treatment of an allylic sulfoximine with a primary
chiral amine furnished a pyrrole derivative. Evidence was gathered that indicated that
the formation of allylic sulfinamides from allylic sulfoximines was reversible.

Initial attempts to synthesise azasugars from allylic sulfoximines proved unsuccessful
when the A/,A/-dibenzyl protected allylic amine gave an unisolatable product when
subjected to dihydroxylation conditions. Later attempts using an intramolecular
rearrangement were more successful, but failed attempts to remove an Cbz protecting
group led to the synthetic path being abandoned.

The initial steps of the synthesis of azasugars from carbohydrates - reduction, chain
extension, protection and palladium(O) catalysed allylic amination - proceeded very
smoothly. The allylic amine underwent dihydroxylation in good yields, but with poor
diastereoselectivity. The benzoyl protecting of the allylic amine was removed to give an
alcohol, which underwent dihydroxylation in good yields and excellent diastereo-
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selectivity. However the diols produced could not be cyclised to the protected azasugars.
The hydroxyl group of the allylic amine was then converted into an amine and the
double bond epoxidised, but this too could not be cyclised. This meant a extremely
frustrating and ultimately disappointing end to the project with neither synthetic
pathway coming to fruition.

Future work would obviously include investigating other methods of deprotecting
nitrogens with a Cbz group and investigations into suitable cyclisation conditions for
the epoxide in order to furnish azasugars.

CHAPTER 7
EXPERIMENTAL

Chapter 7

158

7.1 General Notes

1. All NMR spectra were run either on a Varian Unity 400 spectrometer (400MHz for
1

H, 100MHz for 13C) or a Varian Unity 300 spectrometer (300MHz for 1H, 75 MHz

13
for

C). All spectra were run in deuterated chloroform unless noted otherwise. Each

signal is described in terms of its chemical shift (8) in parts per million from
tetramethylsilane (internal standard). The H spectra are then described in terms of
multiplicity, coupling constants, integration and assignment. Abbreviations used to

denote the multiplicity of the signals are: s, singlet; d, doublet; t, triplet; q, quart
13 br, broad. The

C N M R signals are assigned and an indication given of the number of

protons attached to the carbon wherever possible, as determined from DEPT NMR
experiments.

2. Low resolution mass spectra were recorded on a VG Quattro triple quadrupole mass
spectrometer. Spectra are described in terms of its mode of ionisation (ES =
electrospray), polarity of ionisation (+ve or -ve) then charge to mass ratio {m/z) of
the major peaks. Next in parentheses is the assignment followed by the percentage of
the base peak. High resolution mass spectra were recorded on a Fisons/VG Autospecoa-TOF mass spectrometer. Spectra are described as, firstly, the calculated mass of the
sample followed by, secondly, the found mass of the sample.

3. Melting points were determined on a Gallenkamp MF 370 melting point apparatus
and are uncorrected.
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4. Optical rotations were recorded with a JASCO DIP-370 Digital Polarimeter in
analytical reagent grade solvents. Spe'cific rotations ([a] D) are recorded in degrees
per decimetre, with the concentration (c) given in grams per 100mL in the specified
solvent.

5. Column chromatography was performed with silica gel, 0.063-0.2 mm (Merck).
Thin layer chromatography (TLC) was carried out on plastic backed silica gel plates
F254 (Merck). The developed plates were visualised either under shortwave (254mm)
ultraviolet light or by immersion in an aqueous solution containing 5% (w/v)
(NH4)Mo7024, 0.2% (w/v) Ce(S04)2 and 5% (v/v) H2S04, followed by heat
activation. High performance liquid chromatography was carried out using a Waters
pump model 510 and a Regis Pirkle Covalent D-Naphthylalanine column (particle size
5 micron, pore size 100A, dimensions 4.6mm x 250mm). The U.V. detector was a
Waters series 450 variable wavelength detector operating at 254 nm.

6. Molecular modelling was performed using the CVFF force field parameters of Insight
II, Version 2.3.0, Biosym Technologies, San Diego, CA.

7. Dichloromethane and dimethylformamide were dried by distillation from calcium
hydride and stored over molecular sieves under a nitrogen atmosphere.
Tetrahydrofuran was distilled from sodium/benzophenone under a nitrogen atmosphere
and used immediately.

Chapter 7

160

8. All reactions requiring anhydrous reaction conditions were performed in glassware
that had been oven-dried and cooled in a dessicator containing self-indicating silica

9. The term "dried", unless specified otherwise, refers to an organic extract being
dried over anhydrous MgS04. The terms "evaporation" and "in vacuo" are used
synomously and imply removal of solvents on a Buchi rotoevaporator (water

aspiration pressure) followed by removal of the last traces of solvent on a high vacuum
oil pump.

10. Allyl phenyl sulfide, Jones reagent, lithium azide and palladium
14*3

black

were prepared via literature procedures. All other reagents were obtained

from commercial sources unless noted otherwise.

7.2 Experimental for Chapter 2

7.2.1 Synthesis of the Sulfoximines (77), (78) and (80)

S-Methyl-S-phenyl sulfoximine (77)

0
ll

Ph-S-Me
n
NH

The title compound (77) was synthesised according to the literature procedure and
112
was found to have identical spectral properties to those reported.
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/V-Methoxycarbonyl-S-methyl-S-phenyl sulfoximine (78)

O
II
Ph—S-Me
II

NCOOMe

The title compound (78) was synthesised according to the literature procedure and
113
was found to have identical spectral properties to those reported.

2-(/V-Methoxycarbonyl-S-phenylsulfoximidoyl)-1-phenyl-ethan-1-one

(80)

Ph
O=S=NO0OCH3
Ph
O

To a stirred solution of diisopropylamine (1.4mL, 9.9mmol) in anhydrous T H F (5mL)

at 0°C was added dropwise n-BuLi (1.6M in hexanes, 6.6mL, 10.6mmol) to give a pale

yellow solution. This solution was stirred at 0°C for 20 minutes then transferred
syringe to a stirred solution of /V-methoxycarbonyl-S-methyl-S-phenylsuIfoximine
(78) (1.502g, 7.0mmol) in anhydrous THF (20mL) at -78°C. The resulting
yellow/orange solution was stirred at -78°C for 20 minutes. Benzaldehyde (1.2mL,
11.8mmoI) was added to the solution and stirring was continued for a further 40
minutes at -78°C. The reaction was quenched by addition of saturated NH4CI(aq)
(4mL) and then the solution was warmed to RT. The solution was diluted with H2O
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(40mL) then extracted with ethyl acetate (2 x 100mL). The combined organic layers
were dried, filtered and evaporated to a yellow/orange semi-solid.

Jones reagent (12mL) was added dropwise to the crude alcohol (79) in acetone

(100mL) to give a brown solution which was left to stir for 15 minutes. The reaction
was quenched by slow addition of /so-propanol (10mL) to give a green solution. The
solution was diluted with H2O (30mL) and extracted with ethyl acetate (2 x 100mL).
The combined organic layers were washed with H2O (30mL) then dried, filtered and
evaporated to a yellow residue. The crude product was purified on a short column of
silica gel using initially 5% ethyl acetate/hexane, followed by 10% ethyl
acetate/hexane and finally 30% ethyl acetate/hexane as eluent to give the title
compound (80) (0.783g, 35%) as a thick yellow oil.

1

H NMR: 87.4-8.0 (m,5H,Ar-H); 5.537 (d,J=13.8Hz,1H,one of methylene CH2);

5.069 (d,J=13.8Hz,1H,one of methylene CH2); 3.702 (s,3H,carbamate CH3).

13

C NMR: 8187.6 (ketone C=0); 159.6 (carbamate C=0); 135.9 (Ar-C); 135.7 (Ar-

C); 134.4 (Ar-CH); 134.4 (Ar-CH); 129.3 (Ar-CH); 129.2 (Ar-CH); 128.8 (ArCH); 128.7 (Ar-CH); 60.7 (S-CH2); 53.3 (carbamate CH3).

MS: ES (+ve) m/z 317.7 ([M+H]+,43); 286.3 ([M-OCH3] ,100).
HRMS: Calc'd. for C16Hi5N04S, 317.072180; found, 317.071791.
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Condensations

(E)-2-(/V-Methoxycarbonyl-S-phenylsulfoximidoyl)-1-phenyl-pent-3-en-1-one
(84a)

Ph
0=S=NCOOMe

O

A general procedure for the Knoevenagel type condensation between a fiketosulfoximine and an aldehyde.

To a stirred mixture of 2-(A/-methoxycarbonyl-S-phenylsulfoximid»oyl)-1 phenyl-ethan-1-one (80) (0.194g, 0.611mmol), propanal (0.6mL, 8mmol) and 3A
molecular sieves (~1g) in anhydrous acetonitrile (10mL) was added absolution of
piperidine (18uL, 0.182mmol) and acetic acid (21 uL, 0.367mmol) in acetonitrile
(3mL). The mixture was stirred at RT for 24 hours under an atmosphere of nitrogen.
®
The cloudy yellow solution was then filtered through a bed of Celite

and the solvent

removed in vacuo. Purification of the crude product on a short column of silica gel

using initially 5% ethyl acetate/hexane and finally 10% ethyl acetate/hexane as eluen
gave the title compound (84a) as a yellow oil (0.040g, 18%) and as a 67:33 mixture
of diastereomers.
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Major diastereomer:
1

H NMR: 87.4-8.1 (m,10H,Ar-H); " 7.077 (d,J=9.3Hz,1 H.S-CH); 6.0-5.9

(m,1H,vinyl H); 5.45-5.35 (m,1H,vinyl H); 3.816 (s,3H,carbamate CH3); 1.728
(d,J=6.6Hz,3H,alkyl CH3).

13

C NMR: 8191.0 (ketone C=0); 160.1 (carbamate C=0); 137.8 (vinyl CH); 136.4

(Ar-C); 134.4 (Ar-CH); 134.2 (Ar-CH); 134.0 (Ar-C); 130.4 (Ar-CH); 129.5
(Ar-CH); 128.8 (Ar-CH); 128.6 (Ar-CH); 119.9 (vinyl CH); 68.6 (S-CH); 53.4
(carbamate CH3); 18.3 (alkyl CH3).

Minor diastereomer:
1

H NMR: 87.4-8.1 (m,10H,Ar-H); 6.402 (d,J=9.0Hz,1 H.S-CH); 6.1-6.0

(m,1H,vinyl H); 5.45-5.35 (m,vinyl H); 3.518 (s,3H,carbamate CH3); 1.728
(d,J=6.6Hz,3H,alkyl CH3).

13

C NMR: 8191.0 (ketone C=0); 159.3 (carbamate C=0); 139.5 (vinyl CH); 128-

136 (8 aryl carbons-not all visible under major diastereomer); 118.5 (vinyl CH);
73.0 (S-CH); 53.1 (carbamate CH3); 18.4 (alkyl CH3).

MS: ES (+ve) m/z 358.0 ([M+H]+,45); 199.5 ([PhS(0)NCOOCH3 + H]
158.7 ([M-(PhS(O)NCOOCH3+H)]+,100).
HRMS: Calc'd. for C19H19NO4S, 357.103480; found, 357.105085.

+

, 26);
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(E)-2-(A/-Methoxycarbonyl-S-phenylsulfoximidoyl)-1-phenyl-hex-3-en-1-one

(84b)

Ph
i

0=S=NCOOMe

o

The title compound (84b) was prepared from 2-(A/-methoxycarbonyl-Sphenylsulfoximidoyl)-1-phenyl-ethan-1-one (80) (0.400g, 1.26mmol), butanal
(0.3mL, 3.32mmol), piperidine (29uL, 0.297mmol) and acetic acid (36uL,
0.599mmol) as described previously for (84a), as a yellow oil (0.195g, 42%) and
as a 66:34 mixture of diastereomers.

Major diastereomer:
1

H NMR: 87.2-8.2 (m,10H,Ar-H); 7.055 (d,J=9.3Hz,S-CH)< 5.997

(dt,J=6.3,15.3Hz,1H,vinyl H); 5.3-5.4 (m,1H,vinyl H); 3.809 (s,3H, carbamate
CH3); 2.024 (m,2H,alkyl CH2); 0.793 (t,J=7.5Hz,3H,alkyl CH3).

13

C NMR: 8190.9 (ketone C=0); 160.1 (carbamate C=0); 142.1 (vinyl CH); 136.3

(Ar-C); 134.3 (Ar-CH); 134.0 (Ar-CH); 133.9 (Ar-C); 130.3 (Ar-CH); 129.4
(Ar-CH); 128.6 (Ar-CH); 128.4 (Ar-CH); 118.3 (vinyl CH); 68.6 (S-CH*); 53.3
(carbamate CH3); 20.7 (alkyl CH2); 14.0 (alkyl CH3).
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Minor diastereomer:
1

H NMR: 87.2-8.2 (m,10H,Ar-H);* 6.392 (d,J=8.7Hz,1 H.S-CH); 6.082

(dt,J=6.3,15.3Hz,1H,vinyl H); 5.4 (m,1H,vinyl H); 3.510 (s,3H, carbamate
2.1-1.9 (m,2H,alkyl CH2); 0.940 (t,J=7.5Hz,3H,alkyl CH3).

13

C NMR: 8190.9 (ketone C=0); 159.2 (carbamate C=0); 144.6 (vinyl CH); 12

136 (8 aryl carbons-not all visible under major diastereomer); 117.1 (vin
73.1 (S-CH); 53.0 (carbamate CH3); 20.5 (alkyl CH2); 13.9 (alkyl CH3).

MS: ES (+ve) m/z 372.0 ([M+H]+,53); 213.5 ([PhS(0)NCOOCH3+H]

+

, 23);

172.7 ([M-(PhS(O)NCOOCH3+H)]+,100).
HRMS: Calc'd. for C20H21NO4S, 371.120810; found, 371.120564.

(E)-2-(/V-Methoxycarbonyl-S-phenylsulfoximidoyl)-1-phenyl-oct-3-en-1-one

(84c)

Ph
0=S=NCOOMe

o

The title compound (84c) was prepared from 2-(A/-methoxycarbonyl-S-

phenylsulfoxtmidoyl)-1-phenyl-ethan-1-one (80) (0.269g, 0.848mmol), hexan
(0.2mL, 1.66mmol), piperidine (18uL, 0.182mmol) and acetic acid (21uL,
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0.367mmol) as described previously for (84a), as a yellow oil (0.155g, 46%) and
as a 76:24 mixture of diastereomers. R'f = 0.41 (30% ethyl acetate/hexane).

Major diastereomer:
1

H NMR: 87.2-8.2 (m,10H,Ar-H); 7.067 (d,J=9.3Hz,1 H.S-CH); 5.9-6.0

(m,1H,vinyl H); 5.3-5.4 (m,1H,vinyl H); 3.804 (s,3H,carbamate CH3); 2.0-2.1
(m,2H,alkyl CH2); 1.2-1.4 (m,4H,alkyl CH2); 0.869 (t,J=7.8Hz, 3H, alkyl CH3).

13

C NMR: 8190.9 (ketone C=0); 160.0 (carbamate C=0); 143.1 (vinyl CH); 136.3

(Ar-C); 134.3 (Ar-CH); 134.1 (Ar-CH); 133.9 (Ar-C); 130.3 (Ar-CH); 129.4
(Ar-CH); 128.7 (Ar-CH); 128.5 (Ar-CH); 118.4 (vinyl CH); 68.6 (S-CH8); 53.3
(carbamate CH3); 32.2 (alkyl CH2); 30.4 (alkyl CH2); 21.9 (alkyl CH2); 13.6
(alkyl CH3).

Minor diastereomer:
1

H NMR: 87.2-8.2 (m,10H,Ar-H); 6.404 (d,J=9.3Hz,1 H.S-CH); 6.0-6.1

(m,1H,vinyl H); 5.3-5.4 (m,1H,vinyl H); 3.509 (s,3H,carbamate CH3); 2.0-2.1
(m,2H,alkyl CH2); 1.2-1.4 (m,4H,alkyl CH2); 0.869 (t,J=7.8Hz, 3H,alkyl CH3).

13

C NMR: 8191.0 (ketone C=0); 159.2 (carbamate C=0); 144.7 (vinyl CH); 128-

136 (8 aryl carbons-not all visible under major diastereomer); 117.0 (vinyl CH);
73.0 (S-CH); 53.0 (carbamate CH3); 32.3 (alkyl CH2); 30.3 (alkyl CH2); 21.9
(alkyl CH2); 13.6 (alkyl CH3).
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+

, 18);

200.8 ([M-(PhS(O)NCOOCH3+H)]+,100).
HRMS: Calc'd. for C22H25NO4S, 399.152109; found, 399.152498.

(E)-2-(/V-Methoxycarbonyl-S-phenylsulfoximidoyl)-1-phenyl-non-3-en-1-one

(84d)

Ph
0=S=NCOOMe

o

The title compound (84d) was prepared from 2-(A/-methoxycarbonyl-Sphenylsulfoximidoyl)-1-phenyl-ethan-1-one (80) (0.302g, 0.952mmol),

heptanal (0.3mL, 2.14mmol), piperidine (22uL, 0.22mmol) and acetic acid (

0.44mmol) as described previously for (84a), as a yellow oil (0.269g, 65%
a 69:31 mixture of diastereomers.

Major diastereomer:
1

H NMR: 87.4-8.2 (m,10H,Ar-H); 7.075 (d,J=9.0Hz,1 H.S-CH); 6.0-6.1

(m,1H,vinyl H); 5.3-5.4 (m,1H,vinyl H); 3.801 (s,3H,carbamate CH3); 2.0
(m,2H,alkyl CH2); 1.25-1.4 (m,6H,alkyl CH2); 0.879 (t,J=7.6 Hz,3H,alkyl

13

C NMR: 8190.9 (ketone C=0); 160.0 (carbamate C=0); 143.1 (vinyl CH); 13

(Ar-C); 134.3 (Ar-CH); 134.0 (Ar-CH); 133.8 (Ar-C); 130.3 (Ar-CH); 129.4

Chapter 7

169

(Ar-CH); 128.7 (Ar-CH); 128.4 (Ar-CH); 118.4 (vinyl CH); 68.6 (S-CH»); 53.2

(carbamate CH3); 32.4 (alkyl CH2)*; 31.4 (alkyl CH2); 27.9 (alkyl CH2); 22.4
(alkyl CH2); 13.7 (alkyl CH3).

Minor diastereomer:
1

H NMR: 87.4-8.2 (m,10H,Ar-H); 6.413 (d,J=9.3Hz,1 H.S-CH); 6.0-6.1

(m,1H,vinyl H); 5.3-5.4 (m,1H,vinyl H); 3.509 (s,3H,carbamate CH3); 2.0
(m,2H,alkyl CH2); 1.25-1.4 (m,6H,alkyl CH2); 0.879 (t,J=7.6 Hz,3H,alkyl

13

C NMR: 8191.0 (ketone C=0); 159.2 (carbamate C=0); 144.7 (vinyl CH); 12

136 (8 aryl carbons-not all visible under major diastereomer); 117.1 (vin

73.1 (S-CH); 53.0 (carbamate CH3); 32.6 (alkyl CH2); 31.0 (alkyl CH2); 27.8
(alkyl CH2); 22.2 (alkyl CH2); 14.0 (alkyl CH3).

MS: ES (+ve) m/z 414.1 ([M+H]+,72); 255.6 ([PhS(0)NCOOCH3+H]

+

214.8 ([M-(PhS(O)NCOOCH3+H)]+,100).
HRMS: Calc'd. for C23H27NO4S, 413.167758; found, 413.168015.

, 12);
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Rearrangement of Allylic Sulfoximines

(E)-/V-Methoxycarbonyl-4-amino-1-phenyl-pent-2-en-1-one (86 a)

H. XOOMe

A general procedure for the intramolecular rearrangement of allylic sulfo

To a stirred solution of (E)-2-(/V-methoxycarbonyl-S-phenylsulfoximidoy

phenyl-pent-3-en-1-one (84a) (0.084g, 0.235mmol) in anhydrous THF (10mL

at RT was added tetrakis(triphenylphosphine)palladium(0) (0.028g, 0.024m

The yellow/orange solution was stirred at RT for 60 minutes. The solvent
in vacuo and the resulting red residue dissolved in methanol (20mL). To

was added triethylamine (5 drops) and stirring continued for 30 minutes.

of the solvent gave a red residue. Purification of the crude product on

silica gel using initially 5% ethyl acetate/hexane and finally 10% ethyl
acetate/hexane as eluent gave the title compound (86a) as a yellow oil
50%).

1

H NMR: 87.4-8.0 (m,5H,Ar-H); 6.986 (d,J=12.0Hz,vinyl H); 6.819 (dd,

J=3.3,12.0Hz,vinyl H); 4.859 (br s,1H,NH); 4.561 (br s,1H,N-CH); 3.700
(s,3H,carbamate CH3); 1.356 (t,J=5.1Hz,alkyl CH3).
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13

C NMR: 8191.0 (ketone C=0); 159.3 (carbamate C=0); 149.2 (vinyl CH); 13

(Ar-C); 134.2 (Ar-CH); 128.8 (Ar-CH); 128.6 (Ar-CH); 119.9 (vinyl CH); 68.6
(N-CH); 53.4 (carbamate CH3); 18.3 (alkyl CH3).

MS: ES (+ve) m/z 234.1 ([M+H]+, 21); 202.0 ([M-OCH3]+, 24); 159.0 ([MHNCOOCH3]+, 100); 105.0 (PhC(0)+, 33).
HRMS of M+H: Calc'd for C13H16NO3, 234.113009; found, 234.112775.

(E)-A/-Methoxycarbonyl-4-amino-1-phenyl-hex-2-en-1-one (86b)

Hv .COOMe
N*^

o

The title compound was prepared from (E)-2-(A/-methoxycarbonyl-Sphenylsulfoximidoyl)-1-phenyl-hex-3-en-1-one (84b) (0.120g, 0.323mmol)
and tetrakis(triphenylphosphine)palladium(0) (0.038g, 0.033mmol) for 85

minutes followed by treatment with triethylamine in methanol as described
(86a), as an oil (0.025g, 31%).

1

H NMR: 87.4-8.0 (m,5H,Ar-H); 7.005 (d,J=14.7Hz,vinyl H); 6.893 (dd,

J=5.1,14.7Hz,vinyl H); 4.877 (br s,1H,NH); 4.380 (br s,1H,N-CH); 3.705

(s,3H,carbamate CH3); 1.663 (m,2H,alkyl CH2); 0.992 (t,J=7.3 Hz.alkyl CH3
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C NMR: 8190.4 (ketone C=0); 156.5 (carbamate C=0); 147.7 (vinyl CH); 1

(Ar-C); 132.9 (Ar-CH); 128.6 (Ar-CH); 128.5 (Ar-CH); 125.2 (vinyl CH); 53.9
(N-CH); 52.2 (carbamate CH3); 29.6 (alkyl CH2); 14.1 (alkyl CH3).

MS: ES (+ve) m/z 248.1 ([M+H]+, 28); 216.1 ([M-OCH3]+, 33); 173.1 ([MHNCOOCH3]+, 100); 105.0 (PhC(0)+, 30).
HRMS of M+H: Calc'd for Ci4H18N03, 248.128669; found, 248.129166.

(E)-A/-Methoxycarbonyl-4-amino-1-phenyl-oct-2-en-1-one (86c)

H^ XOOMe
N
^-^^

O

The title compound was prepared from (E)-2-(/V-methoxycarbonyl-SphenylsulfoximidoyI)-1-phenyl-oct-3-en-1-one (84c) (0.124g, 0.310mmol)

tetrakis(triphenylphosphine)palladium(0) (0.039g, 0.033mmol) for 65 min
followed by treatment with triethylamine in methanol as described above
as an oil (0.055g, 64%).

1

H NMR: 88.0-7.4 (m,5H,Ar-H); 6.998 (d,J=15.6,1 H,vinyl H); 6.892

(dd,J=5.1,15.6Hz,1H,vinyl H); 4.927 (br s,1H,NH); 4.403 (br s,1H,N-CH);

(s,3H,carbamate CH3); 2.0-1.2 (m,6H,alkyl CH2); 0.895 (t, J=7.5Hz,3H,al
CH3).
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C NMR: 8190.4 (ketone C=0); 156.4 (carbamate C=0); 148.1 (vinyl CH); 137.6

(Ar-C); 132.8 (Ar-CH); 128.5 (Ar-CH); 128.5 (Ar-CH); 125.1 (vinyl CH); 54.0

(N-CH); 52.5 (carbamate CH3); 34.4 (alkyl CH2); 27.7 (alkyl CH2); 22.3 (alk
CH2); 13.8 (alkyl CH3).

MS: ES (+ve) m/z 276.2 ([M+H]+, 40); 256.3 (100); 244.1 ([M-OCH3]+, 42);
201.1 ([M-HNCOOCH3]+, 79); 105.0 (PhC(0)+, 24).
HRMS of M+H: Calc'd for C16H22NO3, 276.159969; found, 276.160961.

(E)-A/-Methoxycarbonyl-4-amino-1-phenyl-non-2-en-1-one (86d)

H^ XOOMe

o

The title compound was prepared from (E)-2-(A/-methoxycarbonyl-S-

phenylsulfoximidoyl)-1-phenyl-non-3-en-1-one (84d) (0.240g, 0.58mmol) an

tetrakis(triphenylphosphine)palladium(0) (0.063g, 0.055mmol) for 60 minu

followed by treatment with triethylamine in methanol as described above f
as a yellow oil (0.082g, 49%).

1

H NMR: 87.4-8.0 (m,5H,Ar-H); 7.001 (d,J=16.2Hz,1 H,vinyl H); 6.893

(dd,J=5.4,16.2Hz,1H,vinyl H); 4.977 (br d,J=7.8Hz,1H,NH); 4.426 (br s,1
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(s,3H,carbamate

CH3);

1.2-1.7 (m,8H,alkyl

CH2);

0.883

(t,J=7.6Hz,3H,alkyl CH3).

13 C NMR: 8190.5 (ketone C=0); 156.4 (carbamate C=0); 148.1 (vinyl CH); 137.6
(Ar-C); 132.8 (Ar-CH); 128.5 (Ar-CH); 128.5 (Ar-CH); 124.9 (vinyl CH); 52.5

(N-CH); 52.2 (carbamate CH3); 34.6 (alkyl CH2); 31.4 (alkyl CH2); 25.3 (al
CH2); 22.3 (alkyl CH2); 13.8 (alkyl CH3).

MS: ES (+ve) m/z 290.2 ([M+H]+, 62); 258.1 ([M-OCH3]+, 57); 215.1 ([MHNCOOCH3]+, 100); 105.0 (PhC(0)+, 23).
HRMS of M+H: Calc'd for C17H24NO3, 290.175619; found, 290.172888.

7.2.4 H NMR Study of Changes in Diastereomeric Ratio with Time

Tetrakis(triphenylphosphine)palladium(0) (0.011g, 9.52umol) was added t

tube containing 2-(A/-tosyl-S-phenylsulfoximidoyl)-1-phenyl-non-3-en-1-o

(88) (0.048g, 0.094mmol) in d8-THF (0.7mL). The 1H NMR spectrum was taken
after 10, 20, 30, 70 minutes, 21 hours and 28 days.

7.2.5 Attempted Thermal Rearrangement of (84d)

2-(A/-Methoxycarbonyl-S-phenylsulfoximidoyl)-1-phenyl-non-3-en-1-one

(84d) (0.101g, 0.244mmol) was dissolved in anhydrous THF (20mL) and hea

Chapter 7

175

reflux overnight. The solution was allowed to cool to RT, then the solvent was remov
in vacuo. The residue was dissolved in methanol (20mL) and triethylamine (5 drops),
then stirred for 45 minutes. The solvent was then removed in vacuo. The residue was
placed on a column of silica gel using initially 5% ethyl acetate/hexane, then 10%
ethyl acetate/hexane and finally 15% ethyl acetate/hexane as eluent. None of the
compounds isolated could have their structures assigned as rearrangement products
from their H NMR spectrum.

7.3 Experimental for Chapter 3

7.3.1 Synthesis of Allylic Sulfoximines

S-Phenyl-S-(2-propenyl)sulfoximine (39)

O
II
N

*^/» Ph
NH

The title compound (39) was synthesised according to the literature procedure and
82

was found to have identical spectral properties to those reported.

A/-Tosyl-S-phenyl-S-(2-propenyl)sulfoximine (91)

O
n
*^^Ph
NTs
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The title compound (91) was synthesised according to the literature procedure and
98
was found to have identical spectral properties to those reported.

2-(A/-Tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-ol

(92)

Ph
I
0=S=NTs
Ph
OH

The title compound (92) was synthesised according to a literature procedure and was
98
found to have identical spectral properties to those reported.

2-(A/-Tosyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-one

(93)

To a stirred solution of 2-(A/-tosyl-S-phenylsulfoximidoyl)-phenyl-but-3-en-1-ol
(92) (0.725g, 1.64mmol) in acetone (100mL) at 0°C was added Jones reagent
(3.3mL) in a dropwise fashion. After stirring for 5 minutes, /so-propanol (5mL) was
added dropwise to give a green solution. This solution was diluted with H2O (100mL)
and then extracted with CHCI3 (2 x 100mL). The organic layers were combined then

dried, filtered and evaporated to a yellow oil. Purification of the crude product on a
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column of silica gel using 3 0 % ethyl acetate/hexane gave the title compound (93) as a
yellow oil (0.698g, 97%) and as a 69:31 mixture of diastereomers.

Major diastereomer:

1

H NMR: 87.4-8.2(m,14H.Ar-H); 7.179 (d,J=9.0Hz,1 H.S-CH); 5.5-5.9

(m,3H,vinyl H); 2.371 (s,3H,tosyl CH3).

13

C NMR: 8188.9 (ketone C=0); 143.0 (Ar-C); 140.7 (Ar-C); 136.6 (Ar-C);

135.3 (vinyl CH); 134.7 (Ar-CH); 134.2 (Ar-C); 133.5 (Ar-CH); 130.4 (ArCH); 129.7 (Ar-CH); 129.3 (Ar-CH); 129.3 (Ar-CH); 128.7 (Ar-CH); 128.5
(Ar-CH); 126.7 (vinyl CH2); 69.2 (S-CH); 21.5 (tosyl CH3).

Minor diastereomer:

1

H NMR: 87.4-8.2(m,14H.Ar-H); 6.331 (d,J=8.7Hz,1 H.S-CH); 5.5-5.9

(m,3H,vinyl H); 2.421 (s,3H,tosyl CH3).

13

C NMR: 8192.1 (ketone C=0); 128-143 (12 aryl carbons); 135.6 (vinyl CH);

127.4 (vinyl CH2); 68.6 (S-CH); 22.9 (tosyl CH3).

MS: ES (+ve) m/z 440.2 ([M+H]+,95); 296.0 ([PhS(O)NTs+2H]+,30); 278.2
([PhS(0)NTs-H20] ,49); 145.0 ([M-PhS(O)NTs]+,100).
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H R M S : Calc'd. for C23H21NO4S2, 439.091202; found, 439.091691

(E)-2-(A/-Tosyl-S-phenylsulfoximidoyl)-1-phenyl-non-3-en-1-one

(88)

Ph
1

0=S=NTs
, .Ph
O5H11
O

The title compound (88) was synthesised according to a literature procedure and was
123
found to have identical spectral properties to those reported.

/V-Tosyl-S-phenyl-S-(cycIohex-1-enylmethyl)sulfoximine

(95)

O
II
S-Ph
S11

NTs

The title compound (95) was synthesised according to the literature procedure and
98
was found to have identical spectral properties to those reported.
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(S)-A/-Tosyl-S-phenyl-S-(a-methyl-cyclohex-1'-enylmethyl)-sulfoximine

(98)

The title compound (98) was synthesised according to the literature procedure and
98
was found to have identical spectral properties to those reported.

(S, S)-/V-Tosy I-S-pheny I-S-(a-methyl-cyclohex-1'-enyl methyl)-sulfoximine

(98)
O
Me II
*~,^S^ Ph

H«-r^n
NTs

The title compound (98) was synthesised according to the literature procedure and
98
was found to have identical spectral properties to those reported.

7.3.2 Synthesis of the Allylic Sulfone (118)

S-Phenyl-S-(2-propenyl)sulfone (118)

^\^S02Ph
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(119) (16.320g, 0.109mol) was dissolved in

CH3CN (lOOmL) and added to a suspension of Oxone (180g, 0.293mol). The
suspension was allowed to stir O/N and was then filtered. The solution was extracted
with DCM (3 x 200mL) and the combined organic layers were dried, filtered and
evaporated to a yellow liquid. The liquid was distilled at 150°C/10mmHg to give the
title compound (119) (19.400g, 98%). The title compound (119) was found to have
1 53

identical spectral properties to those reported.

7.3.3 Palladium(O) Catalysed Amination of Allylic Sulfoximines

/V,A/-Dibenzyl-A/-(2-propenyl)amine (99)

^5\^NBn2

A general procedure for the intermolecular rearrangement of allylic sulfoximines
using dibenzylamine.

Tris(dibenzyiideneacetone)dipailadium(0) (0.016g, 0.017mmol) and triphenylphosphine (0.034g, 0.13mmol) were dissolved in anhydrous THF (10 mL) and stirred
at RT for 10 minutes to give a yellow solution of tetrakis(triphenylphosphine)palladium(O). To this solution was added A/-tosyl-S-phenyl-S-(2-propenyl)sulfoximine (91) (0.099g, 0.31 mmol) and dibenzylamine (0.08mL, 0.42mmol).
After stirring for 10 minutes the red solution was evaporated to a dark red residue.
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Purification of the crude product on a short column of silica gel using 5 % ethyl
acetate/hexane as eluent gave the title compound (99) as a yellow oil (0.049 g,

67%).

1

H NMR: 87.1-7.4 (m,10H,Ar-H); 5.90(dddd,J=6.0,6.0,10.2,14.1Hz,1H, vinyl H);

5.202 (dd,J=2.1,14.1Hz,1H,vinyl H); 5.139 (d,J=2.1,10.2Hz, 1H,vinyl H); 3.566
(s,4H,Bn CH2); 3.055 (dt,J=1.2,6.3Hz, 2H,N-CH2).

13

C NMR: 8139.7 (Ar-C); 136.0 (vinyl CH); 128.7 (Ar-CH); 128.2 (Ar-CH);

126.8 (Ar-CH); 117.3 (vinyl CH2); 57.8 (Bn CH2); 56.3 (N-CH2).

MS: ES (+ve) m/z 238.2 ([M+HJ+,100).
HRMS: Calc'd. for C17H19N, 237.151750; found, 237.150950.

The title compound (99) was also prepared by reacting A/-tosyl-S-phenyl-S-(2propenyl)sulfoximine (91) (0.061g, 0.182mmol) and tetrakis(triphenylphosphine)palladium(O) (0.011g, 9.5umol) in anhydrous THF (10mL) for 15
minutes. The solvent was removed in vacuo and the crude reaction mixture put onto a

column of silica gel using ethyl acetate as eluent. The isolated sulfinamide was di
in anhydrous THF (10mL). To this was added tetrakis(triphenylphosphine)palladium(O) (0.012g, 10.4ummol) and dibenzylamine (0.1mL, 0.520mmol). The

solution was stirred at RT for 10 minutes and the solvent removed in vacuo. The titl
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compound (99) was not purified, however analysis of the
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H N M R spectrum of the

crude reaction mixture indicated that it was the sole product.

An attempt was made to prepare the title compound (99) by refluxing S-phenyl-S(2-propenyl)sulfone (118) (0.198g, 1.09 mmol), tetrakis(triphenylphosphine)palladium(O) (0.061g, 52.8 umol) and dibenzylamine (0.3mL, 1.56mmol) in
anhydrous THF overnight. The solution was cooled to RT then the solvent was removed
in vacuo. Analysis of the H NMR spectrum of the crude reaction mixture only showed
starting material.

A/,A/-Bis(ferf-butyloxycarbonyl)-/V-(2-propenyl)amine (100)

^>s^NBoc_

A general procedure for the palladium(O) catalysed intermolecular rearrangement of
allylic sulfoximines using lithiated B0C2NH.

B0C2NH (0.148g, 0.681 mmol) was dissolved in anhydrous THF (5mL) and cooled to
0°C. n-BuLi (1.3M in hexanes, 0.79mL, 0.615mmol) was added dropwise and stirring
continued for 15 minutes at 0°C followed by stirring at RT until a white precipitate
formed. Tris(dibenzylideneacetone)dipalladium(0) (0.014g, 0.015mmol) and
triphenylphosphine (0.034g, 0.130mmol) were stirred in anhydrous THF (5mL) to
prepare the tetrakis(triphenylphosphine)palladium(0) solution which was then added
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to the lithiated B0C2NH suspension, followed by A/-tosyl-S-phenyl-S-(2propenyl)sulfoximine (91) (0.202g, 0.602mmol). The yellow suspension was
stirred at RT for 24 hours before the solvent was removed in vacuo. Purification

crude product on a short column of silica gel using 5% ethyl acetate/hexane as el
gave the title compound (100) as a yellow oil (0.084 g, 54%).

1

H NMR: 85.847 (dddd,J=5.4,5.410.2,17.1 Hz,2H,vinyl H); 5.161 (dd, J=1.5,

17.1Hz,1H,vinyl H); 5.121 (dd,J=1.5,10.2Hz,1H,vinyl H); 4.175 (dt,J=1.5,5.4Hz,
2H,N-CH2); 1.501 (s,18H, carbamate CH3).

13

C NMR: 8152.1 (carbamate C=0); 133.6 (vinyl CH); 116.0 (vinyl CH2); 82.1

(carbamate C); 48.3 (N-CH2); 27.9 (carbamate CH3).

MS: ES (+ve) m/z 258.1 ([M+H]+,18); 202.0 ([(M-f-Bu) + H]+,24); 145.9
(100).
HRMS of M+H: Calc'd. for C13H24NO4, 258.170534; found, 258.170255.

The title compound (100) was also prepared from 2-(/V-tosyl-Sphenylsulfoximidoyl)-1-phenylbut-3-en-ol (92) (0.211g, 0.478 mmol), Boc2N H
(0.121g, 0.557mmol), r?-BuLi (1.6M in hexanes, 0.35 mL, 0.560mmol),
tris(dibenzylideneacetone)dipalladium(0) (0.011g, 0.012mmol), triphenylphosphine (0.026g, 0.101 mmol) as described previously for (100) as a yellow oil
(0.032g, 26%) as the major component of a complex mixture of products.
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The title compound (100) was also prepared from 2-(/V-tosyl-Sphenylsulfoximidoyl)-1-phenylbut-3-en-one (93) (0.198g, 0.450 mmol),
B0C2NH (0.117g, 0.541 mmol), n-BuLi (1.6M in hexanes, 0.34 mL, 0.544mmol),
tris(dibenzylideneacetone)dipalladium(0) (0.011 g, 0.012mmol), triphenyl-

phosphine (0.025g, 0.095mmol) as described previously for (100) as a yellow oil
(0.021 g, 18%) as the major component of a complex mixture of products.

(E)-/V,/V-Dibenzyl-4-amino-1-phenyl-but-2-en-1-ol (101)

NBn2

.Ph
OH

The title compound (101) was prepared from (E)-2-(A/-tosyl-Sphenylsulfoximidoyl)-1-phenylbut-3-en-ol (92) (0.199g, 0.451 mmol), tris(dibenzylideneacetone)dipalladium(O) (0.012g, 0.013 mmol), triphenylphosphine
(0.024g, 0.092mmol) and dibenzylamine (0.1 mL, 0.559mmol) as described
previously for (99), as an oil (0.103g, 66%).

1

H NMR: 87.16-7.36 (m,15H,Ar-H); 5.873 (m,2H,vinyl H); 5.110 (d,

J=3.9Hz,1H,CH-0); 3.548 (s,4H,Bn CH2); 3.047 (d,J=4.5Hz,2H,N-CH2); 2.270
(br s,1H,OH).
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13

C NMR: 8143.0 (Ar-C); 139.5 (Ar-C); 135.2 (vinyl CH); 129.0 (Ar-CH); 128.4

(Ar-CH); 128.1 (Ar-CH); 127.5 (vinyl CH); 126.8 (Ar-CH); 126.1 (Ar-CH);
74.5 (CH-O); 58.0 (Bn CH2); 55.1 (N-CH2).

MS: ES (+ve) m/z 344.2 ([M+H]+,100).
HRMS: Calc'd. for C24H25NO, 343.193615; found, 343.192285.

(E)-A/,/V-Dibenzyl-4-amino-1-phenyl-but-2-en-1-one (102)

NBn2

0

The title compound (102) was prepared from (E)-2-(A/-tosyl-Sphenylsulfoximidoyl)-1-phenyl-but-3-en-1-one (93) (0.195g, 0.444 mmol),
tris(dibenzylideneacetone)dipalladium(0) (0.011g, 0.012 mmol), triphenylphosphine (0.023g, 0.088mmol) and dibenzylamine (0.1 mL, 0.559mmol) as
described previously for (99), as an oil (0.065g, 43%).

1

H NMR: 87.2-7.9 (m,10H,Ar-H); 7.0-7.1 (m,2H,vinyl H); 3.644 (s,4H,Bn CH

3.309 (d,J=3.6Hz,2H,N-CH2).
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C NMR: 8190.5 (ketone C=0); 146.7 (vinyl H); 143.2 (Ar-CH); 139.0 (Ar-C);

137.8 (Ar-C); 132.6 (Ar-CH); 130.4 (Ar-CH); 128.6 (Ar-CH); 128.5 (Ar-CH);
128.5 (Ar-CH); 128.3 (Ar-CH); 127.1 (vinyl CH); 58.4 (Bn CH2); 54.8 (N-CH2).

MS: ES (+ve) m/z 342.6 ([M+H]+,100).
HRMS: Calc'd. for C24H23NO, 341.177965; found, 341.177511.

The title compound (102) was also prepared by stirring a solution of (E)-N,Ndibenzyl-4-amino-1-phenyl-but-2-en-1-ol (101) (0.100g, 0.291mmol) and
pyridium dichromate (0.146g, 0.388mmol) in anhydrous DCM (10mL) O/N. The

solvent was removed in vacuo and the resulting residue taken up in ether. The solu
was filtered and the ether removed by evaporation to give a yellow oil. The crude

was purified on a column of silica gel using 20% ethyl acetate as eluent to give t
compound (102) (0.052g, 53%) as a yellow oil.

The title compound (102) was also prepared by slowly adding Jones reagent (2mL) to
a stirred solution of (E)-A/,A/-dibenzyl-4-amino-1-phenyl-but-2-en-1-ol (101)
(0.090g, 0.262mmol) in acetone (50mL). After stirring for 10 minutes, iso-

propanol was added dropwise to give a green solution., which was then diluted with
(100mL). The solution was extracted with DCM (3 x 100mL) and the combined

organic layers were dried.filtered and evaporated to a yellow oil. The crude oil w

purified on a column of silica gel using 20% ethyl acetate as eluent to give the t
compound (102) (0.088g, 98%) as a yellow oil.
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(103)

NBn2

o

The title compound (103) was prepared from (E)-2-(N -tosyl-Sphenylsulfoximidoyl)-1-phenyl-non-3-en-1-one (88) (0.108g, 0.212mmol),
tris(dibenzylideneacetone)dipalladium(0) (0.005g, 5.5 umol), triphenylphosphine
(0.013g, 0.049mmol) and dibenzylamine (0.05mL, 0.26mmol) as described
previously for (99), as an oil (0.054g, 62%).

1

H NMR: 87.2-8.0 (m,15H,Ar-H); 7.090 (dd,J=6.3,11.7Hz,1H,vinyl H); 6.879

(d,J=11.7Hz,1H,vinyl H); 3.674 (dd,J=10.5,122.1 Hz,4H,Bn CH2); 1.1-1.9
(m,11H,alkyl H).

13

C NMR: 8190.3 (ketone C=0); 147.8 (vinyl CH); 139.9 (Ar-C); 137.9 (Ar-C);

132.8 (Ar-CH); 128.6 (Ar-CH); 128.6 (Ar-CH); 128.5 (Ar-CH); 128.3 (Ar-CH);
127.5 (Ar-CH); 126.9 (vinyl CH); 59.5 (N-CH); 53.8 (Bn CH2); 31.7 (alkyl CH2);
31.2 (alkyl CH2); 26.0 (alkyl CH2); 22.6 (alkyl CH2); 14.0 (alkyl CH3).

MS: ES (+ve) m/z 412.4 ([M+H]+,100).
HRMS of M+H: Calc'd. for C29H33NO, 412.264040; found, 412.260241.
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/V,A/-Dibenzyl-/V-(cyclohex-1-enyl)methylamine

(104)

NBn 2

The title compound (104) was prepared from /V-tosyl-S-phenyl-S-(1-cyclohex1'-enylmethyl)sulfoximine (95) (0.106g, 0.271mmol), tris(dibenzylideneacetone)dipalladium(O) (0.015g, 0.016mmol), triphenylphosphine (0.032g,
0.122mmol) and dibenzylamine (0.07 mL, 0.364mmol) as described previously for
(99), as an oil (0.058g, 73%).

1

H NMR: 87.16-7.39 (m,10H,Ar-H); 5.620 (br s,1H,vinyl H); 3.472 (s,4H,Bn

CH2); 2.846 (s,2H,N-CH2); 1.9-2.1 (m,4H,cyclic CH2); 1.45-1.65 (m,4H,cyclic
CH2).

13

C NMR: 8140.2 (Ar-C); 136.1 (vinyl C); 128.7 (Ar-CH); 128.1 (Ar-CH); 126.6

(Ar-CH); 124.6 (vinyl CH); 61.5 (N-CH2); 58.0 (Bn CH2); 27.1 (cyclic CH2);
25.3 (cyclic CH2); 22.9 (cyclic CH2); 22.7 (cyclic CH2).

M S : ES (+ve) m/z 291.8 ([M+H]+).
HRMS: Calc'd. for C21H25N, 291.198688; found, 291.198178.
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(105)

The title compound (105) was prepared from /V-tosyl-S-phenyl-S-(cc-methylcyclohex-1-enylethyl)sulfoximine (98) (66:33 mixture of methylated and
unmethylated sulfoximine, 0.195g, 0.490mmol), tris(dibenzylideneacetone)dipalladium(O) (0.026g, 0.028mmol), triphenylphosphine (0.066g, 0.251 mmol)
and dibenzylamine (0.3mL, 1.56mmol) as described previously for (99), as an oil
(44:56 mixture of methylated and unmethylated amine, 0.043g, 19%). The

percentage yield of 19% was calculated for the methylated amine (105) by taking i

account the amount of unmethylated compound in both the starting material and the
product material.

1

H NMR: 87.15-7.39 (m,10H,Ar-H); 5.552 (br s,1H,vinyl H); 3.543

(dd,J=13.8,107.4Hz,4H,Bn CH2); 3.100 (q,J=6.6Hz,1 H.N-CH); 2.446
(m,1H,cyclic H); 1.992 (m,2H,cyclic CH2); 1.751 (m,1H,cyclic H); 1.541
(m,4H,cyclic CH2); 1.076 (d,J=6.6Hz,alkyl CH3).

13

C NMR: 8140.9 (Ar-C); 139.8 (vinyl C); 128.8 (Ar-CH); 128.1 (Ar-CH); 126.5

(Ar-CH); 122.4 (vinyl CH); 57.7 (N-CH); 53.6 (Bn CH2); 27.4 (cyclic CH2); 25.4
(cyclic CH2); 23.1 (cyclic CH2); 22.8 (cyclic CH2); 9.7 (alkyl CH3).
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MS: ES (+ve) m/z 306.7 ([M+H]+,58); 197.8 (Bn2NH2+,100); 109.0 ([MBn2N]+,21).
H R M S : Calc'd. for C22H27N, 305.214350; found, 305.212768.

(S)-/V,/V-Dibenzyl-/V-(a-methyl-cyclohex-1-enyl)ethylamine (S)-(105)

Me
L^I/NB^

5
The title compound (S)-(105) was prepared from (S,S)-/v"-tosyl-S-phenyl-S-(ccmethyl-cyclohex-1-enylethyl)sulfoximine
unmethylated

sulfoximine, 0.278g,

(98) (85:15 mixture of methylated and

0.687mmol), tris(dibenzylideneacetone)-

dipalladium(O) (0.017g, 0.019mmol), triphenylphosphine (0.043g, 0.164mmol)
and dibenzylamine (0.2mL, 1.04mmol) as described previously for (99), as an oil
(74:26 mixture of methylated and unmethylated amine, 0.124g, 52%) and as one
enantiomer with (S) stereochemistry. The percentage yield of 5 2 % was calculated for
the methylated amine (105) by taking into account the amount of unmethylated
compound in both the starting material and the product material.

[oc]27D = +4.0 (c = 0.9, CHCI3).

The spectral data was identical to that reported above.
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Catalysed

Amination

of

Allylic

Sulfoximines

Utilising a Chiral Ligand

(E)-/V,A/-Dibenzyl-4-amino-1-phenyl-non-2-en-1-one (103)

NBn2

o

[Pd(7i-C3H5)C[]2 (0.0048g, 13pmol) and (S)-2-[2-(diphenyl phosphino)phenyl]4-/so-propyl-3,4-dihydrooxazole (111) (0.025g, 68pmol) were dissolved in
anhydrous THF (5mL) and allowed to stir at RT for 10 minutes to afford a yellow
solution. To this solution was added (E)-2-(A/-tosyl-S-phenylsulfoximidoyl)-1phenyl-non-3-en-1-one (88) (0.158g, 0.310mmol) in anhydrous THF (10mL) and
dibenzylamine (0.07mL, 0.364mmol). The solution was allowed to stir at RT

overnight. The solvent was removed in vacuo to give a yellow oil. Purification of the

crude product on a short column of silica gel using 5% ethyl acetate/hexane as eluent

gave the title compound as a yellow oil (0.024g, 19%) and recovered starting materia
(0.123g, 78%).

[a]22D = +12.2° (c = 0.475, CHCI3).
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Allylic Sulfoximines.

/V-((S)-oc-Methylbenzyl)-5-pentyl-2-phenylpyrrole

(115)

JCY.
X
H 3 C p Ph

(E)-2-(A/-Tosyl-S-phenylsulfoximidoyl)-1-phenyl-non-3-en-1-one

(88)

(0.180g, 0.353mmol), tetrakis(triphenylphosphine)palladium(0) (0.041g, 0.0355
mmol) and (S)-a-methylbenzylamine (113) (0.07mL, 0.543mmol) were dissolved

in anhydrous THF (10mL) and allowed to stir at RT for 120 minutes. Removal of the

solvent in vacuo gave a yellow oil. Purification of the crude product on a short

of silica gel using 5% ethyl acetate/hexane as eluent gave the title compound (1
a yellow oil (0.074 g, 66%).

1

H NMR: 87.0-7.35 (m,10H,Ar-H); 6.172 (d,J=3.6Hz,1H,pyrrole H); 6.031

(d,J=3.6Hz,1H,pyrrole H); 5.607 (q, J = 7.2Hz, 1 H ,N-CH); 2.377
(ddd,J=6.0,9.3,15.3Hz,1H,one of alkyl CH2 next to the pyrrole); 2.087
(ddd,J=6.0,9.3,15.3Hz,1H,one of alkyl CH2 next to the pyrrole); 1.839
(d,J=6.9Hz,3H,Ph-C(-N)-CH3); 1.35-1.6 (m,2H,alkyl CH2); 1.1-1.2 (m,4H,alkyl
CH2); 0.807 (t,J=6.9Hz,3H,alkyl CH3).
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C NMR: 8142.9 (Ar-C); 135.1 (Ar-C); 134.9 (Ar-C); 134.6 (Ar-C); 129.5

(Ar-CH); 128.4 (Ar-CH); 128.2 (Ar-CH); 126.7 (Ar-CH); 126.7 (Ar-CH); 125.8
(Ar-CH); 108.0 (pyrrole CH); 106.6 (pyrrole CH); 52.9 (Ph-CH(-N)-C); 31.6
(alkyl CH2); 28.4 (alkyl CH2); 27.7 (alkyl CH2); 22.4 (alkyl CH2); 19.7 (Ph-C(N)-CH3); 13.9 (alkyl CH3).

MS: ES (+ve) m/z 318.2 ([M+H]+,100); 214.1 ([(M-PhCHCH3) + H]+,80); 105.0
(PhCHCH3+,57).
HRMS: Calc'd. for C23H27N, 317.214337; found, 317.215007.

7.4 Experimental for Chapter 4

7.4.1 Synthesis of Allylic Sulfoximines (134) and (136)

A/-Benzyloxycarbonyl-S-phenyl-S-(2-propenyl)sulfoximine (134)

O
II

^^/^Ph
NCbz

To a stirred solution of S-phenyl-S-(2-propenyl)sulfoximine (39) (2.346g,
12.94mmol) in anhydrous DCM (6mL) was added pyridine (1.3mL, 16.07mmol) and

4-dimethylaminopyridine (0.023g, 0.188mmol). This solution was cooled to 0°C then
benzyloxycarbonyl chloride (2.8mL, 19.6mmol) was added dropwise. The yellow
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solution was stirred at RT for 1 hour before being diluted with DCM (20mL). The
solution was washed with 10% HCI(aq) (10mL) and saturated NaCI(aq) (10mL). The

organic layer was dried, filtered and evaporated to a yellow oil. Purification of t

crude product on a column of silica gel using 30% ethyl acetate/hexane as eluent g
the title compound (134) as an oil (2.857g, 70%) which slowly crystallised over
time to give a white semi-solid.

1

H NMR: 87.2-8.0 (m,10H,Ar-H); 5.695 (dddd,J=7.6,7.6,10.0,13.2Hz,

IH.intemal vinyl H); 5.331 (dd,J=0.8,10.0Hz,1H,vinyl H); 5.106 (dd,J=0.8,
13.2Hz,1H,vinyl H); 5.074 (s,2H,Cbz CH2); 4.159 (2xdd, J=4.4,7.6Hz,2H,C=CCH2).

13

C NMR: 8158.6 (carbamate C=0); 138.6 (Ar-C); 133.9 (Ar-CH); 128.2 (Ar-

CH); 128.1 (Ar-CH); 126.0 (vinyl CH2); 123.5 (vinyl CH); 67.7 (carbamate CH2);
60.2 (C=C-CH2).

MS: ES (+ve) m/z 315.9 ([M+H]+,100); 91.3 (PhCH2 ,8).
HRMS: Calc'd. for C17Hi7N03S, 315.094598; found, 315.094977.
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2-(/V-Benzyloxycarbonyl-S-phenylsulfoximidoyl)-1-phenyl-but-3-en-1-one

(136)

Ph
i

0=S=NCbz

O

To a stirred solution of A/-benzyloxycarbonyl-S-phenyl-S-(2-propenyl)sulfoximine
(134) (1.998g, 6.33mmol) in anhydrous THF (20mL) at -78°C was added n-BuLi
(1.6M in hexanes, 4.7mL, 7.52 mmol) dropwise. The orange solution was stirred for
15 minutes then benzaldehyde (0.7mL, 6.89mmol) was added dropwise to give a

slightly paler orange solution. This solution was stirred for 10 minutes before glac
acetic acid (0.4mL, 6.99mmol) was added, followed by saturated NH4CI(aq) (1mL)
then H2O (10mL). After warming to RT the solution was extracted with DCM (2 x

30mL). The combined organic layers were dried, filtered and evaporated to give a thic
yellow oil.

The crude alcohol (135) was dissolved in acetone (100mL) and cooled to 0°C. Jones
reagent (10mL) was slowly added dropwise and the resultant brown solution stirred

for 10 minutes. The reaction was quenched by the slow addition of /so-propanol (5mL)

to give a green solution. This solution was diluted with H2O (50mL) and then extract
with DCM (3 x 100mL). The combined organic layers were dried, filtered and

evaporated to a yellow oil. The crude product was purified on a column of silica gel
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using 3 0 % ethyl acetate/hexane as eluent to give the title compound (136) as a yellow
oil (1.533g, 58%) and as an 71:29 mixture of diastereomers.

Major diastereomer:
1

H NMR: 88.2-7.1 (m,15H,Ar-H); 7.103 (d,J=9.3Hz,1 H.S-CH); 5.9-5.4

(m,3H,vinyl H); 5.253 (s,2H,carbamate CH2).

13
C NMR: 8190.4 (ketone C=0); 159.1 (carbamate C=0); 136.2 (vinyl CH); 136-

125 (12 aryl carbons); 125.7 (vinyl CH2); 69.1 (S-CH); 68.0 (carbamate CH2).

Minor diastereomer:
1

H NMR: 88.2-7.1 (m,15H,Ar-H); 6.507 (d,J=8.4Hz,1 H,S-CH); 5.85-5.5

(m,3H,vinyl H); 5.234 (s,2H,carbamate CH2).

13

C NMR: 8190.5 (ketone C=0); 158.5 (carbamate C=0); 136.1 (vinyl CH); 136-

125 (12 aryl carbons); 125.8 (vinyl CH2); 73.3 (S-CH); 67.8 (carbamate CH2).

MS: ES (+ve) m/z 420.1 ([M+H]+,100); 311.4 ([M-PhCH20]

+

,19); 144.1 ([M-

PhS(0)COOCH2Ph]+,29).
HRMS: Calc'd. for C24H21NO4S, 419.120810; found, 419.120126.
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7.4.2 Palladium(O) Catalysed Rearrangement of Allylic Sulfoximine
(136)

(E)-A/-Benzyloxycarbonyl-4-amino-1-phenyl-but-2-en-1-one

(137)

Cbz. ^ H
N

The

title compound

was

prepared

from

2-(A/-benzyloxycarbonyl-S-

phenylsulfoximidoyl)-1-phenyl-but-3-en-1-one (136) (1.533g, 3.65mmol) and
tetrakis(triphenylphosphine)palladium(0) (0.193g, 0.167mmol) for 20 minutes,

followed by treatment with triethylamine in methanol as described previously f
(86a), as a yellow oil (0.667g, 62%).

1

H NMR: 87.3-8.0 (m,10H,Ar-H); 6.7-6.9 (m,2H,vinyl H); 5.131 (s,2H,carbamate

CH2); 4.077 (dd,J=1.5,4.2Hz,2H,N-CH2).

13

C N M R : 8190.1 (ketone C=0); 156.2 (carbamate C=0); 144.1 (vinyl CH); 137.5

(Ar-C); 134.9 (Ar-C); 132.9 (Ar-CH); 131.9 (Ar-CH); 128.6 (Ar-CH); 128.5
(Ar-CH); 128.5 (Ar-CH); 128.5 (Ar-CH); 124.7 (vinyl CH); 68.6 (carbamate
CH2); 42.2 (N-CH2).

M S : ES (+ve) m/z 296.1 ([M+H]+,10); 260.1 (8); 91.0 (PhCH 2 + ,100).

Chapter 7

____________

198

HRMS of M+H: Calc'd for C-|8H18N03, 296.128669; found, 296.127228.

7.4.3 Attempted Asymmetric Dihydroxylation of (102)

/V,A/-Dibenzyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one (124)

NBn2 OH

OH O

/V,A/-Dibenzyl-4-amino-1-phenyl-but-2-en-1-one (102) (0.120g, 0.406mmol),
AD-mix a (0.464g), MeS02NH2 (0.043g, 0.452mmol), (DHQD)2PHAL (0.012g,
15.4umol) and K2OSO4.2H2O (0.007g, 18.9umol) were dissolved in tertbutanol/H20 (1:1, 15mL). After stirring at 0°C for 11 days, Na2S03 (0.7g,
5.55mmol) was added and the solution allowed to warm to RT. The solution was
extracted with ethyl acetate (3 x 50mL). The combined organic layers were dried,

filtered and evaporated to a yellow oil. The crude oil was put on a column of sili
using ethyl acetate as eluent. None of the products isolated from the column were
nor could their structures be unequivocably assigned as the title compound (124)
from their H NMR spectra.
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Formation of the Diacetate (125)

/V,A/-Dibenzyl-2,3-acetyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one (125)

NBn2 OAc

OAc 0

XY

Ph

A sample of what appeared to be crude A/,/V-dibenzyl-4-amino-2,3-dihydroxy-1phenyl-butan-1-one (124) (0.031 g, 0.083mrnol) was dissolved in anhydrous DCM
(10mL). To the solution was added pyridine (0.2mL, 2.47mmol) and acetic anhydride
(0.1 mL, 1.06mmol). The solution was left to stir at RT overnight then was diluted
with DCM (20mL) and washed with 10% HCI(aq) (20mL), H2O (20mL) and saturated
NaCI(aq) (20mL). The organic layer was dried, filtered and evaporated to a brown
residue. The residue was put on a column of silica gel using initially 5% ethyl
acetate/hexane and then 25% ethyl acetate/hexane as eluent. None of the^compounds
isolated from the column could be unequivocably assigned as the title compound (125)
from their H NMR spectra.
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Dihydroxylation

of Allylic Amine

(137)

(2ft,3S)-/V-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138a)

Cbz.

M
N

OH

OH

O

/V-Benzyloxycarbonyl-4-amino-1-phenyl-but-2-en-1-one

(13 7)

(0.053g,

0.179mmol), AD-mix a (0.271g), MeS02NH2 (0.036g, 0.378mniol), (DHQ)2PHAL
(0.007g, 9umol) and K2OSO4.2H2O (0.004g, 0.011 mmol) were dissolved in tertbutanol/H20 (1:1, 12mL). After stirring at 0°C for 24 hours, Na2S03 (0.4g,
3.18mmol) was added and the solution allowed to warm to RT. The solution was
extracted with ethyl acetate (3 x 50mL). The combined organic layers were dried,

filtered and evaporated to a yellow oil. Purification of the crude product on a sh
column of silica gel using ethyl acetate as eluent gave the title compound (138a)
yellow oil (0.040g, 67%).

[a]25o = +17.3° (c = 1.3, CHCI3).

1

H N M R : 87.2-8.1 (m,10H,Ar-H); 5.410 (br s,1H,NH); 5.114 (s,2H, Cbz C H 2 ) ;

5.063 (d,J=12.9Hz,1H,H2); 4.039 (m,1H,H3); 3.484 (dd,J=6.0, 12.9Hz,1H,one of
CH2); 3.331 (dd,J=5.1,12.9Hz,1H,one of CH2).
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C NMR: 8199.4 (ketone C=0); 157.1 (carbamate C=0); 136.2 (Ar-C); 134.1 (A

CH); 133.3 (Ar-CH); 133.0 (Ar-CH); 128.9 (Ar-CH); 128.5 (Ar-CH); 128.5
(Ar-CH); 128.1 (Ar-CH); 74.2 (C(2)H-OH); 71.5 (C(3)H-OH); 66.9 (carbamate
CH2); 44.6 (N-CH2).

MS: ES (+ve) m/z 329.8 ([M+H]+,100); 91.2 (PhCH2+,87).
HRMS of M+H: Calc'd for C18H20NO5, 330.134148; found, 330.133326.

(2S,3R)-/V-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138b)

Cbz. ^H
N

OH

\x^xXPn
OH O

/V-Benzyloxycarbonyl-4-amino-1-phenyl-but-2-en-1-one (13 7) (0.051 g,
0.173mmol), AD-mix p (0.276g), MeS02NH2 (0.037g, 0.389mmol), (DHQD)2PHAL

(0.008g, 10umol) and K2OSO4.2H2O (0.004g, 11umol) were dissolved in ferfbutanol/H20 (1:1, 12mL). After stirring at 0°C for 24 hours, Na2S03 (0.4g,

3.18mmol) was added and the solution allowed to warm to RT. The solution

extracted with ethyl acetate (3 x 50mL). The combined organic layers were

filtered and evaporated to a yellow oil. Purification of the crude produ

column of silica gel using ethyl acetate as eluent gave the title compou
yellow oil (0.042g, 72%).
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= -11.3° (c = 3, CHCI3).

The spectral data was the same as for its enantiomer (138a).

7.4.5 Attempted Cyclisation to Azasugars

7.4.5.1 Attempted Cyclisation of N,N- D i benzy l-4-a m i n o-2 ,3dihydroxy-1-phenyl-butan-1-one (124)

1-Phenyl-2,3-dihydroxypyrrolidine (127)

HO OH

H
A sample of what appeared to be crude A/,A/-dibenzyl-4-amino-2,3-dihydroxy-1phenyl-butan-1-one (124) (0.117g, 0.312mmol) was dissolved in methanol
(10mL). To this solution was added 10% palladium on carbon (0.126g) and the black
suspension was stirred under H2(g) for 2 days. The suspension was filtered and the
solvent removed in vacuo to furnish a brown residue. The H NMR spectrum of the

crude residue did not contain anything that could be unequivocably assigned as the t
compound (127).
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A/-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-

1-phenyl-butan-1-one (138)

1-Phenyl-2,3-dihydroxypyrrolidine (141)

HO OH

N Ph
H

Method One

(2S,3F?)-A/-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138b) (0.030g, 0.091 mmol) was dissolved in methanol (5mL). To this was added
10% palladium on carbon (0.055g) and the black suspension was stirred under an
atmosphere of H2(g) overnight. The suspension was filtered and acidified with 3M
HCI(aq) (0.5mL) then stirred for a further hour. The solvent was removed in vacuo
and the residue placed on an ion-exchange column (Amberlite IR-120, H ) using
firstly 5% HCI(aq), then H2O (until neutral) and finally 2M NH3(aq) as eluent. None

of the isolated compounds could unequivocably be assigned as the title compound (141)
from their H NMR spectra.
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Method Two

(2ft,3S)-/V-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138a) (0.042g, 0.128mmol) was dissolved in 4A%(v/v) formic acid in methanol
(5mL). To this was added 10% palladium on carbon (0.040g) and the suspension was

stirred for 3 days. The suspension was filtered and the solvent removed in vacuo. Th
H NMR spectrum showed only starting material (138a).

Method Three

(2S,3f?)-/V-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138a) (0.042g, 0.128mmol) was dissolved in methanol (5mL). To this was added
10% palladium on carbon (0.049g) and ammonium formate (0.081 g, 1.28mmol). The

mixture was stirred for 24 hours and then filtered and the solvent removed in vacuo.
The H NMR spectrum showed only starting material (138a).

Method Four

(2S,3fl)-/V-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138b) (0.038g, 0.115mmol) was dissolved in methanol (5mL). To this was added
10% palladium on carbon (0.040g) and 1,4-cyclohexadiene (0.11mL, 1.16mmol).

The suspension was stirred for 24 hours and then filtered and the solvent removed in
vacuo to give a yellow residue. The residue was put on a column of silica gel using
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firstly 30% ethyl acetate/hexane and finally ethyl acetate as eluent. None of the
isolated compounds could be unequivocably assigned as the title compound (141) from
their 1H NMR spectra.

Method Five

(2/?,3S)-A/-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138a) (0.036g, 0.109mmol) was dissolved in methanol (5mL). To this was added
palladium black (0.040g) and the suspension was stirred under an atmosphere of
H2(g) for 24 hours. The suspension was then filtered and the solvent removed in vacuo
to give a yellow residue. The residue was put on a column of silica gel using firstly
30% ethyl acetate/hexane and finally ethyl acetate as eluent. None of the isolated
compounds could unequivocably be assigned as the title compound (141) from their H
NMR spectra.

Method Six

(2S,3fl)-/V-Benzyloxycarbonyl-4-amino-2,3-dihydroxy-1-phenyl-butan-1-one
(138b) (0.056g, 0.170mmol) was dissolved in methanol (5mL). To this was added
palladium black (0.062g) and 1,4-cyclohexadiene (0.16mL, 1.70mmol). The
suspension was stirred for 24 hours and then filtered and the solvent removed in vacuo
to give a yellow residue. The residue was put on a column of silica gel using firstly
30% ethyl acetate/hexane and finally ethyl acetate as eluent. None of the isolated
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compounds could unequivocably be assigned as the title compound (141) from their 1H
NMR spectra.

7.5 Experimental for Chapter 5

7.5.1 Synthesis of Alkene (146)

(2fl,3fl,4S)-1,4-0-Dibenzoyl-2,3-0-isopropylidene-5-hexen-1,2,3,4-tetrol
(146)

BzO

^L^\=

(-)-2,3-0-lsopropylidene-D-erythronolactone (143) (1.997g, 12.6 mmol) was
dissolved in anhydrous DCM (40mL) and cooled to -78°C. To this solution was added
DIBAL (1M in DCM, 15.2mL, 15.2mmol) in a dropwise fashion. The solution was
allowed to stir for 2 hours before quenching with methanol (4mL) and saturated
NaCI(aq) (2mL). The solution was allowed to warm to RT then just enough 2M H2SO4
was added to make the solution acidic. The organic layer was separated then dried,
filtered and evaporated to a light yellow oil.

The crude lactol (142) was dissolved in anhydrous THF (40mL) and cooled to 0°C.
Vinyl magnesium bromide (1M in THF, 32mL, 32mmol) was added dropwise and the
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solution allowed to stir at 0°C for 5 hours. Saturated NH4CI(aq) (10mL) was added
followed by H2O (20mL). The solution "was extracted with ethyl acetate (2 x 100mL)
and the organic layers combined, dried, filtered and evaporated to a yellow oil.

The crude reaction mixture was dissolved in anhydrous DCM (10mL) and cooled to 0°C.
To the solution were added 4-dimethylaminopyridine (0.01 Og, 0.082mmol), pyridine
(2.5mL, 30.9mmol) and benzoyl chloride (2.5mL, 21.5mmol). The solution was left
to stir at RT for 4 hours and then diluted with DCM (100mL). The solution was washed
with H20 (20mL), 10% HCI(aq) (20mL) and saturated NaCI(aq) (20mL). The

organic layer was dried, filtered and evaporated to a yellow oil. Purification of th

crude product on a column of silica gel using 5% ethyl acetate/hexane as eluent gave
the title compound (146) as a yellow oil (2.574 g, 51%).

[oc]

D

= "7.5° (c = 0.63, CHCI3).

1

H NMR: 87.3-8.1 (m,10H,Ar-H); 6.044 (ddd,J=6.0,10.5,17.1Hz,1H,H2); 5.733

(dd,J=6.0,7.2Hz,1H,H3); 5.439 (dt,J=1.2,17.1Hz,1H,H1); 5.367 (dt,J=1.2,
10.5Hz.1H.H1); 4.57-4.67 (m,2H,one of H6 plus H5); 4.488 (dd,J=5.7,7.2Hz,1 H,
H4); 4.402 (dd,J=8.1,13.2Hz,1H,one of H6); 1.503 (s,3H,isopropylidene CH3);
1.418 (s,3H,isopropylidene CH3).

13

C NMR: 8166.2 (ester C=0); 165.0 (ester C=0); 133.2 (Ar-CH); 133.2 (Ar-CH);

133.0 (vinyl CH); 130.5 (Ar-C); 130.1 (Ar-C); 129.7 (Ar-CH); 129.6 (Ar-CH);
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128.4 (Ar-CH); 128.2 (Ar-CH); 119.0 (vinyl CH2); 109.4 (isopropylidene C);
77.6 (C4-H); 75.4 (C5-H); 72.6 (C3-H); 63.1 (C6-H2); 27.6 (isopropylidene
CH3); 25.4 (isopropylidene CH3).

MS: ES (+ve) m/z 396.8 ([M+H]+,19); 338.9 ([M-C3H50]
PhC(=0)0]

+

+

,98); 275.0 ([M-

,86); 217.0 (86); 152.7 (87); 105.0 ([PhC(=0)]+,100).

HRMS of M+H: Calc'd for C23H25O6, 397.165114; found, 397.165286.

7.5.2 Synthesis of Allylic Amines

(148) and (150)

(4E)-(2fl,3S)-6-A/,A/-Bis(fe/-f-butyloxycarbonyl)-1-0-benzoyl-2,3-0isopropylidene-6-amino-hex-4-en-1,2,3-triol (148)

X
BzO

MD

• NBoc2

B0C2NH (1.321g, 6.08mmol) was dissolved in anhydrous THF (20mL) and cooled to
0°C. n-BuLi (1.5M in hexanes, 3.7mL, 5.55mmol) was added dropwise and the

solution was stirred at 0°C for 30 minutes then warmed to RT and allowed to sti
a white precipitate appeared.
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Tris(dibenzylideneacetone)dipalladium(0) (0.116g, 0.127mmol) and 1,2bis(diphenylphosphino)ethane (0.150g, 0.376mmol) were dissolved in anhydrous
THF (10mL) and stirred for 30 minutes at RT. This solution was then added to the
lithiated Boc2NH solution, followed by (2f?,3fl,4S)-1,4-0-dibenzoyl-2,3-0isopropylidene-5-hexen-1,2,3,4-tetrol (146) (2.001g, 5.05mmol) in anhydrous
THF (10mL). The yellow suspension was warmed to 50°C and left to stir for 24 hours.

The solution was cooled to RT then diluted with ether (100mL). The ethereal solution
was washed with H2O (20mL), saturated NaHS03(aq) (20mL) and saturated NaCI(aq)
(20mL). The organic layer was then dried, filtered and evaporated to a yellow oil.
Purification of the crude product on a column of silica gel using 5% ethyl
acetate/hexane as eluent gave the title compound (148) as a yellow oil (1.716 g,

69%).

[oc]25D = +13.3 (c = 2.1, CHCI3).

1

H NMR: 87.4-8.1 (m,5H,Ar-H); 5.908 (dt,J-6,15.3Hz,1H,H2); 5.716 (dd,J=7.2,

15.3Hz,1H,H3); 4.735 (t,J=6.9Hz,1H,H4); 4.474 (ddd,J=4.2, 6.9,6.9Hz,1H,H5);
4.387 (dd,J=4.2,11.4Hz,1H,one of H6); 4.231 (dd,J=6.9,11.4Hz,1H,one of H6);
4.177 (d,J=6Hz,2H,H1); 1.506 (s,3H,isopropylidene CH3); 1.484 (s,18H,
carbamate CH3); 1.422 (s,3H,isopropylidene CH3).

Chapter 7

___

210

13

C NMR: 8166.2 (ester C=0); 152.2 (carbamate C=0); 133.0 (Ar-CH); 132.0 (Ar-

C); 130.4 (vinyl CH); 129.7 (Ar-CH); 128.3 (Ar-CH); 127.4 (vinyl CH); 109.2
(isopropylidene C); 82.5 (C4-H); 81.9 (carbamate C); 75.9 (C5-H); 63.8 (C6H2); 47.2 (CI-H2); 28.0 (carbamate CH3); 27.7 (isopropylidene CH3); 25.4
(isopropylidene CH3).

M S : E S (+ve) m/z

514.2 ([M+Na] + , 68); 457.2 (45); 414.1 (17); 278.0 (21);

240.0 (100); 183.9 (35); 127.8 (20); 105.8 (22).
HRMS of M+H: Calc'd for C26H38N08, 492.259743; found, 492.259024.

(4E)-(2fl,3S)-6-/V,A/-Bis(ferf-butyloxycarbonyl)-2,3-0-isopropylidene-6amino-hex-4-en-1,2,3-triol (150)

X
HO

NBoc 2

(4E)-(2fl,3S)-6-A/,/V-Bis(fe/-f-butyloxycarbonyl)-1-0-benzoyl-2,3-0isopropylidene-6-amino-hex-4-en-1,2,3-triol (148) (1.883g, 3.83mmol) was
dissolved in -\%(w/v) NaOH in methanol (15.4mL, 3.85mmol) and allowed to stir at
RT for 60 minutes. The solvent was removed in vacuo and the residue was taken up
H2O (20mL) and DCM (50mL). The organic layer was separated then dried, filtered
and evaporated to a yellow oil. Purification of the crude product on a column of
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gel using initially 5% ethyl acetate/hexane and finally ethyl acetate as eluent
title compound (150) as a yellow oil (1.232 g, 83%).

[oc]19D = +3.13° (c = 8.8, methanol).

1

H NMR: 85.852 (dt,J=6.0,15.3,1H,vinyl H); 5.672 (dd,J=6.9,15.3Hz, 1H,vinyl

H); 4.680 (dd,J=6.9,6.9Hz,1 H,H4), 4.240 (dd,J=6.9,12.3Hz, 1H.H5); 4.194
(d,J=6.0Hz,2H,H1); 3.584 (dd,J=6.3,11.7Hz,1 H,one of H6); 3.524
(dd,J=5.7,11.7Hz,1H,one of H6); 1.483 (s,18H,carbamate CH3); 1.442 (s,3H,
isopropylidene CH3); 1.375 (s,3H,isopropylidene CH3).

13

C NMR: 8152.3 (carbamate C=0); 129.1 (vinyl CH); 127.1 (vinyl CH); 108.5

(isopropylidene C); 82.6 (C4-H); 81.7 (C5-H); 76.8 (carbamate C); 61.4 (C6H2); 47.3 (C1-H2); 28.1 (carbamate CH3); 27.8 (isopropylidene CH3); 25.2
(isopropylidene CH3).

MS: ES (+ve) m/z 388.1 ([M+H]+, 49); 332.2 ([M-f-Bu]+,77); 217.9
(Boc2N

+

,100).

HRMS: Calc'd for C19H33N07, 387.225684; found, 387.225987.
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Dihydroxylation

of (148) and

(150)

3-A/-(ferf-Butyloxycarbonyl)-5-[-4'-0-benzoyl-2',3'-0-isopropylidene1',2',3')4'-tetrahydroxybutyl]oxazolid-2-one (149)

(4E)-(2fl,3S)-6-/V,/V-Bis(ferf-butyloxycarbonyl)-1-0-benzoyl-2,3-0isopropylidene-6-amino-hex-4-en-1,2,3-triol (148) (0.262 g, 0.533mmol),
AD-mix a (0.732g), CH3S02NH2 (0.095g, 0.999mmol), (DHQ)2PHAL (0.010g,
0.0128mmol) and K2OSO4.2H2O (0.005g, 0.0136mmol) were dissolved in tertbutanol/H20 (1:1, 12mL). This solution was stirred at 0°C for 24 hours then Na2S03
(0.4g, 3.18mmol) was added. The solution was warmed to RT before being extracted
with ethyl acetate (2 x 50mL). The combined organic layers were dried, filtered and

evaporated to a yellow oil. Purification of the crude compound on a column of sili

using 30% ethyl acetate/hexane as eluent to give two diastereomers in a 72:28 rati
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The first diastereomer (149a) was a slowly crystallising white semi-solid (0.106
44%) with (1'S,2'fl,3'F?,5f?) stereochemistry.

oX
3'
(
4)

I

BzO

2'

1

yj1

HO*"

r

2)=0

4^
Boc

1

H

N M R : 87.4-8.1

(rn.5H.Ar-H);

4.808

(td,J=2.4,6.0Hz,1 H,H5);

4.712

(dd,J=3.0,9.0Hz,1H,one of H4'); 4.615 (td,J=3.0,4.8Hz,1 H,H3'); 4.467
(dd,J=4.8,9.0Hz,1H,one of H4'); 4.375 (dd,J=4.8,7.5Hz,1 H.H2'); 3.981
(d,J=6Hz,2H,H4); 3.767 (m,1H,H1'); (d,J=6.3Hz,1H,OH); 1.512 (s,9H,carbamate
CH3); 1.494 (s,3H,isopropylidene CH3); 1.452 (s,3H, isopropylidene CH3).

13

C NMR: 8166.5 (ester C=0); 152.1 (carbamate C=0); 149.3 (oxazolidone C=0);

133.1 (Ar-CH); 129.8 (Ar-C); 129.7 (Ar-CH); 128.4 (Ar-CH); 109.5
(isopropylidene C); 83.9 (carbamate C); 75.4 (C2'-H); 75.3 (C3'-H); 73.0 (C1'H); 69.8 (C5-H); 63.6 (C4'-H2); 45.0 (C4-H2); 27.9 (carbamate CH3); 27.6
(isopropylidene CH3); 25.3 (isopropylidene CH3).

MS: ES (+ve) m/z 474.0 ([M+Na]+, 100); 374.0 ([M-Ph]+,88); 352.0 ([(MBoc) + H]

+

,59); 294.0 (41).

HRMS: Calc'd for C22H29NO9, 452.192057; found, 452.192400.
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The second diastereomer (149b) was a yellow oil (0.041 g, 17%) with
C\'R,2'R,3'R,5S) stereochemistry.

1

H

NMR: 87.4-8.2

(m,5H,Ar-H); 4.794

(dd,J=2.4,8.7Hz,1 H,H3');

4.570

(m,2H,H2'+one of H4'); 4.398 (dd,J=5.4,8.7Hz,1 H,one of H4'); 4.284
(dd,J=3.1,5.1Hz,1H,H1'); 3.623 (dd, J-3.1,5.4Hz,1 H.H5); 3.120 (dd,

J=5.4,7.5Hz,2H,H4); 1.497 (s,9H,carbamate CH3); 1.418 (s,3H,isopropyliden
CH3); 1.382 (s,3H, isopropylidene CH3).

13

C NMR: 8166.3 (ester C=0); 153.5 (carbamate C=0); 132.8 (aryl CH); 129.9

(aryl C); 129.6 (aryl CH); 128.2 (aryl CH); 108.9 (isopropylidene C); 83
(carbamate C); 75.5 (C2'-H); 75.0 (C3'-H); 69.1 (C1'-H); 68.8 (C5-H); 63.6

(C4'-H2); 48.5 (C4-H2); 27.8 (carbamate CH3); 27.7 (isopropylidene CH3); 25.
(isopropylidene CH3).

MS: ES (+ve) m/z 474.0 ([M+Na]+, 100); 374.0 ([M-Ph]+,69); 352.0 ([(MBoc) + H]

+

,74); 308.0 (28); 294.0 (22); 104.8 (19).

HRMS: Calc'd for C22H29NO9, 452.192057; found, 452.192295.

The title compound (149) was also prepared in a diastereomeric ratio of 46:54 from
(4E)-(2fl,3S)-6-A/,/V-bis(ferf-butyloxycarbonyl)-1-0-benzoyl-2,3-0isopropylidene-6-amino-hex-4-en-1,2,3-triol (148) (0.303g, 0.616mmol),
AD-mix p (0.849g), CH3S02NH2 (0.112g, 1.18mmol), (DHQD)2PHAL (0.010g,
0.0128mmol) and K20s04.2H20 (0.005g, 0.0136mmol) dissolved in tertbutanol/H20 (1:1, 12mL) and stirred at 0°C for 24 hours. The (VS,2'R,3'R,5R)
diastereomer was again a slowly crystallising semi-solid (0.084g, 30%) and the
(1'R,2'R,3'R,5S) diastereomer was again a yellow oil (0.099g, 36%).

The spectral data of both isomers were identical to that recorded previously.

The title compound (149) was also prepared in a diastereomeric ratio of 0:100. To a
solution of (4E)-(2f?,3S)-6-A/,/V-bis(fe/-f-butyloxycarbonyl)-1 -O-benzoyl-2,30-isopropylidene-6-amino-hex-4-en-1,2,3-triol (148) (0.990g, 2.01mmol) in
rerf-butanol/H20 (1:1, 15mL) was added K2OSO4.2H2O (0.036g, 0.0977mmol) and
A/-methylmorpholine-A/-oxide (0.725g, 6.19mmol). The solution was allowed to stir
at 0°C for 24 hours. Na2S03 (1.2g, 9.54mmol) was added to the solution which was
then allowed to warm to RT. The solution was extracted with DCM (3 x 50mL) and the

organic layers were combined then dried, filtered and evaporated. Purification of the
crude product on a column of silica gel using 30% ethyl acetate/hexane gave only the
^'R,2'R,3'R,5S) diastereomer (149b) as a yellow oil (0.435g, 48%).

The spectral data was identical to that recorded previously.
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The title compound (149) was also prepared in a diastereomeric ratio of 100:0. To a
stirred solution of (1'S,2'fl,3'F?,5fl)-3-A/-(ferf-butyloxycarbonyl)-5-[2',3'-0isopropylidene-1',2,,3',4'-tetra-hydroxybutyl]oxazolid-2-one (1 51) (0.066g,
0.190mmol) in anhydrous DCM (1mL) was added pyridine (0.035mL, 0.433mmol),
4-dimethylaminopyridine (~0.002g, 16.4umol) and benzoyl chloride (0.035mL,
0.302mmol). The solution was stirred for 30 minutes then diluted with DCM (20mL)
and washed with 5% HCI(aq) (5mL). The organic layer was dried, filtered and

evaporated to a yellow oil. The crude product was not purified, however inspection of
the 1H NMR spectrum showed only (1'S,2'F?,3'F?,5/:?)-/V-(rerf-butyloxycarbonyl)5-[4'-0-benzoyl-2',3'-0-isopropylidene-1',2',3',4'-tetrahydroxybutyl]oxazolid-2-one (149a).

(1'S,2'/:?,3'f?,5fl)-3-A/-(ferf-Butyloxycarbonyl)-5-[2',3'-0-isopropylidene1 ,,2,,3,,4'-tetrahydroxybutyl]oxazolid-2-one (151)

(4E)-(2fl,3S)-6-/V,A/-Bis(ferf-butyloxycarbonyl)-2,3-0-isopropyl-idene-6amino-hex-4-en-1,2,3-triol (150) (0.901g, 2.33 mmol), AD-mix p (3.756g),
CH3S02NH2 (0.496g, 5.21mmol), (DHQD)2PHAL (0.099g, 0.127mmol) and
K2OSO4.2H2O (0.048g, 0.130 mmol) were dissolved in ferf-butanol/H20 (1:1,
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12mL). This solution was stirred at 0°C for 24 hours then N a 2 S 0 3 (1.2g, 9.54mmol)

was added. The solution was warmed to RT before being extracted with ethyl acetate
x 50mL). The combined organic layers were washed with saturated NaCI(aq) (20mL)

then dried, filtered and evaporated to a yellow oil. Purification of the crude com

on a short column of silica gel using initially 10% ethyl acetate/hexane and final
10% methanol/ethyl acetate as eluent gave one diastereomer with the
^'S,2'R,3'R,5R) stereochemistry as a yellow oil (0.689g, 85%).

[<x]21D = -15.1° (c = 8.5, methanol).

1

H NMR: 84.796 (t,J=7.2Hz,1 H,H3'); 4.365 (m,2H,H1 XH5); 4.266

(dd,J=5.7,9.6Hz,1H,H2'); 3.990 (d,J=7.8Hz,2H,H4); 3.803 (m,1H,H1'); 1.509
(s,9H,carbamate CH3); 1.478 (s,3H,isopropylidene CH3); 1.352 (s,3H,
isopropylidene CH3).

13

C NMR: 8152.5 (carbamate C=0); 149.5 (oxazolidone C=0); 108.7 (isopropylidene

C); 83.8 (carbamate C); 76.8 (C2'-H); 75.7 (C3'-H); 72.8 (C1'-H); 69.7 (C5H); 60.4 (C4'-H); 45.1 (C4-H2); 27.9 (carbamate CH3); 27.7 (isopropylidene
CH3); 25.1 (isopropylidene CH3).

MS: m/z 370.4 ([M+Na]+,100); 248.4 ([(M-Boc)+H]+,89); 190.2 (55).
HRMS: Calc'd. for C15H25NO8, 347.158001; found, 347.157684.
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The title compound (151) could also be prepared from(4E)-(2F?,3S)-6-A/,A/bis(ferf-butyloxycarbonyl)-2,3-0-isopropylidene-6-amino-hex-4-en-1,2,3triol (150) (0.102g, 0.170mmol), AD-mix a (0.396g), CH3S02NH2 (0.054g,
0.568mmol), (DHQ)2PHAL (0.009g, 11.6umol) and K20s04.2H20 (0.006g,
16.3pmol) in ferf-butanol/H20 (1:1,6mL) as described previously for (151) as an
oil (0.066g, 72%).

The spectral data was identical to that recorded previously.

7.5.4: Conversion of Alcohols into Sulfonates

(1'S,2'F?,3'/?,5f?)-3-A/-(ferf-Butyloxycarbonyl)-5-[1',4'-bis(methanesulfonyl)-2',3'-0-isopropylidene-1',2',3',4'-tetra-hydroxybutyl]oxazolid-2-one (154)

X
MsO" MsO S

;'^°\ _ Q
N
\

Boc
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A general procedure for the synthesis of mesylates.

(1,S,2'fl,3'fl)5fl)-3-/V-(ferf-Butyloxycarbonyl)-5-[2,,3'-0-isopropyIidene1',2',3',4'-tetrahydroxybutyl]oxazolid-2-one (151) (0.140g, 0.403mmol) was
dissolved in anhydrous DCM (2mL) and cooled to 0°C. To this solution was added
triethylamine (0.2mL, 1.43mmol) and methanesulfonylchloride (0.1 mL, 1.29mmol)
in a dropwise fashion. The cloudy yellow solution was stirred at 0°C for 30 minutes
and then diluted with DCM (20mL). The solution was washed with H2O (10mL), 5%
HCI(aq) (10mL), 10% NaHC03(aq) (10mL) and saturated NaCI(aq) (10mL). The
organic layer was dried, filtered and evaporated to a yellow oil. When purification

attempted on a column of silica gel decomposition occurred and so the title compound
(154) was used without purification.

(1'S,2'/:?,3'F?,5/:?)-3-A/-(fe^-Butyloxycarbonyl)-5-[2',3'-0-isopropylidene-1'0-methanesulfonyl-4'-0-toluenesulfonyl-1,,2,,3',4'-tetrahydroxybutyl]oxazolid2-one (161)

TsO

Chapter 7

220

A general procedure for the synthesis of tosylates.

(1'S,2'F?,3,f?,5fl)-3-A/-(fe/-f-Butyloxycarbonyl)-5-[2',3'-0-isopropylidene1',2',3,,4'-tetrahydroxybutyl]oxazolid-2-one (151) (0.099g, 0.285mmol) was
dissolved in anhydrous DCM (0.5mL). To this solution was added triethylamine
(0.2mL, 1.43mmol) and toluenesulfonylchloride (0.145g, 0.761 mmol). The solution
was stirred at RT overnight and then diluted with DCM (10mL). The solution was
washed with H2O (5mL), 5% HCI(aq) (5mL) and saturated NaCI(aq) (5mL). The

organic layer was dried, filtered and evaporated to a yellow oil. Analysis of the H NM
spectrum indicated the compound was monotosylated.

The title compound (161) was prepared from the crude monotosylate prepared above,
triethylamine (0.2mL, 1.43mmol) and methanesulfonylchloride (0.1 mL, 1.29mmol),
as described previously for (154), as a yellow oil. When purification was attempted
on a column of silica gel decomposition occurred, and so the title compound (161) was
used without purification.

(4E)-(2F?,3S)-6-A/,/V-Bis(ferf-butyloxycarbonyl)-1-0-toluenesulfonyl-2,3-0isopropylidene-6-amino-hex-4-en-1,2,3-triol (166)

X
Ts0

NBoc 2
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The title compound (166) was prepared from (4E)-(2ft,3S)-6-A/,/V-bis(ferfbutyloxycarbonyl)-2,3-0-isopropylidene-6-amino-hex-4-en-1,2,3-triol (150)
(0.506g, 1.31mmol), pyridine (0.3mL, 3.71mmol) and toluenesulfonylchloride
(0.264g, 1.38mmol) as described previously for (161). The crude product was

purified on a column of silica gel using 30% ethyl acetate/hexane as eluent to gi
title compound (166) as a yellow oil (0.390g, 55%).

1

H NMR: 87.800 (d,J=8.4Hz,2H,tosyl Ar-H); 7.350 (d,J=8.4Hz,2H,tosyl Ar-H);

5.836 (dt,J=6.0,15.3Hz,1H,vinyl H3); 5.506 (dd,J=7.2,15.6Hz, 1H,vinyl H2);
4.629 (dd,J=7.2,7.2Hz,1H,H4); 4.315 (ddd,J=4.5,7.2, 7.2Hz,1 H.H5); 4.148
(d,J=5.7Hz,2H,H1); 4.020 (dd,J=4.5,10.5Hz,1H, one of H6); 3.894 (dd,J=7.2,
10.5Hz,1H,one of H6); 2.449 (s,3H,tosyl CH3); 1.495 (s,18H,carbamate CH3);
1.366 (s,3H,isopropylidene CH3); 1.315 (s,3H,isopropylidene CH3).

13

C NMR: 8152.2 (carbamate C=0); 144.8 (Ar-C); 133.0 (Ar-C); 130.8 (vinyl

CH); 129.8 (Ar-CH); 128.0 (Ar-CH); 109.5 (isopropylidene C); 82.5 (C4-H);
82.0 (carbamate C); 75.5 (C5-H); 68.7 (C6-H2); 47.2 (C1-H2); 28.1 (carbamate
CH3); 27.6 (isopropylidene CH3); 25.3 (isopropylidene CH3).

MS: ES (+ve) m/z 541.6 (M+, 77); 391.6 (33); 217.9 (Boc2N+,100); 159 (29).
HRMS: Calc'd for C26H39NO9S, 541.236223; found, 541.236970.
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7.5.5 Attempted

Cyclisation of Bis(sulfonates)

(2S,3S,4fl,5'ft)-1-/V-Benzyl-3'-A/'-ferf-butyloxycarbonyl-3,4-0-isopropylidene-2-oxazolid-2'-onyl-3,4-dihydroxypyrrolidine (155)

Boc

Method One

The

crude

(1'S,2'f?,3'F?,5F?)-3-A/-(fe/-f-butyloxycarbonyl)-5-[1 ',4'-0-bis-

(methanesulfonyl)-2',3'-0-isopropylidene-1,)2',3,,4,-tetra-hydroxybutyl]oxazolid-2-one (154) (0.126g, 0.250mmol) was dissolved in dry toluene (1mL). To
this was added benzylamine (0.1 mL, 0.915mmol) and the solution was heated to reflux

and left to stir for 24 hours. The solution was cooled to RT and the solvent removed i
vacuo. The brown residue was placed on a column of silica gel using 10% ethyl acetate
as eluent. However none of the fractions isolated could have their structures
unequivocably assigned as that of the title compound (155) from their H NMR
spectra.

Chanter 7

.

223

Method 2

The

crude

(1 , S,2 , fl,3 , fl l 5fl)-3-/V-(ferf-butyloxycarbonyl)-5-[2\3 , -0-

isopropylidene-1'-0-methanesulfonyl-4'-0-toluenesulfonyl-1',2',3',4'-tetrahydroxybutyl]oxazolid-2-one (161) (0.112g, 0.193mmol) was dissolved in
benzylamine (1mL, 9.15mmol) and left to stir at RT for 2 days. The solvent removed
in vacuo and the brown residue was placed on a column of silica gel using 10% ethyl
acetate as eluent. However none of the fractions isolated could have their structures
unequivocably assigned as that of the title compound (155) from their H NMR
spectra.

(2S,3S,4f?,5'H)-1,3'-A/,A/'-Di(rerf-butyloxycarbonyl)-2,3-0-isopropylidene-2(oxazolid-2'-onyl)-2,3-dihydroxypyrrolidine (156)

Boc

ferf-Butyl carbamate (0.033g, 0.282mmol) and sodium hydride ( 6 0 % in oil,
0.020g, 0.522mmol) were added to anhydrous DMF (2mL) and stirred until foaming
ceased. To this was added crude (1'S,2'fl,3'fl,5fl)-3-/V-(ferf-butyloxycarbonyl)-5[1',4'-0-bis-(methanesulfonyl)-2',3'-0-isopropylidene-1',2',3',4,-tetra-
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hydroxybutyl]oxazolid-2-one (154) (0.105g, 0.209mmol) and the solution allowed
to stir at RT for 24 hours. The solution"was diluted with H2O (10mL) then extracted
with diethyl ether (3 x 10mL). The combined ethereal extracts were washed with
saturated NaCI(aq) (10mL) then dried, filtered and the solvent removed in vacuo to
give a brown oil. The crude mixture was put on a column of silica gel using 10% ethyl
acetate/hexane as eluent. However none of the fractions isolated could have their
structures unequivocably assigned as that of the title compound (156) from their H
NMR spectra.

7.5.6 Attempted Formation of Azides

(1,S,2'f?,3'R,5fl)-3-/V-(ferf-Butyloxycarbonyl)-5-[2',3'-0-isopropyl-idene-4'azido-1'2',3'-trihydroxybutyl]oxazolid-2-one (162)

(1,S,2,fll3,fl,5fl)-3-/V-(fe^Butyloxycarbonyl)-5-[2,l3'-0-isopropylidener2,,3'-trihydroxybutyl]oxazolid-2-one (151) (0.151g, 0.435mmol) was
dissolved in anhydrous DMF (2mL). To this solution was added lithium azide (0.105g,
2.14mmol), triphenylphosphine (0.118g, 0.451 mmol) and carbon tetrabromide
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(0.152g, 0.458mmol) and then allowed to stir at RT for 24 hours. The solution was
diluted with H20 (10mL) and then extracted with ether (3 x 20mL). The combined
ethereal extracts were washed with saturated NaCI(aq) (10mL) and then dried,

filtered and the solvent removed in vacuo to furnish a yellow oil. The H NMR spectru
showed only starting material.

(4E)-(2ft,3S)-6-/V,A/-Bis(fe/-f-butyloxycarbonyl)-2,3-0-isopropylidene-6amino-1-azido-hex-4-en-2,3-d iol (164)

X
N3

NBoc 2

Method One

An attempt to prepare the title compound (164) from (4E)-(2R,3S)-6-N,Nbis(ferf-butyloxycarbonyl)-2,3-0-isopropylidene-6-amino-hex-4-en-1,2,3triol (150) (0.040g, 0.103mmol), lithium azide (0,026g, 0.531mmol),
triphenylphosphine (0.029g, 0.110mmol) and carbon tetrabromide (0.036g,
0.108mmol) as described previously for (162) yielded only starting material.
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Method Two

(4E)-(2ft,3S)-6-A/,/V-Bis(ferf-butyloxycarbonyl)-2,3-0-isopropylidene-6amino-hex-4-en-1,2,3-triol (150) (0.036g, 0.093mmol) was dissolved in
anhydrous DCM (1mL) and cooled to 0°C. To this solution was added pyridine (0.02mL,
0.247mmol) and trifluoromethanesulfonic anhydride (0.02mL, 0.119mmol). After

warming to RT, the solution was stirred for 3 hours. The solution was then diluted w
DCM (20mL) and washed with 10% HCI(aq) (5mL), H20 (5mL), 10% NaHC03(aq)
(5mL) and saturated NaCI(aq) (5mL). The organic layer was then dried, filtered and
evaporated to a yellow oil.

The crude triflate (163) (0.049g, 0.094mmol) and sodium azide (0.017g,
0.261 mmol) were dissolved in anhydrous DMF (1mL). The solution was heated to

50°C and left to stir for 24 hours. The solution was then diluted with H2O (10mL) an
extracted with diethyl ether (3 x 20mL). The combined ethereal layers were washed
with saturated NaCI(aq) (10mL) then were dried, filtered and evaporated to a yellow
oil. The crude mixture was put on a column of silica gel using 30% ethyl
acetate/hexane as eluent. However none of the fractions isolated could have their
structures unequivocably assigned as that of the title compound (164).
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Method Three

(4E)-(2F?,3S)-6-A/,A/-Bis(ferf-butyloxycarbonyl)-2,3-0-isopropylidene-6amino-hex-4-en-1,2,3-triol (150) (0.090g, 0.232 mmol) was dissolved in
anhydrous DCM (1mL) and cooled to 0°C. To this solution was added triethylamine
(0.05mL, 0.359mmol) and methanesulfonylchloride (0.03mL, 0.388mmol). After
warming to RT, the solution was stirred for 30 minutes. The solution was then diluted
with DCM (20mL) and washed with 10% HCI(aq) (10mL) and saturated NaCI(aq)
(10mL). The organic layer was then dried, filtered and evaporated to a yellow oil.

The crude mesylate (165) (0.110g, 0.236mmol) and sodium azide (0.020g,
0.308mmol) were dissolved in anhydrous DMF (1mL). The solution was heated to

50°C and left to stir for 24 hours. TLC of the reaction mixture indicated that there wa
only starting material, therfore the solution was heated to 100°C. After stirring for
24 hours the solution was diluted with H2O (10mL) and extracted with ether (3 x
20mL). The combined ethereal layers were washed with saturated NaCI(aq) (10mL),
then dried, filtered and evaporated to a yellow oil. The crude mixture was put on a
column of silica gel using 30% ethyl acetate/hexane as eluent. However, none of the

fractions isolated could have their structures unequivocably assigned as that of the t
compound (164) from their H NMR spectra.
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Method Four

(4E)-(2ft,3S)-6-A/,/V-Bis(ferf-butyloxycarbonyl)-1-0-toluenesulfonyl-2,3-0isopropylidene-6-amino-hex-4-en-1,2,3-triol (166) (0.044g, 0.081mmol) and
lithium azide (0.026g, 0.531 mmol) were dissolved in anhydrous DMF (1mL). The

solution was heated to 50°C and left to stir for 24 hours. The solution was then dil
with H2O (10mL) and extracted with diethyl ether (3 x 20mL). The combined ethereal
layers were washed with saturated NaCI(aq) (10mL) then were dried, filtered and
evaporated to a yellow oil. The H NMR spectrum showed only starting material.

7.5.7 Displacement of a Tosylate with BocNH2/Sodium

Hydride

(2E)-(4S,5ft)-/V,A/'-Bis(fe/-f-butyloxycarbonyl)-4,5-0-isopropylidene-4,5dihydroxy-hex-2-en-1,6-diamine (1 67)

X
BocHN

NHBoc

Sodium hydride ( 6 0 % in mineral oil, 0.036g, 0.939mmol) was suspended in
anhydrous DMF (1mL). To this supension was added ferf-butylcarbamate (0.112g,
0.956mmol) and stirring continued until no more gas was evolved. (4E)-(2R,3S)-6/V,A/-Bis(ferf-butyloxycarbonyl)-1-0-toluenesulfonyl-2,3-0-isopropylidene-6-
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amino-hex-4-en-1,2,3-triol (166) (0.354g, 0.653mmol) in anhydrous DMF

(3mL) was added to the suspension and" then warmed to 100°C. After stirring overni
the suspension was cooled to RT and diluted with H2O (10mL). The solution was

extracted with diethyl ether (3 x 30mL) and the organic layers combined and washed

with saturated NaCI(aq) (20mL). The solution was dried, filtered and evaporated to a
yellow oil. Purification on a column of silica gel using 10% ethyl acetate/hexane
eluent to give the title compound (167) as a yellow oil (0.141g, 56%).

1

H NMR: 85.843 (dt,J=6,15.3Hz,1H,vinyl H); 5.598 (dd,J=7.8, 15.3Hz,1H,vinyl

H); 4.604 (t,J=6.3Hz,1 H,H4); 4.344 (t,J=7.5Hz,1 H, H5); 3.773 (m,2H,H1);
3.449 (d,J=7.5Hz,2H,H6); 1.510 (s,3H,isopropylidene CH3); 1.501 (s,18H,2 x
carbamate CH3); 1.431 (s,3H,isopropylidene CH3).

13

C NMR: 8160.6 (carbamate C=0); 155.6 (carbamate C=0); 127.9 (vinyl CH);

125.5 (vinyl CH); 109.2 (isopropylidene C); 78.1 (CH); 77.7 (CH); 75.7
(carbamate C); 75.4 (carbamate C); 43.0 (CH2); 41.8 (CH2); 28.4 (carbamate
CH3); 27.8 (isopropylidene CH3); 27.7 (isopropylidene CH3).

MS: ES (+ve) m/z 370.4 (41); 350.3 (68); 200.1 (48); 192.1 (100).
HRMS: Calc'd for C19H34N206, 386.241667; found, 386.241154.
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(167)

(1"S,2''fl)-1\3"-/V,A/'-Di(ferf-butyloxycarbonyl)-2-(1'-aminomethyl)-3(1",2"-0-isopropylidene-propan-1",2"-diol)oxirane (170)

(2E)-(4S,5ft)-/V,/V'-Di(fe/-f-butyloxycarbonyl)-4,5-0-isopropylidene-4,5dihydroxy-hex-2-en-1,6-diamine (167) (0.046g, 0.119mmol) was dissolved in
anhydrous DCM (1mL). To this solution was added mefa-chloroperoxybenzoic acid
(0.052g, 0.301 mmol) and the solution stirred at RT overnight. The solution was
filtered through a sintered glass funnel and then diluted with DCM (10mL). The
solution was then washed with saturated NaHC03(aq) (2 x 5mL) and saturated
NaCI(aq) (5mL) before being dried, filtered and evaporated to a yellow oil.
Purification on a column of silica gel using initially 10% ethyl acetate/hexane and
finally ethyl acetate to give the title compound (170) as a yellow oil (0.011g, 23%)
and as a 2:1 mixture of diastereomers.
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Major diastereomer

H NMR: 84.741 (br s,1H,NH); 4.452 (ddd,J=6.0,6.0,6.9Hz,1 H,H5); 3.974
(dd,J=6.0,6.0Hz,1H,H4); 3.718 (m,2H,H6); 3.504 (m,1H,one of H1); 3.312
(dd,J=5.7,5.7Hz,1H,one of H1); 3.123 (m,1H,H2); 2.983 (dd,J=2.1,6.3Hz,1 H,H3);
1.500 (s,3H,isopropylidene CH3); 1.448 (s,18H,2 x carbamate CH3); 1.370
(s,3H,isopropylidene CH3).

13

C NMR: 8155.9 (carbamate C=0); 155.8 (carbamate C=0); 109.9 (isopropylidene

C); 77.8 (CH); 77.2 (CH); 55.7 (CH); 53.3 (CH); 42.2 (C6-H2); 28.331 (C1-H2);
28.327 (carbamate CH3); 27.6 (isopropylidene CH3); 25.1 (isopropylidene CH3).

Minor diastereomer

1

H NMR: 84.7 (br s,1H,NH); 4.4 (m,1H,H5); 4.038 (dd,J=6.0,6.0Hz, 1H.H4); 3.7

(m,1H,2H,H6); 3.5 (m,1H,one of H1); 3.265 (dd,J=5.7, 5.7Hz,1H,one of H1);
3.092 (m,1H,H2); 2.9 (m,1H,H3); 1.487 (s,3H,isopropylidene CH3); 1.448
(s,18H,2 x carbamate CH3); 1.358 (s,3H, isopropylidene CH3).

13

C NMR: 8156.1 (carbamate C=0); 156.0 (carbamate C=0); 109.9 (isopropylidene

C); 77.7 (CH); 77.3 (CH); 55.8 (CH); 53.3 (CH); 42.2 (C6-H2); 28.4 (C1-H2);
28.3 (carbamate CH3); 27.6 (isopropylidene CH3); 25.1 (isopropylidene CH3).
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344.1 ([M-isopropylidene]+,100); 266.1 (95); 156.0 (53).

HRMS: Calc'd for C19H34N207, 402.236582; found, 402.236086.

7.5.9 Cyclisation of the Epoxide

1,2'-/V,A/'-Di(ferf-Butyloxycarbonyl)-3,4-0-isopropylidene-2-(1'-hydroxy-2'
aminoethyl)-3,4-dihydroxypyrrolidine (171)

oX
Boc ^

NHBoc

(1"S,2"F?)-1',3"-A/,A/'-Di(ferf-butyloxycarbonyl)-2-(1'-amino-methyl)-3(1",2"-0-isopropylidene-propan-1",2"-diol)oxirane (170) (0.011g, 0.027
mmol) was dissolved in anhydrous DMF (0.5mL). To this was added sodium hydride
(60% in oil, 0.004g, 0.104mmol) and the suspension was then heated to 50°C. After
stirring for 24 hours the suspension was cooled to RT then diluted with H2O (10mL).
The solution was extracted with ether (3 x 20mL) and the combined ethereal extracts
were washed with saturated NaCI(aq) then dried, filtered and evaporated to a yellow
oil. The 1H NMR spectrum of the crude reaction mixture could not be unequivocably
assigned as that of the desired product (171).
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